var title_f21_55_22384="Adult scaphoid fracture xray";
var content_f21_55_22384=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F73898&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F73898&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Transverse fracture of the scaphoid",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 288px; height: 454px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This anteroposterior radiograph of the wrist shows a linear fracture through the waist of the scaphoid (navicular) bone.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kevin E Burroughs, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_55_22384=[""].join("\n");
var outline_f21_55_22384=null;
var title_f21_55_22385="Chest x-ray rib fractures";
var content_f21_55_22385=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F83501&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F83501&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 617px\">",
"   <div class=\"ttl\">",
"    Chest x-ray rib fractures",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 597px; height: 282px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The PA chest x-ray is from a 43-year-old man with right sided chest pain following trauma. The conventional PA view (A) reveals a subtle nondisplaced fracture of the lateral aspect of the 9th rib on the right side (red arrow). Image B is a magnified and highlighted view of the fracture.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_55_22385=[""].join("\n");
var outline_f21_55_22385=null;
var title_f21_55_22386="Panlobular emphysema";
var content_f21_55_22386=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F57950&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F57950&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Panlobular emphysema",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 375px; height: 326px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFGAXcDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDyPxJrurp4i1VV1W/VRdygAXDgAbz71iT+LdUhlKNqmpkj0uG/+Kq14n/5GXVv+vub/wBDNcjqP/H7J+H8hQM6D/hMdT/6Cmqf+BDf/FU5fF+pswA1PVM/9fDf/FVygBJwOtXYYiicgEn9KAudF/wlOqf9BbUf/Al/8ad/wk2rZ/5Cuo9M/wDHw/8AjWAqlwAuPpUqKOMjmgLm4PEurYB/tbUR/wBvD/40o8R6uTj+1tR/8CX/AMaxgvBOcA+1S7fl+QgjHPagLmr/AMJDrGM/2rqOP+vl/wDGlHiDVznGragSP+nl/wDGsuMEoQo475NS24fzljSPzJJOFjQZLH2FAXL51/WRjOq6jz/08P8A408a7rJ/5i2o/wDgRIf5GtXR/C8aQ2l/4mvl0rSrnzArgeZMrL2aPgqCe9b+gyahczrD4J0q10iQ2Drc3WoMPLu05yymQEA49KAuZkemeMFgs7rUdRvNM0274ivry8dYT9SpJ/SszUrvWrO+NtFr9zejICzWtxM0Tk+jECu08P8Ahq3mubdrudtadNxudPv5XtoF46xyZw34Ci21WxHhi60eTVmsrZZfNTTY7FZQSP4fP+9j3zQFzIHhzx1Ffabb6jdX+npqBHkXFzeMIjkZyWUnFX/GHg7xj4VSOS+8RRTxP0ktdQlcD65ANNn1XVdUsYNF0y2ktNMkAIs4WNy5k7vuOWGfQGtzQfhF4m1aEl4JEiUji+mdD+A5oC5ydlp+o3UJc+P9MgYdY5r65DD8oyKz7tdetrkxt4hkeLtPHdymNvocZ/SvefDfwHhhiZtXvFjkYY22/wA+D9WFdFp3wS8N284kvJLm+HdJSFB/75xQFz5X+3a1uIGvXBUdWF1JipGn8QA/JrF3IMZBS6kINfZEXw18HRKVj0G1APXJY/zNTw+APCsJzHodoPwJ/rQFz4uFz4iO7/ia3vH/AE9P/jSreawVJk8RyRsOCr3cuf0Br7Ok+HvhOT7+hWh/A/41map8JPBl/GVGkR20n/PSFiD+pIoC58ipda3LMkcGvTylv4lupAB+eKtt/aiQF5fGMKOOsTXdxvH/AI7j9a+gNU/Z+0WS0kGnajdpcE5TzdpX6cDNcNrvwZ8R6baCRkj1CJeNlkN0n5ECgLnm2myX94rtL41t7Pb0FzeXALfTahrR8K6XrXia+ks7HxrZxXKnCpcX1wnmf7p2EfniotV0JtMmWG/0+XT5McJcKVb8ayZtOYjIktuPRyDQFy/PYeME1y40m3vNSvLqBirm1nkkT/vocVfXwv8AEQq7CPW8KMn99J/jVjwj4l1fwtA9vpOqm0SQ7nCANn8wea2YPid4nJcHxBesegCov/xNAXOHvIPGdnLHHc/2+jyfdH745/Ko2uNZgOL/AMQ3Vi3926e5jP8A6BXZN4z8fzTedb6zrMrA4UJEpX/0Gs7Uh408QXaXXiJbzUI4vupcR/KPyAoC5y0+rX8bYi8VGf8A653U39QK6Lwj4d8ceLVd9EvrudE6sb1lH55q+NYMFu9pceBtJYgcTLbyFvz3VkjVtf0+V/7F83SIGXcUtAUGfx70Bc2vEfgTx/4dgE2qao0SEZB/tI/41xMF/wCI7m6aC1vtVuHU7SYJpJB/46TVnVLzXLudLnVJbjUdjBil2dytz3FdFZeOILnV4ptWs7jw9DbweXEPDQELO2eC+7dmgLmBq7+IdJWL7ZrGoRtJgBXa5jx9S6gfrV/W9L8VaVYWVyNbe/N4QIoLDUGnl59VB4q3E9z4suEl8Q+PLaO2SX91b6zIznbnI3gYFbxjtdT8aadDo8WnXsVlEZfN8GoLedQMfMzMTQFzzLUNb8Qabcm21K71mzuR1huJZEcfgTUR8SauOuq6iP8At5f/ABrtptUlkt/EN82oadf3d1IbSG112Mz34UNwEk4UNzWdq/hHTBetYCabQtSt41MlvqjBzcSOAVVCoAGc96AucwPE+qnpq2o/+BL/AONO/wCEk1fBzquojH/Ty/8AjVXV9Iv9FuVttXsntrgD7rAEfmOM1Q2kklulAXNc+J9WAz/aupf+BD/40n/CU6rx/wATTUuen+kP/jWKU6A5IpHY/KcjI9BQFzbPijVQMnVdS+n2h/8AGm/8JXquMnVNT/8AAh/8awWJ64ppGAMg0Bc3z4s1QYzqmpjP/Tw/+NMPjDUx11TVP/Ahv/iqwWOefSq8uOMfyoC56l8NfEGqXfizTi2p37Rt5nyvcMekbds0Vk/Cb/kZ9K/7a/8AoD0UAVvE/wDyMurf9fc3/oZrkdR/4/ZPw/kK67xP/wAjLq3/AF9zf+hmuVu0D38mTgDH8hQDI7aPA8wnB7CrGMHkZoVfmG0ZNSsCcDbigQnHPGCf5VKnGO3oRQqljjZz65qRUYcFQTQAAkrgnd7VOqAKCIsj1NNVV2jeNrVveE/D8uvXUga9Wy022XzLu9dSyxJ9OpPbj1oAz9O06a/Zvs8QCKQskrfciz0LH0rsNOuLXS7hrDwbYf2nqiQ7pdQkGWglzy8DDGFxjrTJHm8RXSaT4Zt10/QbUECR8Fyv8Ujt1YHkgHpV9Nl/AdH8Mj7FoNofO1DVW/1kxHBkU/eC9PlFAFi00iGHVbi91CaDXNUhRHnvZSHsIt46TnruHTg9RUeqX1hbyCHULsa1c2U6m1tIW36aU67QDz196xtY1EXloun6UrQaPEflGfmuT3Zz1IJ5APTNehfCz4Xajr7reXbLaaSp4kKAu5GPlC/1oA4yO21fxRqdtZrbSXxMryw2MeTFbg9lB6AV694G+B7fZYJfFF0Y1KHNpbcFSf7zHI/SvYvDXhzS/Ddl9m0m2ESElmYkszE9SSefw6VsUAY+heGtH0KGGPTNOtYXiTYJViUSEe7AZNbFFFABRRRQAUUUUAFFFFABRRRQBUvdNsL5g17ZWtywGAZolfH5iqb+GdBfG/RdMJHT/RU/wrXooAy08PaKn3NH05fpbJ/hUi6LpSnI0yxB9rdP8K0KKAK8dlaR/wCrtYE/3YwKk8iLkeVHg/7IqSigCH7NB/zwi/74FZGueEdB1yIR6ppkEqg5+XMZ/NSDW7RQB5vr/wAHvC+o6cbawt5NNk7Sxu0n5hia4LXPgNeafpw/4RjUI7y4PDLeIqceoIBr6FooA+NfF3w58SaI1ta32mLdSzjJltV3qB9QOK4q4spLK7ngs5ZYbhVKPtJjIB7cV9/1y3ibwF4d8RWs8d5ptvFNMdz3NvGqTE+u7GT+NAHxmNc1GbTLLTtWghv9LtZPMW3RFR2PfMi4b9a6W18W+HNUvDpupaY+jaCyF54FZriS4mUfu/3hJZRn0NejeMvgJdW4lufCOpFYYosi1lBMkjDr8w4/SvE/EGj6no2oSW+u2DW1ygHMikdRwTQB31zo00WgwGya21nQ5F/ti806d9ixEceWJvvFsD7ua4bVfC8L293c6PujMCLcT2l4DE6K/wB1YgeXHPWq2j6tfaP5KWdwj2cU63EllMN0Vyw7Fe4Irr49ag8QWGq3Mrx/2y2wyNf/ADTqgYbY7P0xQB5de29xaTvb3ULwzxnDxuMMv1FU3DA9MA16/wCMLS1Z/P1qO5udNaEvJdRAG/t58fIlyx6g+1cNrHhK4giN1pd1Hq9gkC3Etxa8i3z/AAP/ALQoA5dicc9fpTMYYbznipGQFS276AUzGcEnGPagBkwz93ke9VJ+xPerRJyQDweuaq3HUc5NAHd/Cb/kZ9K/7a/+gPRR8Jv+Rn0r/tr/AOgPRQNlbxP/AMjLq3/X3N/6Ga5qbAvZvXjH5Cul8T/8jLq3/X3N/wChmuan/wCPyb8P5UAyXYdnJx60oTBGT+PpSoAVz6DOPWnAYHAGKBC7eQd2R1p8a78Ddg0kePTt0rb8N6HNrUswR47a1thvubuQHZCvqcflQA/wzoEmt3jq062thCN9zdyHasajqATwXxnA710/2e58TtbaN4YhSz8O2z582RiqSv3mkJ4DEdunSpre2i1+3ttPtYm0rwlbHdJLIMSXWDyWI6seduemak1XVU1K6t/DvhGyltrJyIoYhjzJvdyOvSgDburbTDoBtVeS08I2BzNdMCs+qSj+BFP3kDAglexrlNRv7vXjEJLaOx0/cFtdPhJO30A7kVc8SolzqttY6ZDevZWoWG1spmDYnPEm3tjdXvfws+FFvoqw6r4jjS41YgMkJ5S39sdCaAOf+FPweBlt9a8VoSqfNbaew+Uf7Tg/hgV70oCgKoAAGAB2FLRQAUUV5t41+LuheHXa3sw+qXoyCsBGyMj+8SR+maAPSGYKpZiAoGST0Fcvr/j7w1oluJbrVIJcnAS2YTN+S180+KfiZ4l8RODPqLWduVKG2tSUVhn+L1ri2mHlMdjc9TmgD6V1z456Hb24Ok21xdTHoJlMQ/qa5m4+P2ooQYtEsSMZIa4bP8q8JYqSGdWIbkc9RUiDzXEMcTEt93n+dAHqmtfHDxFqAxbRwacnUeSSx/M1DY/GPxRG0TyXMUpQ5KuOGHvXmCsHOxotzID04qeVLaNIxDMZ5JE3OAMeW3933oA+nvCXxm0LV3gttRD2F04O+Rv9SCP9o16LYatp2oqG0+/tLkH/AJ4yq/8AI18JhwpAUEevpWhDqtxZRL9nuZoyRkCNytAH3TiivjLSfF2vadNBeW2pXZfOF82Qsv4iu+0f43eILSZG1i1gvoTwVgQRn86APo+isfwnr9t4l0OHUrNWRJMqyN1Vh1HvWxQAUUlLQAUUUUAFFFFABRRRQAUUUUAFZfiHQNL8Q6dNY6xZx3NvKMMGGD+BHIrUooA+XviV8EbrRvNvPDpe60vBZojjzID2x3YV4nIXt5TbzKy7WIORhs/Wv0NryD4ufCO28Rs+r6FHFDqyjLxYwk3vx/F/OgDxbwFr9nrFlHoWuHbfx5FndkfLMne3cdCzHgOemaxPE2kXvhO8GteH5c2iTFJYeHFrMPvRsv8AEo/vdK5/VLHUNN1KSzu4prW8hOTGBgqR3rutA1F73TxqumCCLVreL7Pqem3DYt9Rtx3buXJx2oA4wTaP4pe1TUANK1Vt3m3iZdLuRvuDaOEGeM+9c/rWi3ukXEkF/GqyRNsZ42Dxk+zDg10fjbw4dImM9rbyw28w8xrWZdsltu5wR2X0NZWla5PZ2slldRJfadKhXyJ+REx/5aL/ALQ5x9aAMBgMjrn0qlNzg12up+GFbw+uu6DM99YR/LdQMMzWmP45McBSen0rjbkDAwQRntQB3Hwm/wCRn0r/ALa/+gPRR8Jv+Rn0r/tr/wCgPRQNlbxP/wAjLq3/AF9zf+hmubk/4/pcYzx29hXSeJ/+Rl1b/r7m/wDQzXOOM3sw6dP5UAyUA7Bt61MgbaSvQ9abEuW+VsDvW3oOiz6o8rQEJaw4M8z/AHYx7/XtQIm8KeHbjXb6RISUt4l3zz7chFHXHq2Oi9TXpdxZaZ4bs9NXXEQ6TD/pNvpKyDdqBP8AHKw5TPXYRxinzXKaHpNnpWkWTRTSEGC2K/vpX7PN/tA9MVBrMuk+GtIv4/EiDVvF+oR/MxG9LQHoOxWQd8CgDn/GPi3UfFWqsbO3WKKTCx2kKZ2+igDr9cVtSwzeG9Nh0zQYf+JvqluBfXLD96oJ/wBQqdQeAc9azvB+kR6Qh1fVL0QNEB5cELf6SXP3SoxjGcZ5r3b4R+BmEp8U+JFe41a4PmRecQSvo+OzYoAtfCH4ax+GbeLVNYxPrMiDaGGRbj0HqTxk16jRXO+LfGWieFLcyaxeKkmMrAmDI/0GaANDW9b03Q7OW51S7it440LkM3zEey9T+FeSeI/jrbxySw+H9O+0Db8tzPJtAPrsxz+deX/EPxHo/jTxC17p19qFtu4/4mLAKg9FC5wPauPuNPkZd1rILmIZzJEeB+dAG94n+IHiLxA6jUNQkdFbIWH92APoOtc68V3JCLkRSNG5xvCkgn61V2KgwxPmH09Kkku7tIVQXDpbg/JEpwAe5oAIkljnIkJB6kEU66b7qQghRyWx3qvMGXLNIxk64bkk1b1aC0tLhEs74XKvCrlkJwHPVefSgBLXzpQQCXwMKpHOfaoIobhnLyrIqg43FSBu9M+tQo7J8yOysO4P8qkW5kdgHlbaeSrHgn1+tAGjZ2N1feY32mFEjHzK7gE/SqcoCOFyRjnI71A8btJ0I9TmppLZVdVSTzPcUAPlkDoCh2qOCBUkU8f2ZoDbxuzjAlJ+YewqJIFT5QevrVuCDNs8RTMhO4EdR7UAOsrd2hG7zCAcYArpPCfhy58R61FZafvYk4ckf6sdyfSuk8B/DTVfE8Ec1xvsrHtMeC3tjOa+g/CPhXS/Cth9m0qDaW5klbl3PuaALPhnRLXw9otvp1koEcQ+Ygfebux+tatFFABRRRQAUUUUAFFFFABRRVbUrn7Hp13c7d/kRPLt9doJx+lAGZ4i8VaN4d2jV76OCRxlUPVvpWPY/E7wjdLk6xBA2cbZjg18w+OPFF14w1d7vURtCfLGv9xc8D9a523W1VpI7kAoR8r46GgD7p0zUbPVLUXOnXUN1AeA8TBhVuviDwv4h1jwvqS3ejXjxTEYWLlkce6Zwa+ovht8StM8YWqQSlbLWFUeZayNgsemVzjP07UAd7RRRQB598VPhvYeM7JrmJRBrUKEQzrxv/2W9favknV9I1Dw/qLRajFLBNFL5UiE4JH+Ffe9eYfGj4fHxRYDUdLiRtVt1IZDx56Yzt/3vSgD5y0Lx5JpVzDp3iW2j1fS1yJdwHnMr8fM/cL2qt8QPBEWl+XrHhi6W/8ADl188ZXl4Cf4CPvN35xXNX1kqyvEVaOVGZXV/vIR1Vh2rovCMl7c6Tf6fayW1ne20LXMV/PLtcRL1iVSCDnNAHM+Fp7mHW4o7a9FpHOwjm3LlJB2V17/AI1qfEzwxY6Qjyf8eGrpIon05ucqwyJFPTHTj3qac2PifS0vtJjj07WoFHnW0fCz45Ei+rk9RjtUXjfxJb+JfDEf9sh/+EmspVjE5HNzFgg7z6jCgCgCH4Tf8jPpX/bX/wBAeij4Tf8AIz6V/wBtf/QHooGyt4n/AORl1b/r7m/9DNc/wL6YkZ6fyroPE/8AyMurf9fc3/oZrO0q3tX1C5m1GTbbxBTsXlpD6AenrQDL2h6K+oDz3dbexQZknfoPoO9en+GZbTRfDs2tWtp/oMRMdmszD95MOGd0P3lPYGuN0i1m8X60kX+jafpNsvnSxbtqpGOSqZzlj6Gu2sI7fVL64126WWTw3osQWIXKhPPI4CKB1YdaBDLBH0q0l8V+I7of2jdAi0gIyzA8bhz8uDWH4d0G98UX13qkmIbSNjJc387AiPnk4P3j7CsrXdZl17WxPciRbd5FVggyY4884H0r1nwxoTfELULLT9PgNl4T0pQjuo2i6YdXP+2fyoA6H4ceDIfEV7a6pdWoXw/Yn/Qo5Rl7h+7k9duQCAa9xAAAAGAOMCo7aCK1t4oLdFjhjUKiqMAAVynxP8Z23gvw5JdyMGvJf3dvGMEliPvY9BQBmfFb4jWPhDTprW3uI21qRP3UeN2zPdq+S9a1S91i9lvtTmae5lJZpHJP5Z6UurX9zqN/c3l25kubhi7sx5yazCfl+Y5z+dAApBbjqaeHaPH7xhzyFJA/Kog/PA6dzSr94lx1oAuW1z5lyouSEUnHmYztH0p8ixvK/kyB1XozDGazxyw+UEmkwScEHigDTSNmVTkMyntzUU0QAJfhs5xtxUEUjRriNivc4NWYrlt4LoJWx/F3oAZIquFZMYNIsa7Wy2DmrVu6PPh7c8gkrH2qTzNO8nAiuA2c5460AU3mRjubLEY9s1PNPHsVoAVXHKEdDRMbaVlMaFAeoJqzaaV9quEX7TBArsAZJD8qD1NAG98P9Ej8Y+IbXSCDb7ss0yjPAFfSHhX4WeHtFxJJAL24UgrLKCMfhmuK+Ddv4P8AB8dzc3PiOxudUlG1mV/kRe23I617bYXltfWqXFlPHPA3KuhyDQBMiLGgSNVVBwFUYAp1FFABRRRQAUUUUAFFFFABRRRQAVDeBDZ3AlGYzG24e2OamqtqUiw6ddSvjakTsc+gBoA+LPFIsLfWrtBIPKaY7BFztyehqv4qsF8Pat9jeSO5UxrIGj5zlQfz5p/ijUbbUL66MNqqgSn51xyM+wrd8P28viawi0WeNDewqzWVxgEj1Vu5zwOTxQBk+LNGsdJXQprPVIzNd2guGUvlomJPBwOKqxNJpMq3EWpQT3bYdXjJLxHrkHHWpNX0O90qx3a1YRrfI+3InD4WsrToHubkR2sXmO5PyqMk0AfRHwu+MUV4F0zxfItvdKuYrxhhJFA/jPZq9lsLy21C1S5sZ47i3f7skbbga+FLlki3RIxcg4wyYJra8I+JtU8Mzvc6dqFxF5a7lhDsYyfdM4P5UAfbNIc4O0Antk4rxfwH8ctO1FIrXxNE1jckhFuAMpKfoPu17NDLHPCksLrJG43KynIIoA8Y+O/w0tdVtLjxDpduU1FFzcrFx5qj+LGOTzya+bNBFrB4j04a+znThcKJMcfLnkfSvvwgEEEZB4wa+Y/j/wDDFdN8zWNHjVdNnY+bCOPIc/3fUE5PtQB4h4p8qDxJqMmmI9tAtyz22MgrHngj2qDXp7HVtDN89zFBq0EixyW205uAQf3i9hjAznrmu28S2tx440qHU7BY11DS7VLWWxQDc8adHX+8xyePavNb+yvIIHke0uIo8hXeSMqAfQk9DQB1Hwm/5GfSv+2v/oD0UfCb/kZ9K/7a/wDoD0UDZW8T/wDIy6t/19zf+hmsjTrOfUNaNraoXmkwFHpx1rX8T/8AIy6t/wBfc3/oZqHw3eS2mq3K2MLy306qkWwElfXAoBncSGPS9Li8M6NEtxf38yiadlDZk6DZ3UUnjC+OnWcPha0E8NtZP5lyk0m8m6xhyCO2c0unTJ4UsLq+vZRPrtyhijtwNyojcEsex9q5NFmuX3ctIx5yeT7fWgR0Xw/8O3viTX4NNs43KyEF3/ur3Yn09q+y/DOiWvh7RbbTrJFWOFQCVGN7d2P1rlPg94MPhbw9HLfANqt0oaY9ox2Uf1r0CgCO4mS3t5JpTiONSzE+gFfF/wAV/GNz4x8VT3bZSxtyYrWPui9yfcmvWf2hfiA1vu8NaVIMkA3cgOe+dn6DNfPd/cfabhpWyjv/AAjpQBVeRyoO4nmlVyrg4yaYw5PoKYgLPgkLxnJNAE86oCqxncTycdjTZMK2EbcPWozkHJGCfelA3Hj8h3oARThsnOKlHygs+QeoxUL/ACgZU571e1G2EMkO2RHDRK3yt0yOn1oAqs53fL1IpfmUcfjTWBCkEdDzSqMZwODxmgCeKWQPuViGIxn2qTGVGJPmJwV29vWoY0GM/N+FSoq7cEAMD1zQBPHZSyxtOB+5j6mpWZ9qqM+X9OtQ/aHjQwq7GIchAeAaemSqsyuMjIoAt2pwpVFAJ74rrvBHjTUfC14JbWZ2hcgPEx3Aj8elcnb4inWXG/5R8jHvUsccTxl9rrzzigD7K8H+IrXxPocOo2ZwGO10J5Rh1FbdfP8A+zrqZh1W7sF3GCdc47BxzmvoCgAooooAKKKKACiiigAooooAKx/GEiReFtVaQ4X7O4/EjA/WtisDx9Zy3/g3VreD/WNCSPoCCf0BoA+Qbu0s4NrWc0zTyrmVCBtBzzg0yzu7jTJXudKmeKSNSN56jPWnS2i+X5iEop6ZHv0p95c8RQRQxLkcnaMk0AYTb52d3ZpXZssWPLH/ABq/4fvptA1uHUtO+d4FICOcHJGDTZrMx3Ae8ZLbPKk8gt9KzrryYJiVnV2Y5JAoAddzzzSB5mDliW61oaPdWSxX66nHLtePbGYeWU561jB4EZ943Y5yD0pPPjQZ2cHrzzigDRtIhe3gity3Ayok/iFem/DP4nXnhC8GnaqGm0knHl5yYB6r/hXkqtHHLvjm2HHYc07ERy/2gs5PIPf8aAPvXTb+11OyivLCdJ7aUbkdDkGm6rp9tqunXFlexiS3nQowIHcdR7182fBb4gf8IvOmm6pc+bo9w2A//PBz7dcE4FfTqsHRWQhlYZBHcUAfF/xE8Ian8NPFQl0y7kAXMtpcKcPs6fMfXqK838Sa/qWqWzreX91Ikkgd4nlJVm55x68mvu/4leEbbxn4WudOnjVrhQZLZyxXbIBxyO3tXwR4o06402/uLO6R0mhmaJg67TkEg/hQB0Xwm/5GfSv+2v8A6A9FL8JxjxRpY/66/wDoD0UDZV8T/wDIy6t/19zf+hmm+GdZ/sPULyaCJGvJYwkczLlofUqexp3if/kZdW/6+5v/AEM1hw/8hCUDJJAAA+lAM6BZPOmead3lkk+Yljkk+tex/s8eCv7c1l9b1G2DaZZHEW4ArLL9O+K8o8J6TdeIdfs9Is0dprhwHKjO0dz+Ffb/AIS8P2nhjQbXS7BQI4UAZu7tjlj9aBGzXC/FzxpH4O8NtJGwa/uMpCgbDAd3H0ruq+Qfjr4huNb8fXKbw2n2f7iIqeCO5/OgDzrU759QvpbieV3mlcu7SNlmPqTVQ5O1iM0j4WRxjIzj6UnThQSO1ADzkDkjNNAAbc3I9qdF91iwxjoM1c8kwW1vdusbo5OFD8gjuRQBUlCJgndz2z0pvmfLgYA/WllllnmaRjvZjkkDrTORnjGKAFGduDyPerARGslZpMSBjgHPIqszDjIOR608IQgJwM9s80AWLd0CtERkOcljziiWLyT6r2PqKjjXH3iVDdx1qedkn8vGQY02jPf3oAf5JezMit0I3rj7vpUceEJJ59jSpK0MREJKCThx/ex60saea4XgE9z0FAD3KgKVyTn0q1EzSAHBZV4H+zVaSMwOVLK/upBqdBsI2q+W6NjrQBoWkKmU/MSMZ6Vu3sKxw2mAPmDDAGMmszQv3up20CoSzsFx7+1eo+Kfh3qUWnWNzbRvcxAZdFGWXPtQAfA9Gt/FUO9gCVKlQO/1r6LryT4PeFJoCdSv4Hg8s7Y0cYYn1Net0AFFFFABRRRQAUUUUAFFFQ3dzFaQNNO4RF7mgCVmCqWYgADJJ7V5t45+KGmaKz2lpi7umjYYB+QceorE+IvxCYxT2Fg/lE5XKtyw/wAa8OlT7SbmR3zMCAOfXrQAup+MbjUpmY2Uduc8OmTz9KxLi8ln8x5nZ2GMFV/nSXVsYCwmkwMcFeKbYOnkXP2jCAqAh6bqAKd8VkKtEW3fxbqqSJ5cLyJHj/a9almdTKpVTn60TzyMFUIoXpjtQAlikk7KqxMzlTwAT+NDwN9o+zRpvkPDY7n2rW0FI1t7i6ur6CwJ+SEyDPmA9cAVj3E3kXZ+zzpIY2wJFGM+/NADJPlZwysmBjaRUYYKnyjkD8KN8vmFnVT355yTSbWwpYKfUjpQA+NjEEMRYM3JKnpX1R+zp43fWdG/4R/UFjW70+LMLqxJmjzyTnuMivlhwkch2SLKuByvY+ldR4D8T3HhrxNYalG+xI5FEoTGWjz8y/iKAPuSvnP9rDwRFLpcPiu0CiaKZIrpT3U8KR+PWvoWyuor2zgurdt0MyCRD6gjIrg/j7H5vwv1RTt+9GfmGR94UAfJPwxTZ4xsF9HmH/jj0VL8PBjxzZj/AG5v/QHooGzL8T/8jLq3/X3N/wChmsKNjHqEjKSDgYPpxW74n/5GXVv+vub/ANDNUdC0+XVPFFnYwKXluJFRVAyTzQDPp39l7whHbaRJ4mu0Vrm5Jjtn7qnRvzIr3ms/QdNg0fRrPT7SMRwwRhQo7Hqf1zWhQIzPEuqQ6JoN7qNzu8q3jLHHX0H6mvhbVHa4vbh0aVl3M3zHJAJzX2j8VIHufAOrwxgEuijk4/iBr4y1kGO8eEvtkztNAGNvDkAkBc/eNJGcnbnHvUjWzL5ikr8vPUcimLsU/M3FADyQpIZshfSp7lohYQMoIkYtk9vwqFGgd5DJKVOPlG3r7U68uBcqkaRiNUHAB/rQBArdduQfWkB555pgJzwDz607Geox70ASxeVvDy5YDkAevvUtxN5sgcgK20DAHSq+QEI4J9ae3Rdp5K/lQAquSmCTnOc5pQwwCCc+tCsR8pwR3pCpJKjkUAWYZHTDABiOm4ZFPidS3fJ7UkiSGBDjI6Zpka4AwMmgCzLhXBXoB1FWLWVVlBLkqO56ZqJUZVDeWhUjBGe9dT8M/C7eJ/GFjp8yqYgfNlU9Ni9c0Aet/A/wD5ksXiXVI9qDm2iI6n+/9PSvdunSorW3itLaK3to1jgiQIiL0VQMAVLQAUUUUAFULnUoba5MUzxoB3ZgKvdOa+X/AI4Lqek+M7oS308sFzGJkAPCgkjH6UAfTcV1bzD91PE/+64NSF0GMsoz6mvhpdS1GxjWS0uphD3w5zn3rTj8c6osa+Vcnch6SOcmgD7TBB6EH8aXoMnpXxdJ8TPENvIcOUJA6sazb74i+KLoMp1i7iVsgiN+ooA+wfEPizTdHiYNcQvP2XeMfia8N8cfFBr+d4YbhRGOuzkCvD7rVtQvBi6vZ5gTn5270yKOTZlMlc/N60AdNeastzcgr8yuckt1JqnFqZljli2b4wfmGNv05rJjjuJWkKK5SPknHSp7abzpnQbh8vzYHQ44oAkjjm1L7RFbLI0lvGZmCrkhR3/WsZbhbhQpLsvY4xj6+ldN4OvZdG1V9RWch0QiSNuRImfukY6VU1G+W6vJp4bOO2jlYsVjXC80AQQJDFNbLduxjHMgC5wtXtMOkW+pXNxcxtJbxqXt48cSegPpWYWeF0kjIdum0jhh6Gn31ysgVQqxOTyijj6CgCvNOss+8psV+QuOPoKZcbMkBNrgYwe59aesjtJ8wHTgkfyprKxJMmCR0PegCOJjG8XO49x/SnvcLvMZT7Nbu250HOPfmo0AMgOB7kU6d0eeQBSE7GTk0AJFHGZiiOPLP3XfjNSI0anaRuweoqHaDIFUq+ewHSpAQNrfKNp7D+dAH1F+zX4rfVNGutEuTK81l+9jkfp5ZwNv4Gut+Oaq3wu1rcMgIp/8fFeS/srlm8V665xtNmvTgffFeufHEE/CvXyvURKf/H1oA+R/AAx49tR/00n/APQHopfAH/I+2vX/AFk//oD0UDZkeJ/+Rl1b/r7m/wDQzXbfs56Q+p/F2wmXGyxga5Yn/vkfqa4nxP8A8jLq3/X3N/6Ga9V/ZVVl+Il22cBtNZcev7ygGfWdFJTLiZLa3lnmO2OJC7H0AGTQI8Y+PPixo47rw9DceSGhSRzGRliW+6fTpmvm7XIXTVJVknSZhjMiNkN9K7HxfqcWs63qt1G/372WcEjJ2E8CuG1HdJMxHCqcAjH8qAKbsCpwMkHH4VDg9z1qZXeFWwBhvlPFTyQWrWkckExab/lpERjZ6c96AKUTh1BKFeeQRzUpGHA659KEjd32qjZPfGB+dW2tSiqc7G7sTmgCm4IY5Hy1YjjU2Sybhv3kFf4setRMrbsDkU2PKclsA/jQA4SDdzGvtxSIpcHjgc59qXKK2SpZfSno8bDyljYF24wc0ARg8cLnHU1furYQxW7AOBLHuz61TUgOQFbg85qZZ5PNdgxORjB5AHtQBYmcTTIIA4jCgFT0z608KAyx8hx+lQ25KkOCc4/CpbW2kumEiiTbnLSY+UDvzQBe0+0ku7hbe1jaaaQ4Cg/rX1H8IdB0Xw1pybb22uNXvRl3B5AH8I9Md6+WprxVlUWDOkafeYcEn1qWPVrgoQLmffkYIcjH0IoA+7KK+a/hz8XJ/D8cVjr5lu9OyFWYtl4R6+rD2r3zQfEuka9ZJdaXfwTRN23AMPqDyKANimTSxwQvLM6pEg3MzHgCqGsa5p2j23n391HGnYA5J+grwT4l/Eq819J9P0wSWmnAlWwRunA9eOB7UAaHiX403NzNJFo1oYLUPtWV/vvg9fQA122oafYfFXwDHMIzDeLxHIw5SVRyM91Oa+anBeyEkSk7PvkdFPpX1P8AB/S30vwJYrKctcZuMZ6bgOP0oA+RNcEljc3VnLFJDLG5jkRgQcqcZxWHNuG0kdeRXv8A+074WEF7aeI7WNiJ/wBzdYHC7QNp/HJ/KvAWTdkE4wOMmgCTT8TXyLPuKkHJPPaqr4JyisAKu6ZbzyTqIgDzzzVrVLddOuHQMszA/wAJyD+NAGVDG0rhFU7m6c0wOwO3ccA84NTXC+VtngkxnHHdT3Fb3jDT7JfEDyaDFnS5IkaIEkfNj5v1oAr6JdvbtMrputJ4/Lm+bB2+3vVF44oMrbyl0JPPQ47A1WKeYduW3bsY9KftdVzv3HOODQA8zyRq7I20H5WBGciuv+FWiSeK9fawWNSBGdwY4AGDiuVCKLN2nwZCwKnNa2kazcaLGyaQfJknHzSdHU+1AEmt+EtW0W7utPuILiTy2JDpCcYB7EVzsmZjGcEyxkEcYOfTFdrB4/8AEi28ENxqdxIseVVH24YE854rL8Va5BqtzFc2un2lhJGgRzBkeaw6sc0AYb4iR1liYhue4NQHe+4xoMKMkE9BUj3Esu4yyFz6E8CiHcwLMIwoODk9aAIj8qr8mQ3XPFSwSQwzqbm3+0IR90nbg+ua6e20/UNd8NR2mi6U15JZSNNI8S5cg9j7CuUliMjBHDBlyNp7H0oAdei2imzaMWBG45GNrenvTrO4khbeoU8EAMPWp5NLKabFfGWPyDIYihPzKw5p6JbNEEKsJG6OTxQB7J+ys0h8WavlQqNYgnB7+YK9i+N2P+FV+IiUVwsAO1uh+ZeteF/s76lFpfxAS2llQi8hMCkH7zfeA/SvdvjWpb4V+JAASfs2ePZhQB8ieARjx7agdPMm/wDQHopfAh/4uBb/APXWf/0B6KBsx/E//Iy6t/19zf8AoZr1z9lsKPHMxbr/AGc5B/7aHNeR+J/+Rl1b/r7m/wDQzXr37MXy+OoOo36bL264loBn1SBisPx1N5HgvXJN23FnKAfqpH9a3a5z4i2rXngfWoUYqTbM2R14Gf6UCPjXUf3FrCy4Xeoyc9TWM9zHH8qW0TOP4yTmt24ja40pnKkJAuBu/iPtXMTA8gjA9aAJzdwHzM2kTbhgdfkP94c1UY8jc3SkCkDHJBHr1qyylUWa5jPPGF4z6UALJczNbLB9obyevljGAaYsWQANzNTAvmx+YGVVU88dKASGBSQsOxBIoAWRTHC2UPmfwr0z+NQBdyAldr9xnOD9avXZAtoWeXfJg/KByvPc1FETKuI1/eY6HuKAHSxRwuYzMJMAEleVNMgcI4e3ZlkT5gfSowGJ2n73oKeFG5cH5sYz6CgB6SuzlixYt1B7mnx4Z8YI9QtLLGittiJm4+8Pl5+lOs4ZJriKJTtLuFyfegDX0+GNdNmvpVVIFO2FZAf3z91H0zWlb3D2XhfU4rk+V50iGGLnawwclfpVbxZdSTzWml2tq0VpbAEpgZMnRnz71VvriWeO2tpiHitVIXGOc0AVI7eTy96glduSR6VMBEqKoPzHrupqXMkdqUj4BbnIHSoDvIYtyVwaAL6yKFcKykkFee1Nt7fySJmHzscI2Oan0/Tbm8tXu0t5HtozmSYDhfanSu90ryRBUjjAAGR+dAGppst3dXIhgkYAqSgk6ZqvcXsS34jZ28xDiRT1z3xWZatIGbJZQOCQcVMzK2S0W5gfv55x60AakF9FE0dpbBUhuHAn3jORnGR+Zr7J0SGK20axhtyTCkCKhPcYGK+K40Jt454ojhDlifXtX2B4A1WHWPCGm3ULhiIVjkAH3XUAEUAQ/EvQR4k8D6rphYK0kRZG9CvI/lXxDNCoLM4YhWKt2PBr751LUrLTIGl1C5hgjAJ/eMAT9B3r5T8deH7XX/El1qPhq8tmt7iQl4pTsYH/AGR6UAeZzXYMIEK+UQNuV4OKroWyeDg8g+laV3p8tmJhKjxOjmPcRwcelR2jSWhYpgg8k9SD9KAIltY1VZpclW/ujHPpU39puskKFVS3ibKowBJoubu4mRt5Jd+M4xxWekGx8XEbfrQBd1F7S9upbm3Jt3kO5oyeM+o9BUUe1pFjJxnA4HrSxW7SLmMjC/JycYHrUttH9nvNzkEqOJAc4oAm1/Q9Q0iWFL2Jvs5G6OTP3h7Vc0G302Sx1FNXvFtLiSMC0lYE7Wz39eKm8Vaxb61p2jLawSRzWcLRyPyRJz15rDimVZIvNRpFByRQAkkZBeIuWkX+M9AP/r01IvPZUtkZnbhc8/pT7+eOSUzqCE6NkYxW78JEtrr4jaJDqHlrZPOPM3nAf0B/GgDm2ZopRBLFtc9QwOc0+ARvKY3bYrD5TjIzXuX7SS6Lp+p6TaW+jmCcqzfaljIRhjAUHoSK8QkjI+UIjEHqT2oA7XwT8QNY8E29xY6LHFJ55yrPCGO76/0rjdSvGlu3luBuuHYu+xdoBJqzHeiy0tGhUi6DEK46L/8AXrKZZZQzPlhnPNADg6yAj5yv3sZOAfXFSQyIG3MrOq9QKfpTW0IvFukJ3RYjI7NkUlrZSyJ5ywyiJc+Y6j5R6c0AdX8MdRsrHx9oF28UggjugcjJ25BHT8a+pPjQ+PhT4ldD1tCQfxFfIfhIT3XiTTbayBMrzqse7oTmvrj4vJInwg8QI/8ArFsMNj1GM0AfJHgL/kfrb/rpP/6A9FJ8P+fHdp/10m/9AeigbMnxP/yMurf9fc3/AKGa9e/Zmbb45sxn72nTjH0lryHxP/yMurf9fc3/AKGa9Y/ZnYHx9Yr6WNwP/HxQDPrCszxOCfDWrBRlvskuB/wA1p1DeQC6s54GOBLG0ZP1GKBHxFrUEsXhaznfahedhtB56HrXIyEsST1r0P4kW0mmo2myEOltdNGJFGBxng+9efTfKxUkGgCHoePrUltE1zcCFSqlsnc5wBx61ECwpykhs5IJoAbJuTg4JBxweKE4yen0pS3B7+tAwvUn8KAF8xs5OSR0pjOcliTk809fmcA5wOo9qcSqyFowWUH5QfSgAtwzEgkn0NTlQ1sysq7g2c57VGjtNLkYVj2zgcU/7oLbiR9OlAAuAQqP8+OR6VqaHYz3d/HI6t9lgYSzuB0UHn8ajsdJ82yN9cSiC0LYVjyXI69Km/tuSJJLew/cWJ4VHGXI75PegDQ1/wAQ3GoapJcWj+TZqvlRJk5ZR3PvWc6L9jt2jZvPbJP51VfYWQqeOy471MkipOpLEkcEY7UAX9OsyLe4ubudPkTMUWfmZvcelZfzCUB0YZ52jP6VZcKzsUWQLnjLZNAb95ub5cDqecUAdZoviHVdP0efR0Ma6bOhaS3fI3n1+vArD+zDzTsVY0IyM8AV0Fp4dvLybRzcBTHewF4XDgDGccnPH403XvBer6Lc7r8RR2rHAdZkkyO3AJoA56WCaOWaPessYIJKkmlIW4K+Qjq6qAR2NTyIkdwUdyUH8Q4pYo8XLLASUI3K2OooAtabc/Z5HS4Lsr4BjP3fqfpX0H8KNSg0b4X6jfBTJHaSzS7V/iwo6fWvEvDPhnU/Elx9k0yzZ5mBJmZgFQdyT/SvpzRvClrZ+Ck8PygGN4PLnZOCzEcmgD5U8W+INQ8ZztqmpSSAZOyEk7Yl7ACuXBntJPOjchwcqynpXoXjHwLqvhi4ltpkc6WWPlSBcrtzxlvWuMuraKzkMbLIyn7rEfrQBqweJZXsY7XVdPgvrVjuEjLmUMfQmsu+sreYb7JXilziVZP0xWYGd5VgVmK7iy4HetW5msY7WxSNpTeEN9pbBweeP0oAyrlJN/lSYVl6E9PoKiaMzJmWRiR0OeT7Vr3sAtbiBbnLwyqJVA5LL/Sq/l2LLIfOlIzwu0jFAGXB5jSlHi2KRhlHBqxc26CEizD89Y3IJ+taFglm15Gscro6/wB9eG/E1X1GV455IpFdDnrj+H1oAzLeQxRiNVOO4brUZJ3E/dyevtUssAEjModV4OcZzUt1LayQqkdv5bry0u45c+mO1AEEEgtWeVIlm3DaEdcqfelimCXEU+DBKjBhs424+netb+3ZH0ODRRaIYom3LzycnPWsi6kkSRxIrKjfKyEdDQB61f8Axh0rXrfT9O8R+Gpry1t0CGYMnmcDGVJ6Vw/iy78MS3Lf8I9p2o20ZOcTzbua51/JW2iCxETg8tk8imTOWwjs7KPuigBonXcVKkofvGjLkZwQpPy8/epVBQYK8Nxip7RYxNumLICrLlecnFAFZgd2/GSB07Grn2q6lKRxytHHxlecN9RUSWuY84JVRkAc4+tWbO1FyMAMCgyWJwooA7r4O6XPrHxO0mWBVAtZhcygDACqMV9K/GBd/wAMPEq9c2b15H+zFprDxBqWoK6mJbUwkDnkup/pXsHxXGfht4jB72b/AMqAPjrwCMePbUekk3/oD0U7wKNvxAtRjHzzf+i3ooGzG8T/APIy6t/19zf+hmvTv2aJUX4lWEbNh2srgKvrzmvMfE//ACMurf8AX3N/6Ga7r9ne9htPi5ov2h9oltp4Ez/eboKAZ9nU2RisbsBkgEgUo4oYblYeoxQI+S/iYmm6zv1tppobl5CsyJGSrSd/pXk14GWdlZcnH6dq9E1q7Fhq9/Y6gJ2sROytEMZVs9R71jeJNBtxaQ6hpMss8cmdyscsmPWgDi8exGeadgcAk8j0p0n38Dn3FaWiaY9+kzGOTykGXl/gjFAGYgMsgjhVmfoFUZJqWOArLtnJTbw3HI/Cp3uRGGGnK0IU/wCsP3uPeqZd3YvI5ZmOSW6mgCdpR5m6ALHuGCM5yKSCyeZyIyD/ALOeTVcgZ4H1NPikeOQNG7KcdR2oAdlWYqU2EHBrY0i1iaLzb7zBbA5CBeXP+FGjWcE0rT3MmLVOWznJb/8AXS6jJNPN5plTnkRxjAUemKAGX94tzcsxXEQGwJ0AUdKoeXhWKkDBxUsTqGxKdwY9AOlOfLu3lrtTrQA+KSSOLjOe5I7U4xlk8xjtQdQKtXkS2+mwDzFmkkOWK/wD+6aFhme1V9hKPwp/vYoAjglaRdiAKSfvZqeKNcnzTk+1NUAIUGOeuB0p0Lx8IEfd0LE0Aei2uo+H4/hpdaRLPKmsXE4aGSIZKrxwTngdfzriIrQW7rE0xZlPJLEgmoY4hI6+WMunLY4IFbFta2dzFcFZ/JZU3KHy3mHuB6UAVb22mWM3zwMtrwokAOzP1rofh/oc+ua5DYxBj5vO/BKqO5PtVG1nWxkSa3kMsToySQSgsnpkD1r6C+CXhmLR/DY1BoWS5v8A94CxyREeVHtQB2nh/RLHQNOSy02BYol6kDlj6k1pUUUAQX1pb39pLa3sKT28o2ujjIIr5a+K/hy58Ma0thF5sthJl7Z35LDqR+GcV9WV5H+0XpguNC03UGYgWkzKcdTvA/woA+ebvTLuK3jvokkSFm2MpB3A+v0rOljLAbSwPVmq9JOUndp2kkROBHvwKgiuHtZRPGihyCu1iGGD3oAfGF/sNpLiR5LzzcLuPzLHjtWTcJIsjIM4IBz3rSsj58l1FgmRoiI8dWqhO3mIZJUIcfJjOMY9aABXSZ/KcgOI8bj1zUjSS3SCG5LPKgwHzzj0+lPgDTWBlKnZA4QfL2NUxunaTYSCOvagCeO1Z2MURlMoHAJHI74qlJa+QwWXJLfMBntVvdHbylYpjISNqsOMZ7VDOHGElP7xfl65xQBXUEzrtBBJADccGrWoiYyzRXSASBslyOc1VQbZkxlirB8j2NbviWC6kZdTuYf3N4N0cgPygdMH0PHQ0AYl0yeVBIq4lXhzxtIxx+NPWWNbGVGQGVnBRxjgelaNneJpujapBcRFp7uNVtnZceVg8sOOc1iNcM7Abdx/vdMUASBVKNubBA3Dd3PpUqQNJC7Id2znb1OO9VwAHUt+BzW5oF9e6HeHVtIBS6iQp5rJuUBhjoRigDKSVyoEedjDOBxV2ySafEVtExZxgqGxnFRXGpTajLJPeo0lxJy023bk/QcUhQh/OhlZAoGMcHPegD6I/ZbeL7HrEaKwZWXr2HpXqfxKGfAGvjjm0cc/SvMv2WwX0nWpSdw81V3EYOcGvT/iMnmeA9fUdTZyfyoA+NfBQC/ES3UcgSTD/wAceim+Bjnx/aE92l/9FtRQNmN4n/5GXVv+vub/ANDNP8GXiWPjjw/eTOEitrtJHY9gDzTPE/8AyMurf9fc3/oZrFUF79EzgE4z6cUAz9HbW4iu7WG5t3DwzIJEYd1IyDUtcR8G9ct9d+H+mPaqypZxrZHPdo1UE129Aj5P+IwWx+JPiD7fBiC4kIQkfdB/jArjLnztKvgIpNswG9R1UqehIr2H9o+08vxHpN0sWI5bdkkkA77uOfpXlrvp14ot5WmE8Y+S5IHzf7LH0HagChNqdhexuNV05XmAwLiM7cD/AHQKz9WeGPT7eHTJ3ksVYvtAKnceoPrUmmzRprVuLqNmsvOXzwo58vPJH4Ua35J1i4Gk5Fj5paBm4IXtmgDm327uDn1FNI644NaU0H2h3ZlEb5GMdPqaiGnyszJGVlK8/Ic0AVScrwMEVPZWjXBdt2I4xuYkdqsQ6TdmFZpYJEhJxn+9j0rR1R44LaCG22bGGZI/4w3vQBm3dwzpHbIhihT5gMfe96gjmKtnZubHc1OgN1eKJblIxjbuY8D2pXtXicAMjAn746GgCeVCkSNwQ6g5A+77VHEd0bb+gpqu6NtBGFPC9jUjsGZQmVHcGgCMAupTIKg569a7C906/h+G+gX4lj+zSzTKyAjcoBFc7Gh2l3iQRg7S4HFTpJdTwmEXAaFMlIc/KPXAoAZbopQ7SwTHOR1qSIK5UIv0OOat6c6MYZpELQodknoCanuorfzZfsUmVJz15FADEiEUuyUlXA9KvpYypYfbXmh8vdsWMN85b1I9KrWuWIaQ+YzDqTkmuz+G/gyXxTqTRuCtnE2ZpMdB6A+tAGr8KPBV14juYb67Hk6TbPkt3mbrtXjkdia+jYo0ijWOJQkaAKqjgADtUVlawWNpFbWkSxQRKFREGABU9ABRRRQAV45+0JrkcNlYaTGxaWRjLIq84A6Z/WvY6+U/ilrS6v4v1O8gJ8tXEKg/7Hyn+VAHETMZZG4BLHv1rMuvkJMSsVzyzdjXQ6Pfpo+vW2pxJHJNbncqSruRj6Ed62fBs0PiGbWvD91FDHPq5a5juSABCUO4gegPpQBx2nRXMV9DcxMY2hcEP6fpWl4im02+kle0jSFwo8xTx5j92+tY8s5RXWNySrc8/wBKmt7Oa/tZ7iGMGO3UNI2ecE0AVTcTQwtEk2I2OSq9BT90f9lCcIWnRznb/CPWn30Nt9rlXS5/PiIDElfu8c0mlSmSVLJ8RxTPtdiO1AGeZdoWYW6hDwABwfer+iaXdaxdG10+3aedULlE5bHrVvxP4evtB1Saw1BQpVVeNkcMu0jI6Guq+CXiTTPA/iCe/wBYBMVzH5Bk7xcg7vccYoA86u2gjVEtllF5FI6T7vujnGP5123wx1ZJbweGtZt4LvSr+UKHkBPkORgEHjAq98T9Y8N+KfGN1qPh4pNbrCocovlh2GcnHc1xdpdywObayXy45HDYxlgfZu1AGp8U/C194f8AFD2c15Dd22wPE8LZCJnhfqBXLtArI0pYIyYGxure4q1cRu9zI9zcTSEtg7nJ/DmkvIZQFmbcsUv3BtznHv2oAS2tYJWiWR+XPIHQfWut8NeJLLTV1GPU7OOa1nTYYkXkEDAYc+tcaE3FVictK3GMYxRBbyTvIkOXeNWdh64GSPrxxQANFIS8kEkpt9xxvI+U0+1bnDodoHGe59aLVZXjiR/3JkxuQnIUntV8Wcpv4LDy2eeaRUURfPkE47e2aAPpr9m7SJtO8CG7l+7fy+ag9hkV3HxABPgfXQOD9jk/9BNXPC+kQ6D4esNLtsmK2iCAn8z+pNVPH2P+EJ1zJwPscnP/AAE0AfF/gT/kfrPPrJ/6Laik8BnPjyyJ7mQ/nE1FA2Y/if8A5GXVv+vub/0M1hxnGprz3/pW54n/AORl1b/r7m/9DNc8xxqBPoR/IUAz6f8A2VPEMz/2noc0kS20YFxChADFyQGx68AV9FV8GfD3Wx4f8V6Xq7jclvKGZM4yK+7rSdLq1huIiDHKgdSDngjNAjivjN4ebxD4HukjdUksz9rBK5LBASVB7ZFfJ0TJ5iBVyAwbB7kHpX3S6LJGySKGRgVYHoQa+Qfid4ek0HxlqVo6KkMjmeEr02MeBQBieIrqfXvEgxDBBcXbpEiRKETPAHTisnU9OudI1KeyvdqzxHayo25c+xqYabeXUBlgtpp7SD7zxrkIevNVYiHlAlyUB7dc0AMt4087bcSGNGBPTNRiLzVZ7JiqqdvBwcVpR6ZqEllNeW1tNJaQkCSUL8seemfSq6WTwM0kJRsj5sHkD/CgDTg1WddBito5VjS2YsC6hjk9etY1xEl5KswU4kBctu6mtvQ7myt/tNrfW6TQXahVlfP7s+oqK70qS2l8mOS1fHWSJsrtoAyLfTkls7meMLKLYb5ATtKgnHHrVRVfzMsSABVmVfJllijkyOmexFRmCYDfIG2DgO3T6UAOntJLcKzhcOAww2Tir17Pp09x/oelvaxlQNplL5buazxHt+bCkjkYq9CNqspUZIyG9KAL9na2o0icm9K3gl/49SmRtx97dmqctu8UgjddshGVwaJ2iuBAYk8tkj2uB1c56mtOC3W6u0Msv7tEU7WxuOOcCgDd0zxHY2PhG40caSj39wQ8l3v9PQVi6ZHGba+eaMkJGCmOua1df1Oy1e7szaabbWAhiKlo1xvPqao6bNFY30c8rrIicmMdG+vtQBo+EdMOpa5Y2EUfFzKqkc8Dua+stG0uz0bT4rLT4VigjGMDqT6n1NeJ/AzQ5ZPFVzqZMUlvaxlMr0DOMgD8K96oAKKKKACiiigAr461eHy9Yvtw3R/apd3r985r7Fr5t+M2miw8Z3L28flQSqsvAwCxHzEfjmgDz3ULaNLmGBFKxuPMUvwcelUrGzSHUIbm8l2RwTBnCH5imeQMe1T3ssrTq0j72C8FucLUTGKa1hjZxHKHYvI3II7CgC543l0HUfFt5c+G4jHYSgBUK7ecc8H3qtbrptlokytdXC6m55jVBtK54zWaIvJl8zODnqev1FWINNu7nTb7VBHI9rb/AOslAOBzQBSaJoWMkb7JSMMB7+tMgt5J5WiVgGYck4psE8jLuyMvycgnPpVuYjaGwyuFwSOM0AUskb1OWIOCSc5qOV2OFPIC4GeCKvG3kgSORuFk+7kcNVqx1JbW4uhNaRTvLCYdu0fIT3oAwjbPBcRlgQ2MjfxnNXLQNbNJLIGAHy5XqCehFQFjNcbZZSAo27ny2MVKskscoeNhICD94Eg++KAPTNZ8DaZefDe28SaBfNJcQ/8AH1FcEAswHOABnOa8wae7a38uSeVdh+WM4AqwtzdfYcR3s8abiWgV2Ct74ziqhdgymRw3OQxGaAHQTy6eJi0MU0sqFQZOqe4x3psqSR2CSQyoGnPzxhsOMd6fJGb+4lLtnC7gy/KKVkgilUhDIuACQelAFeJ5PJEbx53EEbq9t/Zy8Ky33iE+IJ45UtbIEQuR8srkEHH0zmvJCYpFQ29tMb5ztwSSpPoFr7T8DaJa+HvC2n2FlEYkESu4JJJdgCx596AN6ub+JN4mn+APEN3KCUisZSQP9010leE/tWeKFsvCi+HrWeSO9vQJ5VU4DQAkEE+5HT2oA+f/AIbNv8YaW3qjf+iWoqP4Xtu8WaUR/df/ANFNRQNlHxP/AMjLq3/X3N/6Ga5yQ/8AEwI9x/IV0fif/kZdW/6+5v8A0M1zUxI1E4OOR/IUAzWi4UZ/Kvrf9m3xb/bnhJ9KnDm70s4Z2OQyMSR+VfI9o2+VVOAuecmu9+FXic+FPHNjqM4ZrX5oZUU/eVhgH8M0CPtuvNPjh4QHiDw4dQtVAv7AGTATJlTHK59utelKQyhlIKkZBHcUtAHw9Ff3umuBYzGOFjueHPysR/eHQ1LJrOn3qP8AbtM/00txLbFY0A919a3vit4bk8PeML61JZ7aVhcRSOuN27JIH0PFcfp9o0+r2sUZ5eTBPrQBMdZvk0660u3maPT7pg0sanBJHTn8ah0+5Fn5/nJ5hkiMagH7pPc1HcW224kC+YrLKwKsuOhpZ4ZFcSSKQr/dZgRx60ASQhI4gWIYnqpHStK4iurNGvorbFlcD90zYIYdD+tZbqYlyCwf1A4IrQn1vUJ9Nhsbu5aayThI8fcoAzp23ZdAjs4AYBQNvtUGyXG3JKHnBORmrKRuk26PcQp4fFWLVVMsf21JFtyDhkX+LtQBTnSHbF5aMrFfnBOfmr0n4e+ANQ8beEppleG2htiwtiUG6Vscgn/GvPwo82QswBByEPX64r0Hwh8UNR8LeFX0S1tbd2BZorjccqWPORQBwv8AZ11aPNb3tuUuIWMUgz0OaSOExzY2k/Lx83IrrfCd0mteKbaHWZ2k+33KxSsDx838Wah8e6Xo2jeJrqx0a8uJkhYh/MwQp7gEdaAMjS7ZJ4ZTHCzOoL7t/QD2qKC3lciSSMoDyCw4NaPh2aKC5jYruDtswOmD1qbXTO+pT2z3Ty20LERAnhBQB7r8B9LNn4YubwuX+2Tbh9FGK9MrjPg8VPw60kr0xJ/6MauzoAKRgSpAOD2PpS0UAJS0UUAFeXfHnSZL3RLC9VR5NnIxmPfBxj9a9RrI8XaUut+GtQ09m2+dEQG9COR/KgD5KkdUvystqDbMc4LEZH1qvPbfbJjBYW0nmMTtjjBdmH0qzqcRkiVy6iPn7vbmn+GNduvC2sW+qWaxvcRKwUSfdYMMH9KAMIwuJpEZcnOBng/lXZ6b8Qhp3gC+8Jy2PmvMXBmUfwk9MfhXNa7N9tuXvoNkcZbnZxyaz7aZBNP5hy5jwhGOtAE2niCznhaVgqAh2UDO4D+H8a7bxpb6D4m8I2+u+H7S2029hn+yT27T/OyAE7gD+FedOF8kDOTn5ie30rT0PQrjUtP1G8s1Mv2KMu7AdFHegDprbVfDN54Rs9A1HTmOo2jZivixG3kE8DjtjmuQvoUbWL5oJQIB86AAHJAFQ286G2Z5lZp2A2Y6Y96pzyupOH254OPSgBk2VQZQYJyT2zUdzKXIL4wvAwOKV2XBUzZXsp7GmSxOLETZU27SmIZkG/cAD93rjnr0oAf5ge227QH6lh6elRoN2VUhV9at6Rp7XdhqU8MuZLWIyyRc7tvrVa3mQwIVBVlzwe+aAIp23sVU/KnK+9WmijDFrM7wAu5mGCGPX8KWCCFZ4DdMwt5CCxB5x7VoaZpc2ratFYaPukknl2RKOpHv9BzQB6X8CtCu/EfjCPUNQd2ttKAkWVANvmAjCE/r+FfT9c38P/Clt4P8N2+mwbXnA3XEwGPNfua6SgBksixRPI/3EUsfoK+FvjR4sm8WeJ76985pLMMUtVcYaKMfw4+uT+NfTP7Qni1vDng82dsLj7XqAMayQuFMSjGSe/OcfnXxlqjmQSO2QxHQ0AdF8KDnxRpX/bX/ANFvRSfCb/kZ9K/7a/8AoD0UDZW8T/8AIy6t/wBfc3/oZrn47eW61hYbeNpZXdQqL1Y4roPE/wDyMurf9fc3/oZrmZ3KaiWUkEEEFTg9KAZsmFIZnhnR4pUOCrdRVmKYxEK+DnkZ6gVa07xAlxbpZeIrdb2xVdkTKdjwE/x5GS2PQ0uo6W1oqvDKLmzk/wBTMMZb2I7UCPqz9nvxdH4g8Hx6fNKWvtNAiPmPl5E7N/SvVa+Ffhz4puvCHim11O0K7AQk6Ho8ZPzD8u9fbeh6pba1pNrqNjIr29xGHUgg4z2+ooA474y+Dl8U+Gmlt1/4mVkrSQkHG4fxL+Q4r5i065/sm/t7uKJXlgbJSQZ5r7drxP42/D/esniLQ4l8wc3duF4cf36APBJ7p5b43czxtIZjKUA4HOcfStDXdYOtyCe7t4oX4EaW6hEUfSqdzbQCCKWLfvZjujC5qr5rQzgQJuxwpPcUAOngMgEkbllRRvVRyo9at3mlPYxK9zujSUboiyn56u2HiPUtKvEfSZUs3IGW2B+fxrV8Z+O9e8SRWwu7lF8gEEJEBknrQBjeEZNHuNds7TxI7R6U7/vHjYqV9yRzVnxXDZPrV2nht3fSFA8nzGyeOpya5/cZsBl2/Lndjqa6S+1ewfwdpunW1nHFqULubicHmRc8UAczE4mUlkPmKdu/2poyJMr096ureSi1W2V28ktuZNv8X1qu+wv0P8s0AbXhp4YNYspzJgxuJc9ACDWx8QLWO38TGaEgx3UYuGYnPLZzXKOitaKVabdjlSuMfSrd1dSTxwqZZJFVAgDjoPSgC5p8aPPE5mC4cHjgVa1NgNQuiG/iJFZEZEJQyeYFyCQi1qXIEkkc0IkkgcZ3BeFPv6UAfSfwaOfhxpPzZ/1v/oxq7WuH+C4YfDnTdwx80uPp5jV3FABRRRQAUUUUAFFFFAHgnxZ8K3uiaq+r6Yi/2ZIQ2wJkRPjkEehOTXlV/wDvrgTyTc/eb5MDPpivsi/tIb+ymtbpA8MylGU+hr5P8a2DaZrV3p67mjtp3jVivLAHANAHLXDQiGONBtYHLNnO6oIkMhlKHBA5IFW1MAtZBMAtzuBQKOMd81HCJmuQsTwx+YMMW+4PrQBWih81/JjYl2GVGM10vg3xZJ4Ju72RbOO8S7tmt5Yy+ByRz+lUNetk0zXxFpd7DMhjULLEcjcw5ArO1GxkhkZWZGK8OD1BoAiuZobydpo1EEbsfkBztqu1vCImBlLyo3K47UT27Q2yvHJCc/wjrTV81G8yNQxZcYIzQBBNMGkCIirkY+tV/JUsuQwI64XOKsYLNuAjG0fxHknvT7OC4mhlnicMyHlR1oAk03Um0r7YIVP+kwGCQMMZSqQHmhnSNzGvXCn5alkeWQb5RubGNr06zeeMvEjFVl7Do1AFqN0kjsV+zhPJXBYcl+fSvov4E/DwaUh8Sauu7ULkH7NG6Y8hOmR7kVg/Br4WzTvba14ng2wx4e3t26ucghmH932r6CAAAAAAHAA7UALVXVL+30vTri+vX8u2gQyO3oBVqvmb9o74kvcXTeGdGkH2WFgbuZTyzjPyg+nNAHlvxQ8YzeMPFF3qbEiHPlwoeNqD7vHrXCXhBiYE5OKnuJQ5O0896pzBjE+cDAwRQB1nwm/5GfSv+2v/AKA9FHwm/wCRn0r/ALa/+gPRQNlbxP8A8jLq3/X3N/6Ga5a6ONQbHqP5Cup8T/8AIy6t/wBfc3/oZrmmaFdWzcKWi3LuCnBxgUAy3A3A4HvXTeE9RsbaZrXWBK+k3BxL5PMsfoyZ4BqI+G/tduZvD95HqVvEhackCJoz/dCk5bj0rFdGhkVJUkjc9pFKH8jQI3PEOmTaLrMtncIQ6gMFP3tp5Ga9H+CPxLl8JX403VJHbRJ2zsPPkMf4h/hXGqw1rwSkvlst5pLiKWRnMkl0HPBx1AH41zY2k4br0NAH6FQTx3EEc0DiSKQBkdeQQe9OdVdGR1DIwwVIyCK+X/gX8VV0EroniKdzpjMFguHOfIJ7H2J/KvqCN1kjV42V0YZVlOQR6g0AfOfxh+Hc2g3EusaEh/sqUlp0XkwE9T/u/wAq8qkUOuFOdnAdejV9wyxpLG0cqK8bDDKwyCPQivBfiX8JJrc3Go+GIhLbHLtaDho/Xb/e+lAHkMumypHFKrBoJBxIOit6GqJilG+OSQByeQe9Xo2ntrSSAo8ZY7XjfOR+B6GlmMMiQw/ZSjg/PNnJb8PagDO2vA20nDf3TzTeTh0GcHmnz28YunWOUyLuxkjBNLFNLaj9wVBY4bIzmgAjD3FwsQIX5goOP1pjRPF5qsQ4VsA45qew1B9P1Wzu441kWJxIUI4bB6Vt+J5x4huJtSsIEUEAtEvBU98AdaAMF5jGibiTkcEHirEEe+RPMO6PHRTiqCAkMMAipbed1nQRZHHQjigC+pJAYSb+oCdxV2wE0kaRwsSCQNi9CfpVMgICXQl25zjpXoPwW8Ov4g8RwX2GW005g8jFflduyUAfQnhiyTTvD2n20SbFSFSV9yMn9Sa1KKKACiiigAooooAKKKKACvHvjzo+19O1uOMsFP2eVVXjByQSf0r2Gq2o2VvqNjPZ3kYkt5lKOp7g0AfHNzaRXUzyW67ADjBP3fU+9B0kNZvJBdJJJFL8yHjKf3v/AK1eneM/hhqelyTTaRA2oWbH5Fj/ANYg77h3/CvOLnT47W4lhv8A7RDOI8qijnd6MKAMlB9lnhlidC6OHUFeAQcius8aauniXyLyWyig1MJtnljbCy8feCgcdq597RJIkUtL9qzwCBgj3p7xNbJMmSXTjC88UAYM8X2eUlME4+tQDcd2x9ue5rTubZZHEtuzqrKMq45z3qdIrWLb5oiZQOhzkn0oAiFjYXlg0dk2byJN8jluD7VXtbVfsk0XSYYO4NgV2/h3wBretyD7FpklvaXC586QbYwD79a9U8GfBfT9Nljutem+2zrn9wh/c/jkZNAHhPhXwPrPiW4ePSrOSXgN5kgMcYHrvIwfpXv/AMO/hDp3h2SK/wBYKahqSgFAyfJCe+PX616baW0FnbR29pEkMEYwqIMACpqAEHApaK8r+MPxTs/CVpLp+m3EcmtuMbRz5Ix1Pv04oAqfHP4pReFbF9I0WaKTW51IY5z9nU9yP7x5x6V8hXUzzTyPNIzPIxZnJySTUuqXs19ezXV1IZppWLNIxyzGqh3f3S31oAbnJIZhx7VDc7TGcnPHap25AO0Zx0FVZvutgY4oA674Tf8AIz6V/wBtf/QHoo+E3/Iz6V/21/8AQHooGyt4n/5GXVv+vub/ANDNcpekC/cn1H8hXV+J/wDkZdW/6+5v/QzXJahxfSfh/IUAzRtJjFLHPFlJozuV16g+tdVF4nbUY2j8R20eotJhftrg+dEv+xggfmK4uAkjirKlgRmgR6H4esobTUl1Twvdvc25Bt3tJSPtjI3ysVTGDweKreLfC8uiyi6hWRtMmbEbuPmiY8+VLjpJ14rkrSdoZllt5pI5xnEkbFWH0I5r0Lwd8TbvSLSTTtdsota0ZwWeB1USM/8Af3kE7sZ560AcMRgbW4U/rXtfwb+Lr+HxDpHiCV5dK+7HKRkwe3+7WQ3hbwj40Il8E64mnag6gpod3GzMX7/vS2MH6dq5DxP4P1rw1dG31rTnhYDloSZkx7kcUAfcOn3ltqFnHdWM8dxbSDckkbZBFWa+Ofhb8Tb7wTeeSzPfaIx/eW+7lP8AaXPT6V9Z+Hdd07xFpcOoaTcLPbyjII6j2I7GgDH8VeAtC8SkPe27Q3G7eZ7fCOT7nBzXlXiX4R6vp8N1PpMseoQZGyAAiXH8q+gKKAPjnUdKfTtQeHX7K4t5FXIWNCGz+tY13YYVJG3BSSVHfHvX2zPa29x/x8QRS8Y+dA3864/Vvhj4Y1ETMLIwTSc70kbg+wzigD5TklKbFaOLGw7Tg5p9hdC2uFmt5gJAOo/ka95uPgdG4KR69IsROdptVJ/PNSaf8CdKt5QbrU7i4iJ+ZPKCZ9sg0AeNRJZ307tcxiOZx8nkDC59xUumaLeanObLTdPluJw2fljPT6mvpfTPh74W0yWKW00mJZYvuuzux/U4rqI444/9WiJ/ujFAHgPhj4RapqkEcmty/wBmxq2DCV3SMPqDgV7hoGjWOg6ZFYaZCIoIx+LH1J7n3rRooAKKKKACiiigAooooAKKKKACiiigArP1DRdN1FJFvbG3lMgwzFBu/PrWhRQBwN18KPC8wcx288MjfxLKTj86zm+D2lgnyr6ZQeuU3f1r0+igDzG0+DegKX+2yz3KtxgfJ/U11egeCvD2hW3k2GmQYPVpV8xj+LZro6KAGoqooVAFUDAAGAKdUQniadoRIplXkpnkVLQAUhIAJJAA5JNc14y8b6F4QsmuNYvVDBgohi+eQk9PlHI+tfMfxO+M2s+KfOsdNP8AZ+knKlVHzSjPVieR+FAHp3xd+N9jpEM2leFZlutQcFHukPyweuPU+9fLd/cS3t1LdXc7zXEp3vJIcsxPuahmZyeOM0FXdMkigCuTk8Z496lQbmyQQv8Adz1qe2tZJbhY0DGUkAIoyWPbFd5ofwl8Uamn2jUVt9Bsxz52rN5KEe1AHnLsWbg4A6DPStHRfC2ua/OItJ0+4mDKT5hBWPAGT8x4r01tM+Gngu5V9Qv7zxFrMAJNvbqHsnb03AZx+Nc54u+K2u6nZNp2l+Tomi7Cn2G1+4w9ycn8qAMz4VI0firTEf7ymUHnP8D0Uz4Tf8jPpX/bX/0B6KBsreJ/+Rl1b/r7m/8AQzXI6j/x+Sfh/IV13if/AJGXVv8Ar7m/9DNcjqP/AB+yfh/IUAxLaQ52n8PWrkZ3Dgc+9ZY4PFXbeQMoyfmFAi+oMbKVbk1agDtEwLgD1J61RjbK/T1qeKUqQcAexFAFoKcASFGH1rtvCHj/AMQ+HreKztdQRtNHL2UuNkg7gnqAfauI8xGUbsbvQCpE+Y9BQB61b674A8Q7f+Eh0WTw9chyUm0b595P97cCAPwrY8P+FtR0e+Oq/D7xVo16wO6GyE4NzImeVdRxk+leKplQGLAKDwKsW13Jb3CzWM0trKvR4XKMD9RQB9oeGvGpufLtfFFk2h6m67ljuPljkGcfKx6n2rsuoBHSvj3w78WPE2mLFHdPBq0MZyWvU82QL6BjyK9c8J/GHw7qH2hbqW80O5kw2+7dp4ie4RQTtH4CgD2eis/TtTiv4UntGW4smj3i5RgVPtt61bt5kuIVkiJKN0yCD+RoAlooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAopGZUUs7BVHUk4Aqu1/aiN3WZJAoyViO9vwA5NAFmiuR1TxfOmY9H0DWLyfPWWzkgjH/AnUVwfjf8A4TzV98K6/wCH9HsZRhoDcKHUehbrQB6J4v8AHPh/wnBI2r6jDHOq7ltlYGR/YD/GvB/Hfx31LU0mtfDKf2faugAnY/vge5BHSqE3g/wbp0bv4u8Zsbg9fsJFwM/UBqqwS/CPRC1zHd6nrz9Ps1xA0an8doxQB5dquo3uqXk1xqE73VxK2XkfLMTVjRfDWsa5dLa6Xp01xO/AXG39TXoQ+Leg6U8j+HPAljYXQ/1dwZixX3xisDVvjV461FJI5dXSK3k/5ZxWyLx6bgM0Ablh8EdeS3e58US2mg2SDLTySLLgfRTSrpPwq8O27T32uzeKrhRlYLHMGCPX5sEfjXkt5e3N9K0t1cTSzMclmcn9KhjOwnDEcenWgD1Wf4p2GkWy23gvwxY2UKHcsmpxpcTAn0bk/nXA+JPFev8AiGR/7Y1q9uYnO77O0zGJPYJnAFYowXBHI7imPtw2c5Hb0oAFi2KdjDFVrjeQ27B96nk2hQVYFscbulVZQoQlgM46igDs/hN/yM+lf9tf/QHoo+E3/Iz6V/21/wDQHooGyt4n/wCRl1b/AK+5v/QzXI6j/wAfsn4fyFdd4n/5GXVv+vub/wBDNcjqP/H7J+H8hQDK1KrFWBHakooEaNvJ5kZIGCKtQHnrnisq0lSKZTMrNEfvqpwSPrXUWGhS6iIhok0eoysu5oYwQ8Xs24AUAU4XIbBHPr3qfdlTwcds8UyVHtZmhuIzHMrYYHqKOvO4knv2oAnhLMQzN0PAqYHIO/5c9xVdSVGM4INWC2VGNpJoAkiOGB6KR1HrU4AJG9BVXdjjt3qVGJYBenoTQBpaFq99ol6t7pt08EyH5HRun4dK9U8N/G3ULdrZdf0+31Vom3pcs22WPPXAxivGlc7QGwM9qFkx90e470AfYXhz4n+HtbV1sNRSCXeCRqrrCMdwvqa7tLpHd+GESqH84/cI9Qa+BY7ks43bV+oziuv8L+P/ABPoM6vY6rLLHGu0Q3TGSMr6baAPs+CWOeJZIJEkjboyMCD+IqSvnXSPjnLLZmHX9KNzIGDIdPkMIH1BPP512+n/ABi8O6lY5m1IaHcq2DHcwNMSPqvFAHqdFc3ofjTw/q0aLZa1aXMuOSP3e4+wbFaEmpXG8eTY+bH/AHxcRj+tAGpRWM+q3oZgumAgdCbqMZ/Wnx6pcty9iqgdT9pjP9aANaiud1zxfomkw/6fq1tZykdD+8K/gua4XxF8ZtBsfIhtYpNZHVpoj5K59geaAPWZJY4yokkRCxwoZgMn2pHdldFETsG6sCML9cmvmzVvjh4jmuZDpy2NtAclEeHzGUfXd1/CuC1Xxpr+q3jTXmpXPmt1EchRfyBoA+zRd2zSmJbiFpRxsDjdn0xVabVIrWCWfUY3soEOPMlK4P5E/rXxI2p3zSgm6nU5yMSHP1zXSeHviL4n0Asun6qzx/xLdL5o/U0AfVll4s0G+nSCz1a0mmc4VEfJNW/7QdLiVbmynt7eNSxuZHTy8D6NkfiK+Xf+Fz+N2Q/6dp6K+QCtkAR/49XEaz4l1nVLp31DUrqV25YeaQpP0zigD62vPiH4fsZZ3utd0p4EHypBLvlJ9MdK4rVvjX4WkusJD4kYL/Fa7FQ/+RBXzKZ5HBwFDA9cUPLMcgEbevpQB73rPx+HywaLorTQ9C2osCT9dpNcxe/G3XvJdNP0jRbB26zQRnePpmvJBKwYgn5u2KczMF/eYL0AdXdfEbxrchyfEepIHJwI5MD6Vyt7f3d5KX1Caa5fu0rE1VllYAFRnHvTNrg5LA57GgBZGARQiKCT6VEzkkKQMdKex+QgckHI4qJiJCu7+H0oAjJBdyy8joaYQeFIHTNTM5PyxhSMZJ9KjYnADNnA4xQAnOGBUD0I7VGm4yHHJqQBsHDAemaaoJYBGAcdcUARojsfMVvkHG0DpS8lsj8SRmnrG2MqQB3NOTc0/lq4LngCgCtLgrwAe+MVVmb91hV9zntXQQaDqV1cCIW7W27pLdDyk/76bAqxqXhf7HBJFdTzzXwXKRWUXnI31deBQBb+E3/Iz6V/21/9AeinfClSninTFZSrAyggjkfI9FA2dT4g+HOrza9qUqXFgFe5kYZd84LE/wB2s1vhfqjMS0umMfUs3/xFFFAxv/CrNT/56aX/AN9N/wDEUf8ACrNT/wCeml/99N/8RRRQAf8ACrNT/wCeml/99N/8RVm2+HevWsMsVtfWUMU2BIkc0ih8eoC80UUASDwD4iW0NqupWotic+SJ5Nmf93biq6/DPWFGFudPA9A7/wDxFFFAC/8ACttZ/wCfqw/7+P8A/E0f8K21oEEXVhn/AK6P/wDE0UUAOPw41w/8vlj/AN/X/wDiaT/hW+tf8/dh/wB/H/8AiaKKAF/4Vxrh63lj/wB/X/8AiaQfDjW+15Y/9/X/APiaKKAFHw41sdLyxH/bV/8A4mj/AIVzrn/P5Y/9/X/+JoooAcPh7r4GBf2YH/XaT/4mg/D3X2HzX9mfrNJ/8TRRQAi/DrXVxtvrIY6Ylk/+JqYeBfEwGBqsAHoLiX/4miigBD4D8SHrqlv/AOBEn/xNKPAviVQQNVgAPUC4l/8AiaKKAGN8P/ELZ3ajanPXM8n/AMTTf+Fe6/jH2+zx6edJ/wDE0UUAH/Cvdf8A+f8As/8Av9J/8TR/wrzX/wDn/s/+/wBJ/wDE0UUAIPh3rwORfWQPtNJ/8TS/8K717n/TrPnr++k/+JoooAT/AIV1ruMfbrLH/XWT/wCJpD8OdcPW8sj/ANtX/wDiaKKAD/hXOudPtljj/rq//wATQfhzruMG9ssenmyf/E0UUAN/4VvrQbIu7DPr5j//ABNL/wAK41vOftljk9/Nf/4miigBD8N9aI5u7A/9tH/+JoPw21o9bqwP/bR//iKKKAD/AIVtrX/P1Yf9/H/+JpP+FaayOlzp/wD38f8A+IoooAB8NNYAwLnT8f8AXR//AIij/hWesf8APxp//fb/APxFFFACH4Z6ucA3Gnn/AIG//wARR/wrLVv+e+nf99v/APEUUUAL/wAK01jGPtOn4H/TR/8A4inJ8N9bRgyXdirDoRK4P/oNFFAFy68GeK7uBYbrWo54V6RyXUrKPwK0+18H+LrRdtrriwL0xHdzKP0WiigC94G+H2rWviyzuZrixYAyFsO5JJRufu+pooooEf/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    HRCT shows a paucity of vascular structures in both lower lobes, most evident in the anterior-basal segment of the right lower lobe.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_55_22386=[""].join("\n");
var outline_f21_55_22386=null;
var title_f21_55_22387="Folliculitis";
var content_f21_55_22387=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Folliculitis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/55/22387/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/55/22387/contributors\">",
"     Larry M Baddour, MD, FIDSA",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/55/22387/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/55/22387/contributors\">",
"     Daniel J Sexton, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/55/22387/contributors\">",
"     Sheldon L Kaplan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/55/22387/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/55/22387/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/55/22387/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 16, 2010.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Folliculitis is a superficial bacterial infection of the hair follicles with purulent material in the epidermis. A carbuncle is a coalescence of several inflamed follicles into a single inflammatory mass with purulent drainage from multiple follicles. Both folliculitis and carbuncles involve the epidermis but not the deeper soft tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22387/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A furuncle (or \"boil\") is an infection of the hair follicle in which purulent material extends through the dermis into the subcutaneous tissue, where a small abscess forms. A skin abscess is a collection of pus within the dermis and deeper skin tissues.",
"   </p>",
"   <p>",
"    The epidemiology, clinical manifestations, microbiology and treatment of folliculitis will be reviewed here. Skin abscesses, furuncles and carbuncles are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/51/43831?source=see_link\">",
"     \"Skin abscesses, furuncles, and carbuncles\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Folliculitis is a superficial bacterial infection of the hair follicles with purulent material in the epidermis. The diagnosis of folliculitis is based upon clinical manifestations.",
"   </p>",
"   <p>",
"    Folliculitis manifests as clusters of multiple small, raised, pruritic, erythematous lesions less than 5 mm in diameter (",
"    <a class=\"graphic graphic_picture graphicRef72586 \" href=\"UTD.htm?34/19/35127\">",
"     picture 1",
"    </a>",
"    ). Pustules may be present at the centers of the lesions. Folliculitis is frequently observed in areas of repeated shaving. This finding in the beard region is called \"folliculitis barbae\" or \"sycosis barbae.\"",
"   </p>",
"   <p>",
"    Folliculitis may present with sharply demarcated areas in the setting of P. aeruginosa infection, reflecting exposure to areas of the skin in contact with contaminated water (",
"    <a class=\"graphic graphic_picture graphicRef65119 \" href=\"UTD.htm?33/14/34031\">",
"     picture 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22387/abstract/2\">",
"     2",
"    </a>",
"    ]. P. aeruginosa folliculitis may also manifest with larger lesions, up to 30 mm in diameter [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22387/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Folliculitis should be distinguished from other skin lesions, including:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Pityrosporium folliculitis",
"     </li>",
"     <li>",
"      Superficial actinic folliculitis",
"     </li>",
"     <li>",
"      Folliculitis following application of epilating agents",
"     </li>",
"     <li>",
"      Folliculitis due to exposure to occupational agents (chemicals, oils)",
"     </li>",
"     <li>",
"      Perforating folliculitis (Kyrle's disease)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, clinical manifestations of folliculitis in HIV-infected individuals should prompt consideration of eosinophilic folliculitis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22387/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/50/24359?source=see_link\">",
"     \"HIV-associated eosinophilic folliculitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Folliculitis is usually attributable to S. aureus, and S. aureus nasal carriage is a risk factor for folliculitis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22387/abstract/6\">",
"     6",
"    </a>",
"    ]. Pseudomonas (especially serogroup O:11) is an important pathogen in the setting of inadequately chlorinated hot tubs, whirlpools, and swimming pools [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22387/abstract/2,7\">",
"     2,7",
"    </a>",
"    ]. Aeromonas hydrophila has also caused folliculitis with recreational water exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22387/abstract/8\">",
"     8",
"    </a>",
"    ]. Candida spp may be implicated in the setting of broad-spectrum antibiotic administration, glucocorticoid therapy,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    immunocompromised individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22387/abstract/1\">",
"     1",
"    </a>",
"    ]. Less common pathogens for folliculitis include nontuberculous mycobacteria, Klebsiella oxytoca, and Acinetobacter baumannii [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22387/abstract/9-11\">",
"     9-11",
"    </a>",
"    ]. Folliculitis due to Malassezia species has been described and can be a presentation of immune reconstitution inflammatory syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22387/abstract/12,13\">",
"     12,13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no randomized controlled trials for treatment of folliculitis. Lesions usually resolve spontaneously, with or without drainage. If desired, warm compresses may be applied three times daily. Shaving should be avoided in involved areas. Most cases of hot tub folliculitis are caused by Pseudomonas aeruginosa and are self-limited, requiring no specific therapy apart from avoiding exposure to the source of contaminated water. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/8/43142?source=see_link\">",
"     \"Pseudomonas aeruginosa skin, soft tissue, and bone infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If lesions persist, topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/30/33252?source=see_link\">",
"     mupirocin",
"    </a>",
"    agents may be used in the setting of presumed S. aureus infection, although this agent does not have activity against Pseudomonas [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22387/abstract/14\">",
"     14",
"    </a>",
"    ]. Topical antifungal agents may be used in patients with fungal folliculitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/59/17338?source=see_link\">",
"     \"Prevention and control of methicillin-resistant Staphylococcus aureus in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/58/7082?source=see_link\">",
"     \"Dermatophyte (tinea) infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Systemic antibiotics should not be used routinely for treatment of folliculitis, since it generally resolves on its own.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?22/38/23137?source=see_link\">",
"       \"Patient information: Folliculitis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Folliculitis is a superficial bacterial infection of the hair follicles with purulent material in the epidermis. It manifests as multiple small, raised, pruritic erythematous lesions less than 5 mm in diameter. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Important pathogens include S. aureus, P. aeruginosa, and Candida spp. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Folliculitis typically resolves on its own or with warm saline compresses. If lesions persist, we suggest treatment with topical",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/30/33252?source=see_link\">",
"       mupirocin",
"      </a>",
"      &nbsp;(",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Mupirocin does not have activity against Pseudomonas, however. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22387/abstract/1\">",
"      Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005; 41:1373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22387/abstract/2\">",
"      Ratnam S, Hogan K, March SB, Butler RW. Whirlpool-associated folliculitis caused by Pseudomonas aeruginosa: report of an outbreak and review. J Clin Microbiol 1986; 23:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22387/abstract/3\">",
"      Sladden MJ, Johnston GA. More common skin infections in children. BMJ 2005; 330:1194.",
"     </a>",
"    </li>",
"    <li>",
"     Habif, TP. Bacterial infections. In: Clinical Dermatology: A color guide to diagnosis and therapy, 4th edition, Mosby, New York 2004. p.290.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22387/abstract/5\">",
"      Buchness MR, Lim HW, Hatcher VA, et al. Eosinophilic pustular folliculitis in the acquired immunodeficiency syndrome. Treatment with ultraviolet B phototherapy. N Engl J Med 1988; 318:1183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22387/abstract/6\">",
"      Gira AK, Reisenauer AH, Hammock L, et al. Furunculosis due to Mycobacterium mageritense associated with footbaths at a nail salon. J Clin Microbiol 2004; 42:1813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22387/abstract/7\">",
"      El Baze P, Thyss A, Caldani C, et al. Pseudomonas aeruginosa O-11 folliculitis. Development into ecthyma gangrenosum in immunosuppressed patients. Arch Dermatol 1985; 121:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22387/abstract/8\">",
"      Juli&agrave; Manresa M, Vicente Villa A, Gen&eacute; Giralt A, Gonz&aacute;lez-Ense&ntilde;at MA. Aeromonas hydrophila folliculitis associated with an inflatable swimming pool: mimicking Pseudomonas aeruginosa infection. Pediatr Dermatol 2009; 26:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22387/abstract/9\">",
"      Cascio A, Cannav&ograve; SP, Guarneri C, et al. Klebsiella oxitoca folliculitis mimicking tinea barbae in a diabetic man. Int J Dermatol 2005; 44:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22387/abstract/10\">",
"      Bachmeyer C, Landgraf N, Cordier F, et al. Acinetobacter baumanii folliculitis in a patient with AIDS. Clin Exp Dermatol 2005; 30:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22387/abstract/11\">",
"      Bartralot R, Garc&iacute;a-Patos V, Sitjas D, et al. Clinical patterns of cutaneous nontuberculous mycobacterial infections. Br J Dermatol 2005; 152:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22387/abstract/12\">",
"      Akaza N, Akamatsu H, Sasaki Y, et al. Malassezia folliculitis is caused by cutaneous resident Malassezia species. Med Mycol 2009; 47:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22387/abstract/13\">",
"      Moreno-Couti&ntilde;o G, Espinosa E, Garcia-Romero MT, Reyes-Ter&aacute;n G. Novel presentation of immune reconstitution inflammatory syndrome: folliculitis secondary to Malassezia spp. Mycoses 2011; 54:e252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22387/abstract/14\">",
"      Bork K, Brauers J, Kresken M. Efficacy and safety of 2% mupirocin ointment in the treatment of primary and secondary skin infections--an open multicentre trial. Br J Clin Pract 1989; 43:284.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7648 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-61.234.146.186-B09A38F648-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_55_22387=[""].join("\n");
var outline_f21_55_22387=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H6\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/7648\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/7648|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/19/35127\" title=\"picture 1\">",
"      Staphylococcal folliculitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/14/34031\" title=\"picture 2\">",
"      Hot tub folliculitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/58/7082?source=related_link\">",
"      Dermatophyte (tinea) infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/50/24359?source=related_link\">",
"      HIV-associated eosinophilic folliculitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?22/38/23137?source=related_link\">",
"      Patient information: Folliculitis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/59/17338?source=related_link\">",
"      Prevention and control of methicillin-resistant Staphylococcus aureus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/8/43142?source=related_link\">",
"      Pseudomonas aeruginosa skin, soft tissue, and bone infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/51/43831?source=related_link\">",
"      Skin abscesses, furuncles, and carbuncles",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_55_22388="Mecasermin (recombinant human insulin-like growth factor I): Drug information";
var content_f21_55_22388=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Mecasermin (recombinant human insulin-like growth factor I): Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?12/26/12708?source=see_link\">",
"    see \"Mecasermin (recombinant human insulin-like growth factor I): Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F1618073\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Increlex&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F1621714\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Growth Hormone",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F1618327\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?12/26/12708?source=see_link\">",
"      see \"Mecasermin (recombinant human insulin-like growth factor I): Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;\">",
"     <b>",
"      Primary insulin-like growth factor-1 deficiency (IGFD):",
"     </b>",
"     SubQ: Children &ge;2 years: Initial: 0.04-0.08 mg/kg twice daily; if tolerated for 7 days, may increase by 0.04 mg/kg/dose (maximum dose: 0.12 mg/kg given twice daily). Must be administered within 20 minutes of a meal or snack; omit dose if patient is unable to eat. Reduce dose if hypoglycemia occurs despite adequate food intake; dose should not be increased to make up for &ge;1 omitted dose.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F16317822\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling (has not been studied).",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F16317823\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling (has not been studied).",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F1618332\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution [rDNA origin]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Increlex&reg;: 10 mg/mL (4 mL) [contains benzyl alcohol]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F1618075\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1618329\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     For SubQ injection only; do not administer I.V. Omit dose and do not make up for omitted dose if patient is unable to eat. To avoid lipohypertrophy, rotate injection site(upper arm, thigh, buttock, abdomen). Must be administered within 20 minutes of a meal or snack. May cause hypoglycemic effects; patients should avoid high-risk activities within 2-3 hours of dosing until a tolerated dose is established.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1618076\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of growth failure in children with severe primary insulin-like growth factor-1 deficiency (IGF-1 deficiency; primary IGFD), or with growth hormone (GH) gene deletions who have developed neutralizing antibodies to GH",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F1618311\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &ge;5%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cardiovascular: Cardiac murmur",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Central nervous system: Dizziness, headache, seizure",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Endocrine &amp; metabolic: Hypoglycemia (42%), hyperglycemia, iron-deficiency anemia, ovarian cysts, thymus hypertrophy, thyromegaly",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Gastrointestinal: Vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Hepatic: Liver enzymes increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Local: Injection site reactions: Bruising, erythema, hair growth, lipohypertrophy",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Neuromuscular &amp; skeletal: Arthralgia, bone pain, extremity pain, muscular atrophy",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Ocular: Papilledema",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Otic: Ear pain, hypoacusis, middle ear fluid, otitis media, serous otitis media, tympanometry abnormal",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Renal: Hematuria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Respiratory: Tonsillar hypertrophy (15%), snoring",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Miscellaneous: Lymphadenopathy",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &lt;5% (Limited to important or life-threatening): Alopecia, anaphylaxis, cardiomegaly, hypercholesterolemia, hypersensitivity, hypertriglyceridemia, hypoglycemic seizure, intracranial hypertension, obstructive sleep apnea, valvulopathy",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1618080\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to mecasermin or any component of the formulation; patients with closed epiphyses; active or suspected neoplasia; intravenous use",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1618081\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypersensitivity reactions: Hypersensitivity reactions (localized skin reactions to anaphylaxis) have been reported. If hypersensitivity is suspected; discontinue and instruct patient to seek immediate medical attention.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypoglycemia: May cause hypoglycemic effects, especially in small children (due to inconsistent oral intake); patients should avoid high-risk activities until a tolerated dose is established. Do not administer on days a patient cannot or will not eat. Should be administered with a meal or a snack.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Intracranial hypertension (IH): With headache, nausea, papilledema, visual changes, and/or vomiting has been reported with growth hormone product; funduscopic examinations are recommended.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Lymphoid hypertrophy: Has been reported and may lead to complications such as snoring, sleep apnea, and chronic middle-ear effusions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Progression of scoliosis: May occur in children experiencing rapid growth.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Slipped capital femoral epiphyses: Patients with growth hormone deficiency may develop slipped capital femoral epiphyses more frequently; evaluate any child with new onset of a limp or with complaints of hip or knee pain.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Diabetes: Use with caution in patients with diabetes or with risk factors for glucose intolerance; may decrease insulin sensitivity.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Benzyl alcohol: Products may contain benzyl alcohol which may cause \"gasping\" syndrome in neonates.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: Correct thyroid or nutritional deficiencies prior to therapy. Not intended for use in patients with secondary forms of IGF-1 deficiency (GH deficiency, malnutrition, hypothyroidism, chronic anti-inflammatory steroid therapy).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299652\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6221491\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F1618077\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F1618078\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects were not observed in animal studies",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F1618079\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/ use caution",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F1618328\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Must be administered within 20 minutes of a meal or snack.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16322875\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Increlex Subcutaneous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     40 mg/4 mL (4 mL): $1597.56",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1618331\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Preprandial glucose during treatment initiation and dose adjustment; hypersensitivity reactions; facial features; lymphoid tissue; funduscopic examination; growth; new onset of a limp or complaints of hip or knee pain; progression of scoliosis. Monitor small children closely due to potentially erratic food intake.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Target treatment IGF-1 level: 0 to +2 SD score for age",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Decrease dose for adverse events and/or IGF-1 levels &ge;3 SD above normal",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F1618320\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Severe primary IGFD is defined as follows:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Height standard deviation score &le; -3.0",
"     <b>",
"      and",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Basal IGF-1 standard deviation score &le; -3.0",
"     <b>",
"      and",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Growth hormone: Normal or increased",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F12992803\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Increlex (BE, CZ, DE, DK, EE, FR, GB, GR, IE, IL, IT, NL, NO, PL, PT, SE, TW)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1618318\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Mecasermin is an insulin-like growth factor (IGF-1) produced using recombinant DNA technology to replace endogenous IGF-1. Endogenous IGF-1 circulates predominately bound to insulin-like growth factor-binding protein-3 (IGFBP-3) and a growth hormone-dependent acid-labile subunit (ALS). Acting at receptors in the liver and other tissues, endogenous growth hormone (GH) stimulates the synthesis and secretion of IGF-1. In patients with primary severe IGF-1 deficiency, growth hormone receptors in the liver are unresponsive to GH, leading to reduced endogenous IGF-I concentrations and decreased growth (skeletal, cell, and organ). Endogenous IGF-1 also suppresses liver glucose production, stimulates peripheral glucose utilization and has an inhibitory effect on insulin secretion.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1618321\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : Severe primary IGFD: 0.184-0.33 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protein binding: &gt;80% bound to IGFBP-3 and an acid-labile subunit (IGFBP-3 reduced with severe primary IGFD)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metabolism: Hepatic and renal",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Half-life elimination: Severe primary IGFD: Mecasermin: 5.8 hours; Mecasermin rinfabate: &gt;12 hours",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Backeljauw PF, Underwood LE, and GHIS Collaborative Group, \"Therapy for 6.5-7.5 Years With Recombinant Insulin-Like Growth Factor I in Children With Growth Hormone Insensitivity Syndrome: A Clinical Research Center Study Syndrome,\"",
"      <i>",
"       J Clin Endocrinol Metab",
"      </i>",
"      , 2001,  86(4):1504-10.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/55/22388/abstract-text/11297575/pubmed\" id=\"11297575\" target=\"_blank\">",
"        11297575",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Metz KA, Assa'ad A, Lierl MB, et al, &ldquo;Allergic Reaction To Mecasermin,&rdquo;",
"      <i>",
"       Ann Allergy Asthma Immunol",
"      </i>",
"      , 2009, 103(1):82-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/55/22388/abstract-text/19663134/pubmed\" id=\"19663134\" target=\"_blank\">",
"        19663134",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Torjusen E, Calderon J, and Rivkees SA, &ldquo;Anaphylactic Reaction to Recombinant Insulin-Like Growth Factor-I,&rdquo;",
"      <i>",
"       J Pediatr Endocrinol Metab",
"      </i>",
"      , 2008, 21(4):381-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/55/22388/abstract-text/18556970/pubmed\" id=\"18556970\" target=\"_blank\">",
"        18556970",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9464 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.248-D4C8FA2A70-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_55_22388=[""].join("\n");
var outline_f21_55_22388=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1618073\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1621714\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1618327\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16317822\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16317823\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1618332\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1618075\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1618329\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1618076\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1618311\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1618080\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1618081\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299652\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6221491\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1618077\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1618078\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1618079\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1618328\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16322875\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1618331\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1618320\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12992803\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1618318\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1618321\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9464\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9464|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?12/26/12708?source=related_link\">",
"      Mecasermin (recombinant human insulin-like growth factor I): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_55_22389="Pregabalin: Patient drug information";
var content_f21_55_22389=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Pregabalin: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/31/16887?source=see_link\">",
"     see \"Pregabalin: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F949926\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Lyrica&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F949927\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      GD-Pregabalin;",
"     </li>",
"     <li>",
"      Lyrica&reg;;",
"     </li>",
"     <li>",
"      PMS-Pregabalin;",
"     </li>",
"     <li>",
"      RAN&trade;-Pregabalin;",
"     </li>",
"     <li>",
"      Riva-Pregabalin;",
"     </li>",
"     <li>",
"      Teva-Pregabalin",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10016952\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10016954\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691482",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop or control seizures.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat painful nerve diseases.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691845",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat fibromyalgia.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10016953\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702789",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to pregabalin or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10016958\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not run out of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697179",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have been taking this drug for many weeks, talk with your doctor before stopping. You may want to slowly stop this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696966",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow laws about driving with a seizure problem.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697022",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a man and have sex, protect your partner from pregnancy. Use birth control that you can trust.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10016959\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697935",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in balance.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698392",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698249",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Muscle pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698329",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shakiness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698036",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Emotional ups and downs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698328",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Unsafe allergic effects may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10016961\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699075",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low mood (depression), thoughts of killing yourself, nervousness, emotional ups and downs, thinking that is not normal, anxiety, or lack of interest in life.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698663",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Flu-like signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699094",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling in your legs or belly.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699087",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699038",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad muscle pain or weakness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad muscle pain, back pain, soreness, or weakness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10016956\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take as you have been told, even if you feel well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10016957\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10016962\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10016963\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11441 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-201.211.0.116-8A6BBE0C4A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_55_22389=[""].join("\n");
var outline_f21_55_22389=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F949926\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F949927\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016952\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016954\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016953\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016958\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016959\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016961\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016956\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016957\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016962\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016963\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?16/31/16887?source=related_link\">",
"      Pregabalin: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_55_22390="Ethinyl estradiol, drospirenone, and levomefolate: Patient drug information";
var content_f21_55_22390=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Ethinyl estradiol, drospirenone, and levomefolate: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/41/35481?source=see_link\">",
"     see \"Ethinyl estradiol, drospirenone, and levomefolate: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F10968127\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Beyaz&trade;;",
"     </li>",
"     <li>",
"      Safyral&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10884644\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700856",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not smoke while taking birth control pills. Cigarette smoking raises the chance of very bad heart and blood-related side effects. This chance is higher with age (older than 35 years of age) and with heavy smoking (15 or more cigarettes per day). Birth control pills do not stop the spread of diseases caused by having sex.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10884646\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691546",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop pregnancy.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692029",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat mood problems caused by monthly periods.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691693",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat pimples (acne).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2913419",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Levomefolate is a vitamin used to aid the diet needs of women who may get pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691832",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat endometriosis.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691613",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease painful period (menstrual) cycles.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10884645\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2913399",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to ethinyl estradiol, drospirenone, levomefolate, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3424312",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Blood clots, breast cancer, high blood sugar with blood vessel disease, diseased arteries in the brain, disease of a heart valve with problems, endometrial cancer, heart disease, high blood pressure, kidney failure, liver disease, liver tumor, poor adrenal function, very bad headache, tumor where estrogen makes it grow, or  vaginal bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3415739",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have migraine headaches and are older than 35 years of age.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703789",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have surgery and need bed rest.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701021",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a heavy smoker (more than 15 cigarettes per day) and older than 35 years of age.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703795",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have not started your period.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703881",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you turned yellow during pregnancy or with estrogen-based or hormone contraceptive use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10884650\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697169",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any blood flow problems, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697221",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have gallbladder disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697265",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood pressure, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697308",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have migraine headaches, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698416",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure and heart rate checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698528",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking a blood thinner, have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698554",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do monthly breast self-exams and have a gynecologic exam every year.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have an eye exam every year.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696901",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take St John's wort, dong quai, black cohosh, saw palmetto, red clover, or ginseng with this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid cigarette smoking. People older than 35 years of age and/or smoking more than 15 cigarettes per day have more chance for heart disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Limit your drinking of wine, beer, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697712",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To protect from diseases caused by having sex, use a latex condom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10884651\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698392",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698236",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Mood changes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698231",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Period (menstrual) changes. These include lots of bleeding, spotting, or bleeding between cycles.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697923",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Enlarged breasts.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698386",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Vaginal yeast infection. Report itching or discharge.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Gallbladder disease, blood clots, heart attacks, and other blood vessel problems may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10884653\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698619",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in strength on 1 side is greater than the other, trouble speaking or thinking, change in balance, or blurred eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699095",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling, warmth, or pain in the leg or arm.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698615",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in how contact lenses feel in the eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698598",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A lump in the breast or breast soreness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you get pregnant while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10884648\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694870",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow how to use as you have been told by your doctor or read the package insert.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698535",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you miss 2 periods in a row, take a pregnancy test before starting a new dosing cycle.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10884649\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696559",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696550",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Missed dosing facts may be found in the package insert or call your doctor to find out what to do.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10884654\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10884655\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16081 Version 23.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-61.234.146.186-043A92644E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_55_22390=[""].join("\n");
var outline_f21_55_22390=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10968127\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10884644\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10884646\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10884645\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10884650\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10884651\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10884653\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10884648\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10884649\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10884654\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10884655\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?34/41/35481?source=related_link\">",
"      Ethinyl estradiol, drospirenone, and levomefolate: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_55_22391="Laboratory and radiologic evaluation of nutritional status in children";
var content_f21_55_22391=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Laboratory and radiologic evaluation of nutritional status in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/55/22391/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/55/22391/contributors\">",
"     Sarah M Phillips, MS, RD, LD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/55/22391/contributors\">",
"     Craig Jensen, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/55/22391/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/55/22391/contributors\">",
"     Kathleen J Motil, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/55/22391/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/55/22391/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/55/22391/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 24, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goal of nutritional assessment in childhood is to prevent nutritional disorders and the increased morbidity and mortality that accompany them. To meet this goal, pediatric clinicians must know the risk factors for obesity and malnutrition and must understand the normal and abnormal patterns of growth and the changes in body composition that occur during childhood and adolescence. In addition, they must be able to accurately perform and interpret the results of the nutritional evaluation.",
"   </p>",
"   <p>",
"    Nutritional assessment is the quantitative evaluation of nutritional status. A comprehensive nutritional assessment has four components:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Dietary, medical, and medication history",
"     </li>",
"     <li>",
"      Physical examination",
"     </li>",
"     <li>",
"      Growth, anthropometric, and body composition measurements",
"     </li>",
"     <li>",
"      Laboratory and radiologic tests",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The laboratory and radiologic evaluation of nutritional disorders are reviewed here. The dietary history, clinical features of nutritional disorders, and measurements of growth and body composition are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/61/28631?source=see_link\">",
"     \"Dietary history and recommended dietary intake in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/40/36487?source=see_link\">",
"     \"Indications for nutritional assessment in childhood\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/14/31976?source=see_link\">",
"     \"Measurement of growth in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/38/6760?source=see_link\">",
"     \"Measurement of body composition in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     LABORATORY EVALUATION OF UNDERNUTRITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory tests are useful in the evaluation of children who are at risk for nutritional disorders for several reasons. They can:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Identify nutritional deficiencies before clinical findings are evident (eg, iron deficiency)",
"     </li>",
"     <li>",
"      Confirm the presence of nutrient deficiencies that commonly are associated with specific disease entities (eg, fat-soluble vitamins in children with cystic fibrosis)",
"     </li>",
"     <li>",
"      Monitor recovery from malnutrition that occurs as a complication of illness",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The laboratory evaluation of the child with or at risk for malnutrition is directed by the history and physical examination. The most valuable studies in the assessment of nutritional status in children are the hemoglobin concentration and red cell indices (mean corpuscular volume, mean corpuscular hemoglobin) and serum albumin or prealbumin (transthyretin) concentration. In addition, assessing the presence or absence of vitamin deficiency in patients at risk for malnutrition often is important. Potassium, phosphorus, and magnesium concentration, serum prealbumin and albumin concentration should be monitored during refeeding of malnourished children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Hemoglobin and red blood cell indices",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hemoglobin concentration and red blood cell indices can be used to identify children with nutritional deficiencies of iron, folate, or vitamin B12 or with anemia of chronic disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/45/35543?source=see_link\">",
"     \"Mean corpuscular volume\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Iron deficiency anemia, associated with hypochromic, microcytic red cell morphology, is the most common nutritional deficiency in children (",
"    <a class=\"graphic graphic_picture graphicRef64267 \" href=\"UTD.htm?21/45/22232\">",
"     picture 1",
"    </a>",
"    ). Plasma ferritin is the most sensitive measure of the adequacy of body iron status (",
"    <a class=\"graphic graphic_figure graphicRef66419 \" href=\"UTD.htm?13/52/14159\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef76236 \" href=\"UTD.htm?32/58/33708\">",
"     table 1",
"    </a>",
"    ). However, ferritin is an acute-phase reactant and may be elevated during infectious or inflammatory illnesses. Additional tests that are useful in the evaluation of microcytic anemia include serum iron, total iron-binding capacity, and transferrin. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/18/22826?source=see_link\">",
"     \"Iron deficiency in infants and young children: Screening, prevention, clinical manifestations, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/14/4329?source=see_link\">",
"     \"Iron requirements and iron deficiency in adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/18/22826?source=see_link&amp;anchor=H16#H16\">",
"     \"Iron deficiency in infants and young children: Screening, prevention, clinical manifestations, and diagnosis\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A macrocytic anemia suggests the presence of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/31/22005?source=see_link\">",
"     folic acid",
"    </a>",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    vitamin B12 deficiency (",
"    <a class=\"graphic graphic_picture graphicRef58820 \" href=\"UTD.htm?4/47/4854\">",
"     picture 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/0/5130?source=see_link\">",
"     \"Diagnosis and treatment of vitamin B12 and folate deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Children with chronic illness can have anemia on the basis of the above nutritional deficiencies or from their chronic disease. The anemia of chronic disease typically is normochromic, normocytic, and hypoproliferative. The laboratory hallmarks include a low serum iron, low iron binding capacity, and a normal to increased serum ferritin concentration (",
"    <a class=\"graphic graphic_table graphicRef65701 \" href=\"UTD.htm?43/41/44699\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9434?source=see_link\">",
"     \"Anemia of chronic disease (anemia of chronic inflammation)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Prealbumin and albumin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum prealbumin (transthyretin) and albumin are surrogate markers of the adequacy of short- and long-term dietary protein intake, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22391/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. In critical illness, these markers are negatively influenced by the acute phase response (due to increases in vascular permeability and reprioritization of hepatic protein synthesis), so they do not accurately reflect nutrition status in children with inflammatory processes and disease.",
"   </p>",
"   <p>",
"    Prealbumin is a tetrameric unglycosylated plasma protein that is synthesized in the liver. Hepatic synthesis is exquisitely sensitive to the adequacy and levels of protein and energy intake. It is turned over rapidly with a half-life of approximately two days [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22391/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. A normal range for serum prealbumin in most laboratories is approximately 20 to 40",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    with borderline levels between 16 and 20",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    and low levels &lt;16",
"    <span class=\"nowrap\">",
"     mg/dL.",
"    </span>",
"    The threshold defining low levels is 13",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    in children, and 4",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    in neonates [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22391/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Serum prealbumin concentrations fall rapidly with poor dietary intake and rise to low-normal values within 10 days of initiation of nutritional therapy and adequate refeeding. Thus, prealbumin is a good predictor of the protein and energy adequacy of the diet and can serve as a marker of acute malnutrition. It is a more sensitive marker of mild malnutrition than are anthropometric measurements [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22391/abstract/2\">",
"     2",
"    </a>",
"    ]. However, it is a negative acute-phase reactant, and concentrations fall in the presence of infection [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22391/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Albumin also is synthesized in the liver but has a half-life of 14 to 20 days and is reflective of dietary intake during the preceding three weeks. Serum albumin concentration gradually returns to normal after initiation of nutritional therapy, but this may take up to three weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22391/abstract/7\">",
"     7",
"    </a>",
"    ]. Serum albumin is not a good nutritional marker in the setting of disorders causing large protein losses from the circulation, such as ascites, protein losing enteropathy, renal losses, liver disease, or extensive burns and inflammation. Serum albumin, which reflects intravascular oncotic pressure, may predict enteral feeding tolerance. Higher protein and energy intake from enteral nutrition can be provided when serum albumin levels are greater than 30",
"    <span class=\"nowrap\">",
"     g/L",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22391/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Serum albumin and prealbumin concentrations are inversely correlated with morbidity and mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22391/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. In one study of malnourished children, the mortality rate approximated 40 percent when serum albumin levels were below 15",
"    <span class=\"nowrap\">",
"     g/L",
"    </span>",
"    but averaged only 10 percent when serum albumin levels were 27",
"    <span class=\"nowrap\">",
"     g/L",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22391/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Cellular immunity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The effects of nutritional disorders on cellular immunity can be estimated through the measurement of total lymphocyte count (TLC) and cutaneous delayed-type hypersensitivity testing [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22391/abstract/12\">",
"     12",
"    </a>",
"    ]. Compromise of cell-mediated immunity is suggested by TLC less than",
"    <span class=\"nowrap\">",
"     1000/mm3.",
"    </span>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/58/43945?source=see_link\">",
"     \"Laboratory evaluation of the immune system\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cutaneous delayed-type hypersensitivity testing is done with a series of common antigens (eg, candida, trychophyton, tuberculin, diphtheria) and a glycerine control and is read 48 to 72 hours after placement. Compromise of cell-mediated immunity is suggested by induration that is less than 5 mm or less than the induration surrounding the control plus 5 mm. Delayed-type hypersensitivity testing is least useful during an acute illness because cell-mediated immunity may be depressed in this setting, even in the absence of malnutrition.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Vitamins",
"    </span>",
"    &nbsp;&mdash;&nbsp;The assessment for specific vitamin deficiencies may be necessary in children who have illnesses that are associated with gastrointestinal malabsorption or inflammation. The nutritional management of the following specific diseases is discussed in separate topic reviews:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Inflammatory bowel disease (Crohn&rsquo;s disease and ulcerative colitis) (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/46/2794?source=see_link\">",
"       \"Growth failure and poor weight gain in children with inflammatory bowel disease\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/6/43113?source=see_link\">",
"       \"Nutrient deficiencies in inflammatory bowel disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cystic fibrosis (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/24/15754?source=see_link\">",
"       \"Cystic fibrosis: Nutritional issues\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/26/29095?source=see_link\">",
"       \"Cystic fibrosis: Assessment and management of pancreatic insufficiency\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Short bowel syndrome (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/9/26778?source=see_link&amp;anchor=H9#H9\">",
"       \"Management of the short bowel syndrome in children\", section on 'Enteral feeding'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/45/29400?source=see_link&amp;anchor=H12#H12\">",
"       \"Chronic complications of the short bowel syndrome in children\", section on 'Nutrient deficiencies'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The laboratory assessment of fat-soluble vitamins usually is more readily available than is that of water-soluble vitamins. Fat-soluble vitamin concentration should be monitored in children with malabsorptive disorders, liver disease, inflammatory bowel disease, and failure to thrive. Fat-soluble vitamin concentrations generally should be monitored at six-month to yearly intervals in these children, depending on the history and severity of malabsorptive disease [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22391/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. Serum concentrations of vitamins A, E, and 25-hydroxyvitamin D can be measured directly. Prothrombin time is used as a proxy to measure vitamin K. Supplementation with individual fat-soluble vitamins is indicated if the serum concentrations are low or the prothrombin time is prolonged.",
"   </p>",
"   <p>",
"    Deficiency of water-soluble vitamins is less common, and levels should be measured only when clinically indicated. Serum folate and vitamin B12 levels can be readily measured [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22391/abstract/15\">",
"     15",
"    </a>",
"    ]. Measurement of the other water-soluble vitamins is more problematic [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22391/abstract/16-20\">",
"     16-20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/4/38983?source=see_link\">",
"     \"Micronutrient deficiencies associated with malnutrition in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/62/28650?source=see_link\">",
"     \"Overview of water-soluble vitamins\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Minerals",
"    </span>",
"    &nbsp;&mdash;&nbsp;The assessment for specific mineral deficiencies also may be necessary in children with certain types of chronic illness.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Children with chronic inflammatory diseases (eg, Crohn disease and juvenile idiopathic arthritis) are at risk for metabolic bone disease and zinc deficiency. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/46/2794?source=see_link&amp;anchor=H17#H17\">",
"       \"Growth failure and poor weight gain in children with inflammatory bowel disease\", section on 'Bone disease'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/54/30569?source=see_link\">",
"       \"Metabolic bone disease in inflammatory bowel disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The assessment of zinc status usually is made by measurement of plasma zinc concentrations, but they can fluctuate rapidly during infection [",
"      <a class=\"abstract\" href=\"UTD.htm?21/55/22391/abstract/21,22\">",
"       21,22",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/3/29753?source=see_link\">",
"       \"Zinc deficiency and supplementation in children and adolescents\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Plasma copper levels and ceruloplasmin levels are reduced in severe copper deficiency; levels of erythrocyte superoxide dismutase may be a better marker of mild or marginal deficiency if the laboratory assay is carefully standardized [",
"      <a class=\"abstract\" href=\"UTD.htm?21/55/22391/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Others",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypokalemia and hypophosphatemia caused by intracellular ion shifts may occur during the early refeeding period in malnourished children and can produce serious arrhythmias and muscle weakness. Serum potassium and phosphorous concentrations should be carefully monitored early in the course of aggressive rehabilitation of malnourished children and in those with anorexia nervosa [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22391/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/57/32659?source=see_link\">",
"     \"Signs and symptoms of hypophosphatemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other laboratory abnormalities that can be seen in patients with malnutrition include [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22391/abstract/25-28\">",
"     25-28",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Low concentrations of serum sodium (caused by increased total body water associated with starvation)",
"     </li>",
"     <li>",
"      Low concentrations of blood urea nitrogen reflecting poor protein intake",
"     </li>",
"     <li>",
"      Low concentrations of zinc or magnesium in children with chronic diarrhea",
"     </li>",
"     <li>",
"      Low concentrations of trace minerals in children receiving parenteral nutrition without trace minerals",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Nitrogen balance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nitrogen balance is defined as the difference between nitrogen intake and excretion, which occurs primarily in urine and feces. Direct measurements of nitrogen balance have been used to calculate protein requirements in health and disease, but the technique requires complete collection of urine and feces and exact measurement of protein intake for three days [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22391/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. Thus, this technique is not usually practical for clinical use. In addition, inaccuracies in the measurement of dietary intake and lack of accounting for dermal and other sources of nitrogen loss lead to falsely positive estimates of nitrogen balance, which has occurred even in carefully executed research protocols.",
"   </p>",
"   <p>",
"    Measurement of nitrogen excretion in the urine only has been termed \"partial nitrogen balance,\" and has been suggested as an index of total nitrogen balance [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22391/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. However, this technique is inaccurate because it relies on the false assumption that urea nitrogen is a fixed proportion of total nitrogen excretion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     RADIOLOGIC EVALUATION OF MALNUTRITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies of bone age and bone density are useful in the evaluation of children with malnutrition. Bone age may be indicated in children with short stature or delayed or advanced sexual maturation. X-rays of the child's wrist and hand are obtained to determine differences in bone formation for the child's chronological age compared with reference standards for children of comparable age and gender [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22391/abstract/31\">",
"     31",
"    </a>",
"    ]. Bone density studies may be indicated in children who are at risk for osteopenia (eg, adolescents with anorexia nervosa or inflammatory bowel disease). Bone density is assessed radiographically with scans of the whole body, spine, or hip to determine total body bone mineral content or areal density of the selected sites. These values are compared with reference standards for children of comparable ages and gender, and expressed as z-scores. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/37/42583?source=see_link\">",
"     \"Overview of dual-energy x-ray absorptiometry\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     LABORATORY EVALUATION OF OBESITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory studies in children with obesity can help to identify possible endocrine causes of the weight gain (eg, hypothyroidism, Cushing's syndrome) or complications of the obesity (eg, insulin resistance, hypercholesterolemia, polycystic ovary syndrome, or fatty liver disease). Depending upon the clinical scenario, laboratory tests to consider in obese children include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Thyroid function tests",
"     </li>",
"     <li>",
"      Serum or urinary cortisol",
"     </li>",
"     <li>",
"      Serum total cholesterol, LDL-cholesterol, HDL-cholesterol, and triglyceride levels",
"     </li>",
"     <li>",
"      Fasting serum glucose, insulin, HbA1C, and a glucose tolerance test",
"     </li>",
"     <li>",
"      Serum testosterone, estradiol, LH, and FSH",
"     </li>",
"     <li>",
"      Serum liver panel including AST, ALT, alkaline phosphatase, gamma-glutamyl transferase, and bilirubin levels",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The etiology and evaluation of obesity in children and adolescents are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/5/32858?source=see_link\">",
"     \"Definition; epidemiology; and etiology of obesity in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/11/8378?source=see_link\">",
"     \"Clinical evaluation of the obese child and adolescent\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30774603\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The laboratory evaluation of the child with or at risk for malnutrition is directed by the history and physical examination. The extent of the evaluation and selection of specific tests depends on the degree of the nutritional problem and on the underlying disease, if any. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/61/28631?source=see_link\">",
"       \"Dietary history and recommended dietary intake in children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/40/36487?source=see_link\">",
"       \"Indications for nutritional assessment in childhood\"",
"      </a>",
"      .) &nbsp; &nbsp;",
"     </li>",
"     <li>",
"      The hemoglobin concentration and red cell indices (mean corpuscular volume, mean corpuscular hemoglobin) are used to identify children with nutritional deficiencies of iron, folate, or vitamin B12 or with anemia of chronic disease. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Hemoglobin and red blood cell indices'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"     <li>",
"      Serum prealbumin (transthyretin) and albumin are good indicators of the adequacy of short- and long-term dietary intake, respectively. These hepatic markers, however, are negative acute phase reactants and will not adequately reflect nutritional status in children with inflammation or infection. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Prealbumin and albumin'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      During the refeeding of malnourished children, potassium, phosphorus, and magnesium concentration, serum prealbumin and albumin concentration should be monitored. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Minerals'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children with illnesses associated with gastrointestinal malabsorption or inflammation are at risk for a variety of vitamin deficiencies. The assessment for specific vitamin deficiencies may be necessary in children who have illnesses that are associated with gastrointestinal malabsorption or inflammation. In most of these patients, fat-soluble vitamin concentrations should be monitored at six-month to yearly intervals. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Vitamins'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/24/15754?source=see_link\">",
"       \"Cystic fibrosis: Nutritional issues\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/6/43113?source=see_link\">",
"       \"Nutrient deficiencies in inflammatory bowel disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Radiographic measurement of bone age is helpful in assessing a child with short stature and delayed or advanced sexual maturation. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Radiologic evaluation of malnutrition'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/18/10537?source=see_link\">",
"       \"Causes of short stature\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In children with obesity, laboratory studies are sometimes indicated to identify possible endocrine causes of the weight gain such as hypothyroidism or Cushing's syndrome, or complications of the obesity such as insulin resistance, hypercholesterolemia, polycystic ovary syndrome, or fatty liver disease. These considerations are discussed in a separate topic review. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Laboratory evaluation of obesity'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/11/8378?source=see_link\">",
"       \"Clinical evaluation of the obese child and adolescent\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22391/abstract/1\">",
"      Potter MA, Luxton G. Prealbumin measurement as a screening tool for protein calorie malnutrition in emergency hospital admissions: a pilot study. Clin Invest Med 1999; 22:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22391/abstract/2\">",
"      Elhasid R, Laor A, Lischinsky S, et al. Nutritional status of children with solid tumors. Cancer 1999; 86:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22391/abstract/3\">",
"      Measurement of visceral protein status in assessing protein and energy malnutrition: standard of care. Prealbumin in Nutritional Care Consensus Group. Nutrition 1995; 11:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22391/abstract/4\">",
"      Ingenbleek Y, Young V. Transthyretin (prealbumin) in health and disease: nutritional implications. Annu Rev Nutr 1994; 14:495.",
"     </a>",
"    </li>",
"    <li>",
"     Choukair M. Blood chemistries/body fluids. In: The Harriet Lane Handbook, 15th, Siberry GK , Ianonne R (Eds), Mosby Inc, St. Louis 2000. p.125.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22391/abstract/6\">",
"      Malav&eacute; I, Vethencourt MA, Pirela M, Cordero R. Serum levels of thyroxine-binding prealbumin, C-reactive protein and interleukin-6 in protein-energy undernourished children and normal controls without or with associated clinical infections. J Trop Pediatr 1998; 44:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22391/abstract/7\">",
"      Helms RA, Dickerson RN, Ebbert ML, et al. Retinol-binding protein and prealbumin: useful measures of protein repletion in critically ill, malnourished infants. J Pediatr Gastroenterol Nutr 1986; 5:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22391/abstract/8\">",
"      Ford EG, Jennings LM, Andrassy RJ. Serum albumin (oncotic pressure) correlates with enteral feeding tolerance in the pediatric surgical patient. J Pediatr Surg 1987; 22:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22391/abstract/9\">",
"      Fuhrman MP, Charney P, Mueller CM. Hepatic proteins and nutrition assessment. J Am Diet Assoc 2004; 104:1258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22391/abstract/10\">",
"      Seres DS. Surrogate nutrition markers, malnutrition, and adequacy of nutrition support. Nutr Clin Pract 2005; 20:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22391/abstract/11\">",
"      Waterlow JC. Protein-energy malnutrition: Challenges and controversies. Proc Nutr Soc India 1991; 37:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22391/abstract/12\">",
"      Zaman K, Baqui AH, Yunus M, et al. Malnutrition, cell-mediated immune deficiency and acute upper respiratory infections in rural Bangladeshi children. Acta Paediatr 1997; 86:923.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22391/abstract/13\">",
"      Grey V, Lands L, Pall H, Drury D. Monitoring of 25-OH vitamin D levels in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 2000; 30:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22391/abstract/14\">",
"      Pappa HM, Gordon CM, Saslowsky TM, et al. Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics 2006; 118:1950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22391/abstract/15\">",
"      van der Dijs FP, Schnog JJ, Brouwer DA, et al. Elevated homocysteine levels indicate suboptimal folate status in pediatric sickle cell patients. Am J Hematol 1998; 59:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22391/abstract/16\">",
"      Bailey AL, Finglas PM, Wright AJ, Southon S. Thiamin intake, erythrocyte transketolase (EC 2.2.1.1) activity and total erythrocyte thiamin in adolescents. Br J Nutr 1994; 72:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22391/abstract/17\">",
"      Bates CJ, Evans PH, Allison G, et al. Biochemical indices and neuromuscular function tests in rural Gambian schoolchildren given a riboflavin, or multivitamin plus iron, supplement. Br J Nutr 1994; 72:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22391/abstract/18\">",
"      Seear M, Lockitch G, Jacobson B, et al. Thiamine, riboflavin, and pyridoxine deficiencies in a population of critically ill children. J Pediatr 1992; 121:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22391/abstract/19\">",
"      S&aacute;nchez DJ, Murphy MM, Bosch-Sabater J, Fern&aacute;ndez-Ballart J. Enzymic evaluation of thiamin, riboflavin and pyridoxine status of parturient mothers and their newborn infants in a Mediterranean area of Spain. Eur J Clin Nutr 1999; 53:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22391/abstract/20\">",
"      Vel&aacute;zquez A, Ter&aacute;n M, B&aacute;ez A, et al. Biotin supplementation affects lymphocyte carboxylases and plasma biotin in severe protein-energy malnutrition. Am J Clin Nutr 1995; 61:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22391/abstract/21\">",
"      Kili&ccedil; I, Ozalp I, Co��kun T, et al. The effect of zinc-supplemented bread consumption on school children with asymptomatic zinc deficiency. J Pediatr Gastroenterol Nutr 1998; 26:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22391/abstract/22\">",
"      Brown KH. Effect of infections on plasma zinc concentration and implications for zinc status assessment in low-income countries. Am J Clin Nutr 1998; 68:425S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22391/abstract/23\">",
"      Milne DB. Copper intake and assessment of copper status. Am J Clin Nutr 1998; 67:1041S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22391/abstract/24\">",
"      Boerkoel CF, Nowaczyk MJ, Blaser SI, et al. Schimke immunoosseous dysplasia complicated by moyamoya phenomenon. Am J Med Genet 1998; 78:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22391/abstract/25\">",
"      Singla PN, Chand P, Kumar A, Kachhawaha JS. Serum magnesium levels in protein-energy malnutrition. J Trop Pediatr 1998; 44:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22391/abstract/26\">",
"      Van Wouwe JP. Clinical and laboratory assessment of zinc deficiency in Dutch children. A review. Biol Trace Elem Res 1995; 49:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22391/abstract/27\">",
"      Ashour MN, Salem SI, El-Gadban HM, et al. Antioxidant status in children with protein-energy malnutrition (PEM) living in Cairo, Egypt. Eur J Clin Nutr 1999; 53:669.",
"     </a>",
"    </li>",
"    <li>",
"     Committee on Nutrition American Academy of Pediatrics. Assessment of nutritional status. In: Pediatric Nutrition Handbook, 6th ed, Kleinman RE (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2009. p.559.",
"    </li>",
"    <li>",
"     Food and Nutrition Board of the Institute of Medicine. National Academies Press, Washington DC, 2005; p 611 www.nap.edu (Accessed on February 23, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22391/abstract/30\">",
"      Pencharz PB. Assessment of protein nutritional status in children. Pediatr Blood Cancer 2008; 50:445.",
"     </a>",
"    </li>",
"    <li>",
"     Greulich WW, Pyle SI. Radiographic atlas of skeletal Development of the Hand and Wrist, 2nd, Stanford University Press, Stanford 1959.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5359 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-200.61.31.66-186E1AD1F7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_55_22391=[""].join("\n");
var outline_f21_55_22391=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H30774603\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      LABORATORY EVALUATION OF UNDERNUTRITION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Hemoglobin and red blood cell indices",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Prealbumin and albumin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Cellular immunity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Vitamins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Minerals",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Others",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Nitrogen balance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      RADIOLOGIC EVALUATION OF MALNUTRITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      LABORATORY EVALUATION OF OBESITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30774603\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5359\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5359|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?13/52/14159\" title=\"figure 1\">",
"      Iron deficiency testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5359|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?21/45/22232\" title=\"picture 1\">",
"      Microcytic hypochromic anemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/47/4854\" title=\"picture 2\">",
"      Megaloblastic smear",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5359|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?32/58/33708\" title=\"table 1\">",
"      Lab tests in iron deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?43/41/44699\" title=\"table 2\">",
"      Laboratory differential dx IDA",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9434?source=related_link\">",
"      Anemia of chronic disease (anemia of chronic inflammation)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/18/10537?source=related_link\">",
"      Causes of short stature",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/45/29400?source=related_link\">",
"      Chronic complications of the short bowel syndrome in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/11/8378?source=related_link\">",
"      Clinical evaluation of the obese child and adolescent",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/26/29095?source=related_link\">",
"      Cystic fibrosis: Assessment and management of pancreatic insufficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/24/15754?source=related_link\">",
"      Cystic fibrosis: Nutritional issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/5/32858?source=related_link\">",
"      Definition; epidemiology; and etiology of obesity in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/0/5130?source=related_link\">",
"      Diagnosis and treatment of vitamin B12 and folate deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/61/28631?source=related_link\">",
"      Dietary history and recommended dietary intake in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/46/2794?source=related_link\">",
"      Growth failure and poor weight gain in children with inflammatory bowel disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/40/36487?source=related_link\">",
"      Indications for nutritional assessment in childhood",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/18/22826?source=related_link\">",
"      Iron deficiency in infants and young children: Screening, prevention, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/14/4329?source=related_link\">",
"      Iron requirements and iron deficiency in adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/58/43945?source=related_link\">",
"      Laboratory evaluation of the immune system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/9/26778?source=related_link\">",
"      Management of the short bowel syndrome in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/45/35543?source=related_link\">",
"      Mean corpuscular volume",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/38/6760?source=related_link\">",
"      Measurement of body composition in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/14/31976?source=related_link\">",
"      Measurement of growth in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/54/30569?source=related_link\">",
"      Metabolic bone disease in inflammatory bowel disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/4/38983?source=related_link\">",
"      Micronutrient deficiencies associated with malnutrition in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/6/43113?source=related_link\">",
"      Nutrient deficiencies in inflammatory bowel disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/37/42583?source=related_link\">",
"      Overview of dual-energy x-ray absorptiometry",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/62/28650?source=related_link\">",
"      Overview of water-soluble vitamins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/57/32659?source=related_link\">",
"      Signs and symptoms of hypophosphatemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/3/29753?source=related_link\">",
"      Zinc deficiency and supplementation in children and adolescents",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_55_22392="Diffuse astrocytoma";
var content_f21_55_22392=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F58446&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F58446&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 523px\">",
"   <div class=\"ttl\">",
"    Diffuse astrocytoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 503px; height: 376px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Histological features include the prominent eosinophilic cytoplasm in some astrocytic tumor cells (gemistocytes) as well as the fibrillary background.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Dr. David Louis.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_55_22392=[""].join("\n");
var outline_f21_55_22392=null;
var title_f21_55_22393="RPGN Light High II";
var content_f21_55_22393=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F76472&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F76472&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Light micrograph showing crescentic glomerulonephritis II",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 259px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High-power light micrograph showing an active hypercellular crescent containing fibrin, which has a bright red appearance (long arrow). Note that the severe inflammatory injury has led to fragmentation of the glomerular tuft (short arrow) and to creation of a rent in the capsule (double arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal glomerulus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 253px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAD9AYwDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD1C+8maG3hV8yzNhyOB+NLDYGK4hS0AVm+8c9ua6DU7Ow1LSWu4mWMKCwcetYmnC9uEVoI2YgbRIRjOfSqjO8dD0ozb20OTkvLiLWrm1mJxuIAzU0zxWYaScgAjDZq7q2lPHqCtcoElxuLbuSK4nxsl6+qp5UhW1jT7o/iz61304xqNJM6MRVjGClE6J5rbU4GuLOXdd22CoHcDt71p6dcxwweYwzDcElWPRWxyK53wLZPPfLtzFCeWJ6E46fpW74g019KDNbyCW3lJJi7fh6VM1Hm9ncuhU9vBQn8iadDdho5jiNlzjPWsS+0do3WSEDJJwPQVr6e0MTxLeFmjdf3TE4yP7prnfFOtyQXslrAQhAGST7/AMqdJS5uVBKtLCleYvDJ5U+RjpzVjTojez/u8lf7xPSqOmvLrenzs+GaGXy1b1GBXU+H7EwWkhXkjBPHb0rWcuReZ3fXIzoqa3NKLMUeFO1uAMnmuV1xS/iCzhZgVL54rqpR5ZwzdBkg9RXNaJbnV/FpkiXdFE3J6+3WsaWl5eRlhXZub6I9i8M2i2unpgZ8z5qo/EvQW8ReEbyxTG/AlQHuVOcV0drCIoI0H8KhRzVbXLlLPSLy5kOFjiJ/SvHjUarKcd7nhS/eSfmfNvgfRnsI72Rk2mUiMn2Bz+HP8q760tVkjBn5K9CRWTb+a7NE21Uxkknpntn1qO91grEIY2Kx9B7gV70+apK59Dh8M401Th0Na6uLW3gkkUebMowinoD0ya5uTWpQqI4AZVxlRjJ9T61Rvr7ZDGzKczE7VB+Zqg+yCC2e51aOdZG/494V5L+pNXGmludUnRwseaqJrN/MmnTSpvZQdvHTJ6Cs/QNKvNa1AW9plyhxMx6IT2zXTR2baloCafc25xLKskSoNpLA+tdx4anh8KWgt30prbJDO453kdyfxpVK3JBqKuzzKuLxFaanQ0j08zJg+FBiRZZ5jx2Fb1v8KdLe0Ilkk88jG8Hoa7PTtf0/UFVIrhVc/wAJ61orJGzhEcEeleRUxmI6uxyVcdinpJtHzR4l+FPijT7uQaUourfqGVsHGe+aseHfh/41lUyybbWPHyhm5PPfmvpUAEkg5Pr6UbQV2nqPSr/tSo42aVzGnjK9N3U389T5w1fQ/F+hWjzzQmdFbHyDccDvXMweMNRhk33FjONvRmiI5H4V9aPGrqoYAgeo61Tm0ixlzvtYSPdBzVwzKO043OiWaVn0X3HzXofi681a+FvDCWuGOQMYNWdb8I6jqkzz3WnT5chmw5+YivdrrStF06+guRaW0Uu7aGwBj6CtopE67lCEEDBxVyzBRacI2uEsa5wSqU0z5w0fSYdBlXbp8sPmDBfburTn8RWi7khuZWQjDBjkE969o8R6DFq2kXNomIpZEIV1HKnHX9a8Om+Ht3bXZghgkkC8E45IzW9DEU66bm7MFj4Q+Gn9wlrrWlT7Ujk+dDncBVHxRof9vvHPZ3wMW0R+UBg8d67zwB8MorH7ZcalH/rkCLE3OBUniH4b/ZLSS70W4MUsYLeWTwe9V9apRqcsZG0cRRxUVGto/wADi9A02LRbPynfLjBY+vbFdfp9wsqmIM4Y89f8+v61xpv5UVoNShdJM/ex3Fa2n3a5RkbJ/vg1dSLlqzuqYa0LRWx0wnuPMYI4RRxhTwKsWchkiG7crSjuO1cze37BHOAshbnB+U1oaQ0/2UzzccfL6dun8655U7RueZJOMuVo6q2VIlYgZYcAg+nNc94w1e5so5PsEixytydw681V8YeMH8O2lvDYReZdTL5hdhkYrnbbW77VHtm1yCOWK4k2MqrtK5HB/WlSoS+OS0OKpVTfKty54C1nUh4ktk1GZJbS6PlkE9Seh5ruPGmmLbOk1uSM/Mw7daztO8O6Zp9y0/mkzRMJIhnOCBwKL3xEtzeQ2c0RkRzvZj2A6VM5c9VSprQKfNB+8U7q5by1nOQUGAMc1jxx6jdyM3mlcjjd0Wuh1mCEIHDBiMnH+faqtru+zb0/ixtGOQK0g1bQ9Wjy8nNYW20S18kvezPcP2DHgfhVHW5ILaJAoCpjjHp3qS+u0tI0SWYo+eQvPFc5dLdatOqLG0dsTgFvvNVwi27t6HRRhrzyegyBbjVrgiJmSBeDg9a17LSLRlkadXZl4VvepLO2ESRW8ZCryOnJIqa+uFsrK5k2cKN4XtnFVKTbtEivinq46IqSae0eNruuPX/PrUtrqsmmT/Zr0iSNuME5OK4y317UZb21kDq6u2XHUcdhXS6xp73kqSA4z+anFVKFrKZy08b7XRq6L88SWd6r2xzZTkEHspNbrS6HaHy76eUzdTg1zmiESxz6dcnJB+QmsjUY7gXTrMu9hxuJ6gVk6fO7NmuJozn8Gr/Ndz0y+vx/ZsFjZKWtlG6ZiMZwfuiuptdWsFt4VjYRhhhQRjpWPpC20pX7YM7Y/MUL0Ap+nWtlqFyzIhECOVQH9a82fK1Z9Dz6kY7M5/xP59zdFmk3DG0EDPGeBWZLcwXwEVxGpMaY5HUiu71XR1W3m2sqRbc/N656V5lqltOt1JJEm2IHAK9xXZh5Kasuh1YZQqx5DSEsdrC77dkajp0qCbxHb6pbR20iuityjHgg8c4qmsq39g1vJIIpOeScbqrWOkJbXC+Y2/BDKmf0rdQild7iqRqU6iUVsdJYyQ3EMelanEFmBIjlXo3cfjXnnjDQ7q01mS7ljknjC+XnPB9Ca72/tWubcYwkw+dCD0Yc1NeX1te+FtS1C4C/6Pbu8in+FkUk0qdX2T5unU1qRjVh7+35eZieCdOhtNFkiuWCTzM0gAOdp7D8q6KydrdWXGd3Bz0xXyrpvi+TXNN07Q9TvjZp5mby9klI8yJeVUHsx6E+wPc17vbatearpqHTZYrmzb5RPG4dWxxjIqf4zbTFhqMKqtTemm/+Rp+IdVCL9ntjuuHOAF/Ku7+Gvhk6XYi4uf8Aj5k+Y57Vyngnw6i6hFdXzb3Vg2evP1r1bUdV0/RbYz6hcxW8K8Zc4rnxdSyVKn1FjaqpR9jT+bL4IXcM8Hoa8++Jms+ZCunwsCm8NMR6D+H86pa78QheOsfh9SYf4p2GN30FcVJcyzXHmXYPl5LEt/E3NLC4SUXzzFgsDJtVJ/Ih1G8aCFVj5yfmya5zUbzMYyxV8EcVPq1ws6Lh8EE7hn34rO0qwuNc1eGxtdpkk42166Sirs+khy04c0tEjW8C2z6p4gg81DMhRggPbtmverbwdpx+ySXKebLGmPm6VS8MeArHRJorxmZ7tV+ig49K7AShY8kHgV4+LxXtJfunofJYvEyxEm29P6sed3dqo8exwRAIilQu0dOM1vasvmTSQXSqyg5xjr71538WPFtv4O1u31WRTNcMQLe0T7879gPbkZP/ANYHmfAXiO/utVvvEHii9ml1fUyE+zo5W2s4RyqIueo7t/8AXLXyTnyuPY0lJc0Irt9x2es6c2nkXNo5C5JBHQH/AArkItd1y1v47y3vJJQ0oWSPPA/DtXq1+LebSJGWVDE0ef8ADFeQ3mtroltfQJbxyTzMDE/cfX8q68PL2kWmrs2qxlXp3vbl/I9Un8aSWcKh4t8rYCrnnJ56UQ+K9XKqxs2GRyNnWvIvAXidZPFsA1VknAySwzhOK+j9IW1e0Royknqw5zXLiacMPo43MnOjGCko81+pyUXxAEUoXULVoge4BH8617/xdaQWccyDMbgFSSOa1tZ0fT7+zljvIIyhBO4jkV4DpMzm7lhld5LSCUqr5yAM8Gs6FGjXTaVrGmHoUcVdpWsdTf6teavK08+4xhjsXpxWl4e1+4srm3gu5Ga3ZwOe1WbDTYbpVZG8yNhxt61j+L1gsDbR2uWn3ghAck4710+5P93Y6/3c/wB0keuLcRCBpjKqp3YnAArz/UviEy3k6abYmS2jcp9ok6MfYVmaPZ3niHS0u7y+kWGQEiJOMYJ4NS63ZwxaSkFtDiMHGc9f8e9c1PDU4y5Zas46WFpRnyzd2bdh4z+2AQrHiVjgN2H1rpLC1LhmuZfMDDOCcjmvH4ruLTo95BMzHCAfqa7bwnrFzcQMTG+yNtpJ+hqq+GUI3hoZ4mnCEnCkbeu+G7G/UExKpPAyOTXD6h8OjJAZ9JnMcw48snj/AD/9en+LfiGIpfItgY3ViAGHXFdX4d1/TbyCDfdwx3BUZhLjrilH6xQgpEUsTVoq0X8jyK7hv9NmMWpQNvX+NOnpVzTdXnjXy0KTW+MkE816z4g06HVFXao2MCGfHbtXhvi61n0/U5XskljcHIRVJzz2xXbQqxxCs1qd8cfSqR/fRsdVdLp+vwRJLIYLiFSqE9vY0aZpkseoW0urTrLHAQUEa4DdgDXH2WrTowh1C0kidxgO0ZA+vtVjXrvUrC0im0uV5YXJLKo3FfTitPZSXupnPXwdGzrReh6dqEtvPdbrcHYoyeO5zWFNoUYvxOk5IU4AHp6VyHw/8Ra9qmuGwlsy6PH80zRldldlcPdxNm4JtzG2Gbbj8q53TlSly3MIUo1tYvQdrEqmVUj/ANa20BV9MVBe3v8AZNiqDDO3RF78/wBKqi+s7V3Z1d3X5vTP41Aqte3Rup9pweEU5Ce1Uo6Wex6UaappKey/ESw06W8la5vsbwCwU9BzU1xdGH5oSFwcrx3FTPIVR1J/dg5UZzism7+afcVwGGBjuapLmeo4N1Z3lsSx3uCpbqCST7+tSLNDeW8ltcDCyDBwcGqUds7TCIjk9D14qS6tzbHOf4tvvmraRpOjTl7rIrHwza2NzHJ9oaUK25I26Z/yK3VU5G1hu6DPesOKZxMjMxO08ZPSta2mLhS5wVJPFTPmerZyPCqivdK+sW5iEc8J2zoeTimySvKEeZPMYqPmwOf1qXXJytkoBdguPlPXJ6n+VCpmKLd12CiPw3Z1Un7iua8msQ6dqaQhz5ZwsjDp/wDqrs4NQ02y0hZoZYZJs9Izkk5rzDUE0uK9e03u1wWwMDIq74buRo2p7Lu3DrKoHzAZXNc1SgpK6/4c5q2GjOKavf8AM7W6vptYMSTRNb20mCrE/eqpfW/kzpFEEl3HKAfwjPJPtWjrLpLbWrooEKEYKjhQOgp2jo0UcsoRWcggD+6v/wCuueMuWN0cMW0ro5PVvC15LepJEYokdsbR0WsTWNGu9LjNwzCSMHaXU8d69C1nVFWJVCBQuMjPOcda5DWNaZrNrRSSpJbkDqa66NSpK1z08LVrTaTWhBo98JEEb8MPWuJ+Kl42j+GNdkgLLFd2hiYDuXYJ/Jj+FdVo28yPK2OwPHT6Vb1iQQ3OnzrkSLMFAI7HrWjWriupU4rnlTXVHiHgH4Tm2SLWfG0RS08sSxWAJDk9vN/ujGDtHPPOMEH1238UWqwfY4rJbaGFQqmMAIFHAAHt7Vva3NA9qLORS7OSXycYGeAPyrBXwylzdwzedmMoUMQHAzRRhTjH3jgVGdC0qa0/Myrrxlq9vP8AZ9OAjRidrFMn6j8aLHS7rxKiXPiJp8l/uMeCB04rpNQGlaXfxWgMKXDp8oxyB61oxzpLbuIxwuD0xzWjmkk4K3mbxptvmm7+Rmiwt7FQIz+7QYCDoMVha/J5kkgRgkYHT0Pc10N7dJBC7uyrJ/CP89q5LTNPv/FOom2sYwecM7dFHenDT3pHq4eKgnUnsjC02wutSuxb2kZclvvdB+Jr2z4b+AX8O/8AEyuJVk1B+Bt+6gNZ1n4TlttmmabNDb26MPtV65+dzjlVH1r0q3u7PS9PSITiQRr1LbmNceLxLkuSHU8jMce8S+Sn8K/EmvdStLC0jl1CZIInlSEMxwDI7BFX6lmArmviL4603wJo32q7DXV7cHyrGxh5lupT0VR1xkjJxxkdSQD4L+1p4+juv7I8OaQ7xGKT7fcsp2kN0jHH1Zv++ah+DPjPT/FHi641nxQ17qHjJx5VqTalrazh6YiC52E85ZgOvXlifPVF7M8hay5Tu/DXw41bW5p/FXjV47jxHcpiG2BzFYREZESDpuwTk+565Jbkb/w1NaXMtuD+4LZAY4KV7zpN0nlNG0hL+nWuF+IenSySvNaQlvM6+v8A9avTwdWUJOHQ9KhQhUfsqnyZnwXSWfhyK3SYySJHh887Rj1rlD4avNbha8bMSsSY3Y4zVqz0bUDKkM7BIXx5iqc4HvXeeMdcs7bw9aW9ohSVVCeWOQpHBrp5nTklDW56UoRhH2NON7nkMfhu80oW0cogjIkEgZeZHyMYJr1rwr4X1b7IsiXEsTMAwIkOBmq/gDw5HrN2b/UsuiqNmTzng8V7FahY4FQAKQMVy43GNe6tzhrzhg06NL5nmmu+HfFS2Y261JLFj505Bx9a5aNBo0DWEsKrHKwDNjJ4/wD117pLJkZI4HevLfiCba5LvAAQxxuXpkcZFZ4Wu5+5JF4Gu6suSS+4zbS+a1iYWpcDAPB7Vq2kll4f8P3Gv6sPNu5N0cKNzn/PNc74LhfULyOGbdt6MO+Aefp0rR+K2nDU9X07RdKYrII8yoRlUXoM/lXRNJ1FTfz9EXjJP+HT3ZU+GWotqJ1AurQaezl40XjBPYfWuh8VCe0s088qp+8q/wAWO2fetPwzYWWk2NlYiNP3AyzqMbm9T+Ncz8QtXtB4hiW4f90qZKqc5YDoKyUvaV7xWhnTm/aXlsl+RzWraJqhnjcRTG3lRWjlQZKHvXoGhwy6T4OvJ7hw02zLfU1f8Ga/bahpDWrRSGa2ABQryQehqr4tQt4cvlZCiyLtVSeh9f50p1ZVGqclazOOHv1HLuzzjW/B+t3tm+riDfbiNmVFPzY7H8K86gZkt7ea3klS7gYBl3fMWya+iJ/iRp1lpsUb27O6RLuA6AdK4DwxpularqM+tyQnyjctIkAHykZ4rtoYiai/axsuhNSjKq5WVnE9t06QHQbVgPmaFGwevIGf51zGu6vZadfyG4tfMdUC7eOPc03xJ4idJEtLABHRAWOPu5xgflWDo+lXmuawz3LkoOWYjP8AnrXmUqKinOeiN6GGSXtKuiLd3rvhvVrdIbyMWzMSuW9fwrldQ0LUdLgur22hmaBeUHqPp+Ncl8RdMudE12+tM5DodrHsCNwI9692+Gmpf2/8PdKluR5k3kiOUOO44/liuqq/q1NVIaxZk8RKjNqlseUaN4xCTm1l3Ws5xkjjg+tdVKF/s7ElwZd+dvfHpV74j+AotQ0yW602PbcINwVeDx71xHgTVWVJ7PUIneS0PCOcbiKtOFWHtKfzR0Yesqzs17y/EZLbPcxSnPzBsZ+napNFjms7lI3jfyyhBzxnjrV7wtH9vhMtxhUaZ3bJHr0rf1AxNF5joPIjGwKeDxzmqnUs+VmuJV6130MC5m5KoucAAk/pToIJTCssowByvHWpPDtpJf3TvEm6IHcR7V0msoi2XkLCd5AK8cAVMpqL5UdPNGk1BHISSHzQyKxx0PpUM0rXBQO2D0yegrdtlRAXeJht4YH6Hp+lYswi+1SJG+5SSQcVcZJs2hPndmi/DpsVxEI1kCyKMlj0Off0qjBMiTrCsis2edrA1la1dSx2kcSyOivKBIRk8Dvn0qj4Ts7sagn2xMsGbcVPAQ4wa0UPdbbOGriXTq+ykro6rVGGyJFYMxOAAtW4Y444wlyh3rx8uOlU4YlvLl3YEQq21RnkmqGqeIbC2vpYJL6MyRna2X5yOKys2uVG8moRUW7CaSy3OqJNIql5JMjPYdK7HVbTdHLLgbl+ZWHr6Cud8QfZba5ECo8dzE2Y3AxwB/jWpY3pn04SS7j8uCep69ambbtNCxV5xVSGi2KWlajdhpUuJneFmDHcTjI6Aelb9xrv2eCJwxVs4Ow8n1+lY+sRKlhD5BGB94AY5rLs4JLqQKSfLB5J6UckZ+8Rh8ND2V5HaSyJf30cT/KXyxLfyzXI66h/ti6VU2YfAXNdFC0kEiTtuMedqt/e9RVS4sUu9a3M5jjc8tjJGBnP9Kim+R67WFhqipyb6EGn3VnpsYtp5M3J7Hp9c1Ut0Gpa3vkm/wBFgYMO+TxWB4iiuodRdTG7xkEIQnbOAc+1V5ri9sNAWaFHk3TsGCKc49K6VS6p6s56WJb9pOXQ7/W44jcecBtwAAwPA+lN0o72dS5CxpuUZ+92xUPgWO4fw7qk2tfNEIysIYfdb09ar6Q8gtpBncBhdoxmsbbx7HThqntqOnQ5uLTtXuviOt+9ttslUhnk6MmMcV2f2mPTYrgzRDeY8IPr0pst/DZWYeViZSmPpXD6trNxql4UhIWMfePbHTmtLOq7taI2wmEet9nqMvJ21PUYLdCSWcbiDwR3rvNOv/7Nga20eJI0UcyH+I9+a5rw94WvrkefDDNsbjzSuCw9s9q6uWx+wQBJQ6kLnDDpmio4t8p0YidOo1BO9uhDZwXepTENOMN8wI4xzSXWnX+mMZpmkSMk4ZwdpxVDRdSksvEVsEXzI/NVe3zZPSvYNe8i50K9Fwu1BEzYIxjANc9Wq6U1G2jOHEVXRmo20Z8tax8MV1XxJNruszvqf26Qu0EeY1hX+AZBy3AAyMfSvoX4eQabp+gx6dp1ha2McYy6Qxqm4+px1PvXA6Qs2q2tnaCSWC12fvJVHOAec1oXNtbWjO+hXd0ZoTjaW3F/WlVoxkuTZ/1uczwMVNq+/wDWp6LDDbQzu0cSgE84/pWL40v4baAlthBBHvk1P4IvP7bsZPMYq0LDIA5/OvJ/ilqd3a+NxpbSk2oQSRl+ARj2rGhRc63I3qjOCjTqtVXaxrah4lsLTToEUh7gj5sKAB7fjXGapfz3dyry48oKMBe3P869G8N6LoOv6RBcxxATL8rcg5P0rI8d+GZLV7RI4wkcpKqxGMHriu6lUgp8nU9bDV6F+WO77nffDy7iutL/AHQjV0IVhnnoOa0fFmsx6baqonAlJ6K3Irw63tfEGlypHatKPPPybCQTk9K66LwWyWc15rGpbrqONpZI95LA4+7/AErnnhoKpzyloznr4SlGrzyno+hYv/H8l5/osLeUnCknq341TRptUmS0s4hJJIcgdce9cJZR/aGRovmwWbaT2FejeEdP1lbea9stsSopHK5Le2fyronThRj7uh11KVPDQvCy9S/aRjwjaSkRiXVCBGnOQSx7/jXVeHvDcK6eby8mNzqN4BLNcE85I4A9APSuKtorq+1R1uizTbxgMMc9a6S3vrq2t2gSVkAHIBGVNcdeMmvdevU82vSk17stWJfXdpp09xbSTF5YsFccDn1rxbWJrm71qea62sAzKjNwoJ/+sa9STw/earNLLbqzIcYkb/PNIngiQ3MRk8sRBiW3jOG244/IVvRqU6N7vUyxNo0vZwd27XJvhfYT29zKZCJYgn3hwOcfnVz4g65b6fZS2w8tvM4IJ+6TXSXElr4c0ldvB2hF/wBtsV83+Lb/AFLXtd1FnyHhm+4CB9MDv0rPD0/rVV1HojlpNUl7Sa0WxDq4FyzQTStEApxh8YGc8+1dJ8O9Xt9MuEgdxLb+YGUZ4rznxBBJc3MN2inyjGFbHO1sYwa6PwNB5OtWfmKWDspMYPTC8V6lWC9m0z1KFVYipK0LJrVnrnil0tr+e8tSHWUK7AYwhxTfBXj2wRHgvswuT8rlePxxXKeOXbw9Mwa9/d3KEbRyVB5x/OuF0i7S+b93FLEu/Ypk78Z6dq44YaNWlaQqbo1Kap1XZvbueweP7Kw1ryrosksrL1HO0ds1l/CbXJdI1e80q8UraykPH/s9q6D4e6FDcaZ9ovCZVY7V6gemK5T4m3SS6nJ4Z8BRmXXoVM2oXq8xadDjnce8h7L+Nc8qsFF4eWpz1XSg/ZPU9vt7q2u2lFtcQzGF/LlWNw2xsA7Wx0OCDg+teZfE3w/Bp0kGsWcCp++AnKjqp/ya2/hXpWl+GPAMH2JSqNuuby7mb5ppD96V2P069ABWib/SvHXg2a50S6F3Yz71jlCMAzISpwCAeoP1rhozdGp5bM5KE3QrJvoeO/2wuhW9zEArt9pCwq/A+YZz9KX+3724ma31OGNBK5gWSJsgP6Gsl7NtTaOEgG6Rti7hwWTsfqKt6boGoswlvBGkEMxmEa5JJ+vTivdcKe73O3GKrDErl2dj1LwKILfwvdsdv2hW57nGOBU1yS1izIA8uMY64NUPBU8C+cNzMxAyuB7V0ZaziV/tDbd5BAxyR6ivJqXjUbJr3jVl5nFjbBLKoZWZhlVPb2rm5wqTHy2y2eR15rrNWtbeRZmto3CAHGew7ZNcr9knQ7greo9a7aLurnoUNuZsgKeYcsFZQc4PNbEDwxRyMqKuU+YoOtRWdshyRuLgE5NQatLM/kWFmubq6baoxzz3q5PmdhVUqs0gi1C2tNGluJHXdHnYmep968jlk1GKeUW0SzIzlt525yea+m9H8A6ZBpYj1GJZ5mj2sSOBnuK8o1jw1Y6Vq97ZH5hFKQp9sDFVhcTTlKSiefiIrGz5afQt6uZLllk53rx83Gfet7QowLABlDMBnr0rltTM92AkG523YZF64rQ8AWV1dzSNdI8EfKADgk9uDSqJKne+x2YysouNGxtyRyXk80MOAu0kA+1WbG3WIRgjchUBh+gP4VftraKCeRMqX2kFlOaIoma0ZQyou7bnrt9DXM5dDnc2o8qOck8Taepe3jaSWCN2jZwOA4OOO/FbsMoIR1l5C8Nt6/jXmE9v9gS5sVtZ/tjnAZl+V/8AaHFekabFLBpFvE2CEUDdzwe4+tb1qcYW5TjoVZTbUgv1/ds7goxGFbHFc/4RuxDDM0i+YkFwWBHO/Jpdf1IqTawFjJIPug5xWjpNkmn6SkUqASNmRm7ihRtDXqezSp8tJ83Usaje3V6ZTuKQKcqmcY/xqrpb+QjHO04zkjtSzSo4VA2Yiu5j1rn/ABPr2WawskLTBedvr6VUI391G0YLl5UtCp4gkm1KeR0ci2jbYAo5c+wqPTLOC3vtLkvEcW0siMRu4YZ5Bqloeg6lq+r21taPJFPJHuDPkLGa7+f4S6zcC1jmvoAIGLiRBznjt+Fa1J06S5JSseTUzSc5qMVaB7UkcTQR+SqiPA2hQABXn3xSxZxRPGw+dSpHHH+eabNo3ie0VfJuZ2IAGVlzmuO8UNfibyNVMzkAAbh615mFw6jU5lJM0wmGUanMppnLWet+Rq9vIqM3lPuxjJJr0XxB4/t9T8PyWlrmK4lGxz6V51BoEPnfaILhwUY444Un0ov9OezjiZmcrJnJI4J9jXp1KVOck+qPQjCNaS9uveT0sem+AkgkspbaS5iVJU2IcYPHPBrfh0C106cXdvMjxjq5ORmvGdMh1DULlrO1lbEY5Cn+WK2tPurnTbb7NqVw6QAkhd3H4+9c1WhJybUvkZ18LJyclK1+h23hKT+zPGF3bw/Pb3BBBX061R+MvhqHW2ttTWOeNrTKSTIBkr3H/wBetD4bWdtNJLqUlwGk+7Gu4HA9au+LtfXyr3T4SjloTtJGQzHNc/M44i8N1ucFZKddJK+1yl8HrDT4NKc21x50wcj58EqM8f8A660/iwsTeH1LMBPGd6D6V5Z4Au5NG3XjSsqDDPk4GQ1WvFHjBtVlfcRNEmFG0/pWrw03iPabo6FgXTxKUHojT1DUPLk0xEgbdCu4nPX0wfzq94jltrnTL640+d1vWhCqmeP9r8TzV290v+3/AA5ZaxpKLGFi2+Wf4iOPwrkLXVzb3CM6ApuYPH02kHkVpBKesd0bQ5ai93eJz+jQ2lxcWSKHADATb+MHPP4V9JaV9hgsIYrRo/KAHC968EnsFuNeu5LSR7bSpyGkfbuCZH3c/wCeldppGma/4dvI7qNBf2wQ87iQwPORUYyCqpa28iMxj7bl1t5F/wAWs2l6hHqJTZG7YPHf/wDVVu5e3uo0v1b9zKqkqnG49/pWF458Uw67pcdkttNaBJN1xLMhCxgdvcmsODxTZ2kIikSQWpCqJUyfmBOcj8qiFGcoJtar8jl5lGMVUdn+h6ZH4gt7e1jVLfYqgAoCOPpSWviiykmaFuJnb5FPfgd64WxvRe2zXL4KLng9/en6DDHqmvwCHYqICxJ7Y6VEsLBJtmksHTSbl0O18YaW2paPwWMsZDjB4FcDpfgrSvFVq7sjjVbdwDMr7fLI6H36V6lEVZ9rElh1wcKBXKaPex+HfHF9ZXS+VbartkhkYYHmDIK+2R+tZUas4wahutTjjJypOna/VGM3wvubbR5rS1uIDGW80hwSxfuS1ecahp954f1RfPjMN1Ed49x2I9q9o8dePrDw7Z3QgP2m5ReRGeEz6/4V5LrnixvF2nw6jc2iQF/ki2nkgdc/ma7cJOvNc1RaM6ssxE+f2PRm54k8NSeNvDsGqWjIb2NNrRtwGGOo965q28Kr4X1PSYPE94kFxq1ylpawqejFSQxPpkKv1cVo6F4iudKjW36xKu5QeMHvxXh3xs8X3fiXxtGsUz7NMUQQCNvuyZyxGO+cD/gIoq1KtGPKnp0IxtJ4eXtV30PebrxFq1nqt18P/CEsB1R2PnX7ENHp0R5Le746L61r6zBp/wAMfh3f2elbmlmRvOuZ8GW5lb70rk9Sf0rwn4deI77Q9Rs9H1LTk066uke4+1zuySSE5O+QNk87TycdvxveI9fvfiHqMNtPPLF4dgJBmQEG6YdQv+zn/PphCkpyU932MZOHL7eTvLt5/wBbs9F8ItrHxe0bTtHXzdN8Dacix380ZKyanKvPlJ3EY7n198Y+gNOsbXTbCCy06CO2s4EEcUUahVRR0AFea/AFZ7Tw1cWH2do7SKYm3BwMIR1x9a9RA3kHcRjPHauHFQcaskziae8t2fO+pFdP8UazDHz5N15iFvQn/wCvXYPL59rhJPkdBuUY/IVgfFGGLT/HBkiH7m4iAfHc1h+INX3Q2luJHWEIAyRHG445yfyr2Ix9rGLR7mLqqNCFY7bw6htr6RWdYleM7c9c/wCRW9qBSaPdGemOSeQMeteV+Dbx21Au0kktqu0necgHk4B+n8q37/U3S0mvLiYwW+/b8oJLE9h71NSg+cmMlWgq8nZFy8vXjcQxneOh5p9na3d47bAAg5z35rI8Oz21+8joxdoz86t1X0/GtnxHrlxoNoi2oWGXJ3Puyx7fjRJNPkitQrYqMY3p6osC2S0jkaRPmjGG5IxVP4fsl/42+2zj5VBWDJ7+tcvJ4pmvzeWtwJDI0Sur4Azz/wDX/Sq1zrFzpt9ZWOnJ/pSwm5aQdExk5J/A1XsZcri92RCtB4eVST30PovUb6HTrZ7m5lWOFB1NfPviPVpLrWbq43BfOcvtx0BPH6YpsPiu91m4mi1SZrt4NqxGGTdGxPoOma6Ww8NzNbLI6h5JPmfK5wfT+VY0aKwus92GEdPDU/bPW5hadMIdXZ0YFS+dyn1zXWzbt+9HPHzHB7fhXB6ajraWkzN95QenXmu+gQS2p2k/OB8/4c1rW3udGKXNGE+6EsmWSVniUjK7Qzdc1Q8TXlzpemo8QQTO2Fdug6nPv0/WtWzjjWN4mU5IOGOcKfUVzmra3p2u29zoUdvc3EloGaSWLChB7Z6kYqKavO7Wh5+JnyppMo+H/Elzca2tpeSRzEgMsuwLg9unauj8Q3ZtbAuhAkJxnPU1y/hrw2YZLW9N35toiAxkIQT9a2PFlwjokK8tkHGK1mououXYvL4ym0pj/DeivNqUN3co22Q5XI6j1/StmaKSWG/kY7Ao2de3IrR8E2dxqFtal5NoRSq/7I/x/wAa4Xxh4te38U3OlaUEFtA/lzM4J8wjggY6H3rOLlUqOK6HVXxcY1OWfp+JBq1ybHQ5DGuHZditnHeu7+EHgW3t9MTWNWiE13c/NGr87F9fqa891pG1HV9L0qMcBgWUe9fRukxRQ6fBFCCqIgG3HIrHHVZQgoxerLzKq6VGNOP2t/Q5PxsBpMmnHSBFBfyzfKQoweMcj06VBc+L9b0KLzfEWiBrZCN1zaNlRn1B5FHiB01Dx5Z25wVt2QHPr1NdR4okthot1HcDKzRlAMZzkcVzXSUIzV7/AHnmcqjGEXG7ZXPjDQhaRXEmowpHIgYFm5waxdY17w7qts8Utys28YBUEla5f4a+GLLWZry51ONblbKbyI4m+6cAHJH49K7e58K6LcxvHBb/AGc9MxcDPsKbhRoztd3Ro4UKFTlbd12ODTTtCs1kNs2o3MrtlIYkyGOOuB+FVNQuG1bw++lG2Mc8IJRXX5hzkivVPDeh2mkLI0Y3TOeXJ5I9K4r4k+XpOuW16koid/mboMgcY/KuilXVSpyrXsdNHEKrW5Y3fZs8p068l027E9vMLadcjLHr7VY1KW88T30cl1CZkACho2xtOTk7R1zXJeKbmddYuLmzeN4VlCmFgPmVu4+ler/CLwxNq2hie/nlis2k3bY/lMhH+16V6VaUaMfaMnFV44hzpSVuXr+h2PgCxOhWTLcQstxIABEPT1PYVN4titzFJcLB5bhPvHrkjFN1nwWltY3F3pF7d290q7l3Skocc4Oa8ybxdqk22K7uVaPG0R7MnNebTh7abqQfqLCYVVfepPbuZoykEtvMdqnOcnt+H1qnpXhyOCO5u5dSj+xhCyouT847fyq/qOmXt4iTSxsnQbMdRVG3WaCymtJeEM3mYxjjFeom+XRndWh7XERSW3VHceCvFM2iRWOneVJNasoeVGH3SxHI/CtPxboqyiXWNIjF1ZXLb3WMfMjY9BXEyaZaawsItpsSqBgeYQT6f/qrf03VNW8B3sZvZDc2hGHt0bdgccn3rknT5Zc1P4u3c5JqpRrylpr+J1fw71HT7rRJrGYRpNkhopF6gisvxC+paLeJp/hzV91tjK2svzeXnsD6exrpINN8K+NLcajbgQ3LD5nhkMbqfcD/ADxWJq/w28oQ3Wm6ldy3O4BvNkHIzxz+lcsJ0/aPmdvJrqTCrSdVuel+jWlzL1B/E+seGprC+0V51J8wTxYwfqK8l1C6lhUac6tHOHw4cYC5OOn1PSvpCCx12y01beNpPlwowwOBXAa1oE9tftdXEK/aS+4eYoOT1yDXVhq8U2tLeRnLD08S3ytJ+RPpPhG4t0trG0u2uoHUNKF42nA4598/lXVRJpui3Bju/wB3KB8yr1xVjTdVX+z4IXPkXRcZkGMZPFcf408NXc99BcPdvPtYlWjlABznkj1Ga51J1ZctR2RlVrVUuToek6dd2s8IeyY4DYIP9f8APas3x5pEfiDTY7aGJTdId4cEZRf/ANeK85a9vtK0i5iiZHnRcrnOQf61zOleMtT0zUJpVv3uZxGPMkkJ2H2A9qcMFPm54PYx51TkpbMpah4Q1q2vJZG89WQtuk64z3HPpVixs109rddji3iO35jyeMk17r4V1ay13TleRc/ulZ9wGCx61meKfCWn61o9y9qzW84LNGwHGcHjFaLHNy5Kisd9CvCjN3haT6nz9rWobWYlt8jqDvU/dJJNT6DFomiIFt7GGK6DEyXsgMkhJ65duh61CmkLFpw/tIJAsVyQ8jScyEdFC/Xk5qh5I1KWGFZRO0kxSWHBw6E46fjXoypxkvQwoVqlN3qq7vpf8TznUodb+InjG9uNHsLq+kmkxGsaEhEHC7j0XgDrjmvoL4QaXq+lWt7aeLYtNmFrEkNvDHCC8TdvmGFxjPQHJ716H4UttH8J+GolKxJebSWjiAVV4OAAOMVj+H7yKa4vrq4Kw/apAI2YZBUf/Xrx4RfvPUcKHK5zk3r8r6npXha3gTSkaFQGb75HHP8Ak1rtGvIIb8zWL4S05rC0meSfzHnbfx0A7f59q2vMjLFd4LjtmvNqv33ZnBUfNJs83+K3hNLvQ5r60B863w49cDr+Fea6NZWGs28K3wO8A4ZTg47rX0jcQxzQSRyrujdSpGM5Br5qj09rHxTq2mElTazMYiOMc5H6V6eArSnFwb1R62CaxNGVCp01R09xpUNvZRw6bsjSNclB3J96j1Pw5d6t4cjto3WKaJ/OiZ2wNxBGD+tXNMmNygDcOuBlR345qhqnjq206f7LFbi4jtiVmmDY59Pw55rde0btHVoyxM+Sn7GeiMHwvpOpaRq5/tNFRdhSTYBtY9ePxrsdbjs9RiCzLI0XGN2OPXFO+1Q6lZQXlvKH8xdw3A5xnvWRrl4IbYRQKDcSnaq55GablKpNPZiw+GjNKCON8UahpeihTal5HHCo2Msc5wOOma7Q+AGv7SDU7yd1sms1mmKjDOcfcB9KxPiz4GbTvAGn6rGDJcqV84Y5G48f0FXrbUb690qC1juZWt0gAEbNtU4Xv61o5upBSpS62ZdOCxE5UIWUI/1cq+DLCH+0yLeNY4YlzGo4wScD8a9Os9MvRDgTrHz9wg8d64b4fKv9ozhhhkCtyOce1eufvJQr2jxSREdXO05+lceNqNSsh5g+Spyx0SPHdUsBp8VraggmGNQfQHFbOi3Qa0ZSCzJleSao+IpUe9dkOVP3Peq+mXbwurHLFuCBXQ480D0Z03OgkdRNEFgZS21imBg565rzubTtQsZJgtrNJLKDEpSMlHXHBLg/jzXaXt9Ha6dPeM2FUbj3/SsDRvEU17dr5pzG5wvTv3HOadHmjFtao8HERjKSjJ6m74ftU0/RbeCabDRLyoHBPU4rMijfVdTAdcljjjsKdq98EBQyBIyw4J7+lXfCVhNfX6iBXJIOSvRRxyfSl8MXNnrYeKo03O/Q7vwvKumQmMLhduB9e1fPGjWEl14wvCxZl+0v0HH3iSTX0/Y6XCIxCz/vABzivPdX8NWnh06hcw7jMzFizHjB54rHC14pzS3djzFCNevF/ec/oEfl/EKB5VVzENxwc4GK9Y1nxAljZjyConIwmfXHcV494Iu0t9Su727DMV4UZrX8S6hPqf2Sa3MoRJcKmACPxH4Vdaj7Sor7I9PE041MRGEuiOu8DRvfavPqN6v3TkSdAWPWrvjuTyriHe58kDH0rj/+EumsoUtRHGu4DkcdO9cd4k17Vb27853YxcKFJJ4FTHDzlV53oh08HUnW53ouh0tp4iXwtqc08Ez/AGW6IdkXkPgenr7+9OuPjH8zR2+l7Yw33nk+Ygf/AKq86uPtl8ymZCwAyqjjH5d6teG9Dvbi6Mz2TS2R+WRm4BPXAxXTLD03701qdlbDYeKU6yuzqb34p6pdEtasIOcCNEycepPrVfRtO1rxZqH2m+MkozuZ3XICg9Bmr9hbaHY332meyXAO0RglgfwHeui1vxqxsVXw/GLKGOMm4lmj6dcBf8ah+5pSjv1OaVRUlalBLzPPNb03S21pba5liijLYw4GQfQV6F4N8Rf2DZjTW2tbRsSgJ2ECvNfDNidY8bWavOJZrqXzGmVslI8enbjOa7Dx5G2q+P5bPRpkggFuZJpNwAbYADgnjPP6VdaMZtUpdrnn1MbCpzc0Pd/E2vF3j9JLeS0tkKeZgbickj2xxV34beFLC4MmpXluskg/1YbkA+uPWvIJ70yg2+nxG5+zSsiTH+IHoTx2NepfBzX7ua5+w3o3TMCG+XGMDqe3asq9F0qL9np3HVxNONL2dDRtXPSNa0O01G1ZGiXzVU7CB0rxi0tLaXSNRtdhfVrq9+yxEj5VAYZPp616J4z8b/2Jcz2kEG+aNcksxHUduOteZ6JrSi2ivipDpf8Amujf7R5/z7VhhKdVQbe3QMvnOSlFPazIPE3gjWPDaJexy+fEhBLx8FfqPSqCQ6nrunI2n3Ekl6hPmQ45VeTvz+le0eJ9Y0+TwzdySTRM8sOUiVgSSRwBivDLC+utDv0ltGKTBSDtwcg9RXVh6s6kbyWqOzklmFBxqq0lszpvD9pNomiQX67RcqzLPbg8uuTz7HFbNnqt/ryPbafcTxuWV4kz90jB5/KuKu9UmutTZluNsbxdHBwzE5xj1Hr7123wf1O1e8jjZ0Eu0rtb/GivHlg6jV2Zq0KbTV5R7lrxR8Qta8IG1g1W0tJfNBAkJIHH9ea568+JP9uiIXix26SDaoByuT/WvYPEvhuw8S2nk3io6kYyQG47V5NrPwPSGeM6TcnySdxR+qkelc2GqYWSvNcsjylWtPmSWvysa3gfTYwt9d6hcqtpGuWJfIHuc9K7TTrrw1fosVpd2dzOcYBkBP5V4/dw3pgudKjlEcVtLlozkGQ4+6W7464NczNp2rajqKKRaWTRklLgSkun0IH6e9bTwvtW5OdjWvGpGfLBNo+iLzwjYT3PmsnLjL4GPy9K5vWvhPojlrm0R1kbHyO5K5riH8TatBJNCdRa4+zoAsuTkeuPWn6F8UNXttUitr5ftVmxyzAZdOBWSw+JgrwkaVMHOKi5O/kes6FoMWhWaohUPjnJ46Ve+z3K534ZC2RgY/IU/Q7y21S1+127iUnnGegq/fTRwW7O3QdhXmznLn13OWc589pbnzX8T7cWXjRLq1s2MMZ3mH+8SOo/GqfwotvJ8QC91GN5LdicMQOw4/Hk16Pb25t7nVLvVtE1GW9nZzCwiLxqpOQMjgDmqFrbPp0P2mSNY1uJiRDn7h6cj8K9yNa9P2fyPShRpSqe062tv5WPNtV8U3F340u2uA6af5xSGI9AoPHSunM8z/ZmtZMusTOFYfKDn+Y44rY1XwXo2sWtzeorLdEGQbX2pvH3ciuc8J69p6eIhp2p2/kxyyeTDcj5yJT13egJPUVfNGUfcWxy1faKi4VXs9D2zwLrP9raYY/vGLALqeD6478c10K20aTeaRl8Y5NZfhbQ00WOZQhDE4B68cmtzdvGQQR6g189WlHnbhscOq0EcAA/xegr5/8AHEgt/ijJNtKeevzL0zgY/pXvV5bG4a3ZLiaERSCRljIxIAD8rZB45zx6V4L8U7iNviIjFtqwr8zZxiurL1+8a8j0sp/jP0ZNBOLS5V1yUJJ2jtXASQXltPNDDBJmViGIHyuM5z0r2jw34c0XWtOJivZ3vGTcWB2gZ7gHqK5/VtCfTdUmspZQzKocE9HXBOR+R/KvTpYiKk49TarChjZWTs1+Jl2VybPTo7ZAAqRhS/v3rT8CaG2r62Z7okpEd/P1rj9V1FG8QWNtZh5IkYCQqerZ547iu10bV5tMuW2FldgAcU6sZKLcd2bUpKVOUMP00ueo+LLi2s/Dt213EssQjICsuQWxwPzr5/ldbSUQSK3zEhgO5xkiu78U69NcQRpPOjRKQwzwCR0z681xdz5sjWt2kIkMMxkZwwxKp4IyO9YYOk6UXzdSKEJ4WjOUbcxo6Fcx3WvrHY7gRHuaMjDD0H867yNrsou3c4A7jOPavOvCUyHxWlxGTKrJjamTsU9BuPOa7bxDeaxZ34htLKR4QgwURcd/UZzTxEffSX4nJVxHtYxqSRwutXYto1lCbnJKj2FLpWpifMkcRV0bGCcg0/XrVrmERKFLBuvpVTRLQ2cTxMys27J56CunTlPZvPnt0OiN7HcwzxTRLll2spyM5rmrHSJYNWWQTN5cBzH7Z7e9dKqp9n3sqk4yzZzj8vxqCSSO4RXh+dW/n61MZWTS6nPOhSqS95alW9smvvlLg7DuwT19q9t8F6Mmi6JEpj/0iVRJN7n0x6AV5tpqwR/2eHA2ySKXPTvnH6V7LGc4IxtxxjFebj6rsodDgzCVrRW3+Q7apGSuePTqa8w+LN95McsKOBkDK989q77UdQFpu2gs+CSB1FeQTwTeLvHNvZuR5fmebKV/hUcms8FT5ZOpLZE5fC0/ay2WpZ0zwsIfDiX5lKSeWRJnOMH29feoob/SPsH2CVSt0HBE2eM/T6V3PxB0GQ+ELoaV5zXUQBWNMncB1GPpk15x4F8OJ4l8z7TdssUSDeiR5bPSuylVVSDqTeiZ0UfZ1efETetylrk+jW+fMufOK87txwo9M9/wrL0bWNKbUdsloWBbKtId2Rjriun8SfC29kuFfQbmK4fYVMVxGR34IYd6p+GfhTqv2tm1uRIDGCysEzvbsMg9P/r11e2o8msifr03Plj8K+9lC5uUhbLpk9F2/wCf1o0rUyVSOCRocnkKxA/LvXd+FvBdnqdpKuowNHdRkqGPAb3xTNG8KWMXjj7G4EkduDJtJ9+nX3rN4in7y7Hf9eoyi7p3RJp2gyz2ySrbTMNoweayfEWhTT2slsQcP13dB+Fe0WzIqsq7QqnAA6VnatYxXiBo4wX65JxuFcEMa+bVHlrG8zcZrRnkXgPQH0+7uDEY/tTL5fmlQNo9B9a1tW8Bwm2ea91B7OcBwrQgcKe3P0z+Fafi4P4Ys2ubMiWb7wz3xXm138Sb/Ube4jvLd3TlbgAcxrnnH4d67Ye1rP2lN6GNWpRcuVaRO8+EmiaVdaTeQyW/nr5md0mCTjv9a9A0DwxpWhPM+nWwSWbl5GJLH8a4D4QXNu8cht5U2SklB688fpXpwnHJLH5PQYFcGLlP2kld2FiqfLU93ayPPvivpmmyKJhdiDVZNqgZGSo5yfwBrxG6vpLcLBbxLEg/icklsdyfXNa3j3xVBJrt3FLM7bHb93GmTvHQsewrCs7aS4u3u2UyIyL5W7k+5wPr1r2cNSdOmlN3KwftHUUKW/VnSaIl9qVxFZxMWLHO4j7g7n6126/DCe6gE/2qQOvKiQ9T0rL+HMZSZ22EtJjkjgAV7dDMPJQZGcDv1/zmuDF4mdKVoHp47GVKMkqeh8w+JvDeo6dcfZ7mKRSW+STacN+fWqlvaXkCm4BO5xlPJGAMcV9WTxRzxkXMKPHwdrqDz+NeXnTbO0+IN3YSAJazqJwoOACRyB7Z/nWlHHOpFprYihjIVZupKHvJfeW/hr4rJtorC/Lm6bj5zjHYY/Ouw8Q6ibXSrqfO10XCkHofWvG/il53hnxNHPYDZbuAy8YG4YNMuviHda5aQWNyFjMf+sJBXJ9+azlhPaNVYLR7mEqVOvWUodd0bWo6dHJ4NutRAPmtMCfUjof8+1dH4b8K2VxosMq5DyLnPT2/GuY8Q6ys+gabpcMkUsZk+Z1fqe+a9Y8OWqw6RaxA5VIxUYipOnC/n+BWJqVKUObZt/gea+NvApS3W6sZsTYIbHG7vXJeCNDD6zJDIoW4/wBXgrkHPvXvmvmOPSbqVwvyRNjPr2/WvGdX1UaDdRalEhO6UDA74GcVeFrzqwcepphsVOpSfPuupvTnUfA1u08cbvEMkqhDbh6fWovDnxYt9b1yGz1WwOnQE4Essgxu7Aiun0rxXpPiqAW06eTLIPlDkYYY7H19q8x8ZaDZWOvwRfuVMk4DAkABffHSlTjCq3GtG0zlhF4uST0Z65J4x0dG8mOfeWOF2DiuA+JF9bTySLaMPPZFPyn8z+VOWys9c1Fxp9ukNjZJhjH8okYDt6jOK3dAstLjtryO7hhD7BsdwBuP19aiEKdB86vfsbRp06DU1e66Hl9ld308CWjzCCFgB5sgwPzrP8F+H7iTxrpcdwgaEXYuCQwIk54Ofaum0/xVa2WqXELaXG3lT8MxypAOPp0rQ1vUtGnnt73S/Ls7iJwyvG2CDnocV3ucleKjuaYpLEySaske2sQSeM4PrVcxYcyRHBI+72NQW0sktlDMkxJZQxBHFWY3Z1yQu31BzXznK4niNNGZquuQaVZS3V/+6hjBJIGfwxXzL4+vpde1qefSI5boXcyrGEQscY9BzXp/7SN/cW2gabBCQFlmbcxzzxjH615foou9K0aGexMiyB9wkVSdvft+Ve3l9FRgqq3Z24OPPGolppuexfCrwxqempDe6vHJHII8IkhG5QeNuAf/AK9UviBdHVfE89tZcG3gMO+PqWIyRn2ziuPt/FvjTVL1LOza4niOA5NuYwVxyQ3bHPNdjDa2ukxfvpPNvohkBG4U5ycnuTnrSlTnCp7Spa72SHg4xV5Xu9jyddFv7XVY12Th0YFHCEEH6jt2refXrJLiKNvNDo+xpgP3ZcdV3exr0qHV5LpWnaONHEe1w7YQj1Hoa8gOk6xbteWFuEa0lnZ1mRhnY4wQc966qdX2r99Wt5gnXwv8NXTfqdNrFtLexx5kHkbcrz1HXggda1NGSBdHeyvmS5mkVppJB8gjx0xnr/OodK8q2srW2mXBhVYhKf4yB3HvV6WwiaIyT7VRgduBwT6VjKWnKeg6cZSU5KzK11evHJaz2v2dljIEjKBuPbp+Fd3pniG2ubOOSSZEfoVwTivO20udbZjaozpnDEYOORWQkl984DhAGI2knioqUI1Y2T2KqYWFVWT2PRNW8LMFLH9z6kjg/jXEWelm7vH8uVSoO1WUY6GvRvH3iKGLS3gL5LggRjqx+lcBpl3cRQKqqkY6kjrSw8qjheQ8I6sqfNI1oEt4dscrluASqj9KsxRaYXVIoJFj6joM+prGdZVzkqW65FEl2+7YigHqPb6Vpy36mrgm99TRu49t7AIgCEbIGRzivS/DTxPpsfnNiUj5wW6V5VpZZrz94FZlXoa6K0uJZJltzjYxypYYrDEUueNrnLi6LnFK+xr+PNatLJY4bF0N25IO09qyfgvbefc6rqcjEuWES8dq4y/mebXZYwEYo5Un0HSvQvgtGDoFyckFbhlIHalXpqjh3FdbE1qSoYRpdbHoJLJ8o5z0Feba1c2fhvxrdGz2RfabMSTRoOPM3nBOPUZr0PULY3VrPDGxiaRCgcHlcivnPxbpWreHdaktbmaOR5GDfaOpZSTjJNc+ApRqNpv5Hn4R04tuo9O3c978IXMd5pK3MTbmkclx/dPpW2yqylSMrjvXz/8ADXxjqGk3M6y2U9xFIP3kC9iOjL7EV3Z1fxX4qZoNLsBo9i3BubgHzMe3/wBalXwk4VHd2XcVSjzS54v3X1NPxHrFppt3tW7ijjVPmIblT+Arlfhot7qvii41VUlNs24PNICA2egXPX1rrtK8B6ZbKjagX1CdSGLzH5c+uBXVqohiVIlVI1OAAMAD6UOvCEHCGrfUuWIhCDp09b9SpqME7IVtzt3dSPSmzXdvEUt2BM7ZRV2nng/lxWgc7SDg1BcQ+YC6MAQpGRXInfRnIpdGYHiPw8Nc0wRyTFWA+XB7Y6fnXmY+Et3dXM88UsUMgciQSnKzDHHAr168uIrPTjczSKAgBOa5x/iBpVoERo72eVgC3lQE7fWu2hWrxjanqaqjKom1G5yfh7RLvwDfKLtEeFlLK0fI/lXa23i20mkAkidY/wA/8iug0m9tdZ06K+t1EkMy4G9cHGehrNvPD1jczqViWLBOdhxSlWjVf71am6qwn7taOq0PHvGfwti1bV7nW/CmohZ3y0lrI2wdOxrjtJtp7GxtIJ1JcymNW3BiTnoD6CvddW8IXT3HlWN8I4ZEb5iOc9AK8x8TaBeaBqNtaXqpt3F4nDZU/j27V6eGxCnHkcr/AJm+ChCFW9GWr/I9U8F6Nb22mWxDBwF2vuHU11EWzYYzzIoxkdPauC8La/DDYRJNJ0+9kZ5+lbkniKGG2kdRliN2wEA4+teZWpTlNkYihVlUdzo5LxYrN5pZVAjQu4PoBXzpqPji71Px699BGn7pf3GzPzKh5UnpnmvXrnxpoM9pJbXMpKzq0TIgyeRg14e+mQWWoyC0vJbq3tSxt1aPaRnOQeffrXZgaKjzc61FhcPXjWjaOnX0PU/iSdP8Q+CLe6mKpPKBMhJxt9RXh7aYXK/a/tc9jGu0mBgGJySOT0H+FekahpU954AsJbhlaO2d/kcYAHbPr1q94O0fUrHSbgapoV1dWtyqsjx4DAeuCc9DXRRmqFNpO+oVKSbdJrRPe/4eZ5r4YgncFrouEjfcmeu0YzX1hYLGLK2eBiIjGu05zkY45r5+1rT47G6a/wBKmZrFzteORcMh7qQe9d94F8X2MOhQ6dqF4IZbdsI75+aPqPxHSufHwlWipROvGYeUqEPZttR+86f4gXosvC95JI2fu/L6ncOK5KfwzDrPg+zjuSoVQZdxOCNwOTn2qf4ia7pt14bltLW5SeW5I2Kp5BBGMmpfiBrUGl+CEt1haJ5YAu1ekYx/X2rnoxnCMVFatnLThOMIwtuzyjT9Jms9aNnYTfaYg+4NCx+UA8D86NaTUJdcjhmKy3LLwS3p6+9YC6nqmn6pZMkb2zzRrLHEerRnPzHHY89a7HT9Mvr27/tW9UrGPlBQDIz14PpmvWneLuz0cFOkoynS229Wel+BvDkuk6BPFcbZbqdC3HQA9v1qPRkie5ks9ShVo3Plsrjv2Oa0PDN9e3NokbEttXarc5YdM1keL7HUYJ5LyxDqmA0gPr/eFeQnKU5Rk9WcMajnVlGb1fU831vSDZazcpZRmSLzHARsHCk8VxPiMy2F7bx3FtJAhYIItjAy5PXJ6V6RY6xHbask2oIQm/BfHA+prv8A4j2dnq1z4UhMcUwmvkZHwCNgGSPpXofWHSlGMle/U0x6k+SD+86DwXplxp/h2yS8kkkuPLBcMSdvHT8K2QJkIC/MpPPHNWXGVAAye1MYnI/p1r56U3NuT6njyk5O7PLPj3psWoeHbd5fkngmQxjrnOQRWXpdq9to8NqqjbOo2k4G31J/WtH4uX4u9Y0zSg2BEfPl46emfwrnYZrnWp13yMmnRDYNvBkAJ6+3869igmqEU9tz28LRUKCk9L6v9DRklLs1tpEjTBPle55VAehx61LHaTLC0a33ynKuI8DJ+vekhdLaARJ8sQbCqMDFVJ75nuPLtB5jHIUYOfXir1eiGpSm+WA+LSbS2uEjdXnCkZDyEhv1pz6RYM8XlRiIyFsbCQVGe+OtB0LxBcKJxaz/AN4DOMfhVN5b6xuIl1CGSHbkgOpB96NXtILTesZ3fqXJtBuDF5mm3TzZyNsy/Kw9z2/HNaXhTV3mlh0a8jiZmcxPFIuSjYOP8iq8N4fKVIZSMbmCcdx6elYHiIyW00OpW0p+0wMpYY5xkYJ+lRyua5JfIUXKqvZ1N+nqewQeG9PjiEbRNKgycMxxnvxVW58FaLcSeYYHQ46K3H61qaJqI1bSLW9TC+egbb/dPcfzrhNS8Sa1p2o3NsZPMCSEKREOB6VwU41pycVKzR5DqVIN66nA6jvtohf6mzvuOEAxnPsKt6Fd2N9c+TIgEmFwhbJ57H0rR8U6dJqejSrZx7548Oq+oHH9axfDeksdQjmeFYHCjeSOCR6Huc166lGVO/U7MRi6zq2WxN4svhHqFxDZsyJEpMUanmQjsa27DSYdV0a3u4J1R3j8xlkYDA6kfzqhq2hNJdPMk0SiVi+4g5GRyeP8aS4iFqFtIGTyYovkLfT1PHWh2cYqDMYYitSbk3oN069TTtTVbkkpna4BzxXRefFcDzI2+VjhcenfFcJFBdy2X265tRbYO0fMX3D1zWx4dvd6zW0jcqxKjHb0pzgt0e3TaxFJV1ox5tgdemaMZbGck8Guj+DOoLbavrGkzsUZnE0YLYHcH9MVyuq6jFo93JcX4ZTlUUDqSR/gKdYalDpXjbS9SQ5tbsAMV96itB1Kbj5fkTWUasJUlvY+hTkHO3J9q5/xJ4ctPEM8JuVKPCDhwOea3EfzUBUgqVz1pwwAAvA/pXhwm4O8XqfNmLZ6Xp/h3THe3iWOOJS8j4+dvUk96yF8f6HCi/aHuYY85DPA2MdsYzW/4nTd4d1IMeBAxx9BXl1r4gXTdOCCFLhTEAVxlgcV10aSrpylds7cLh1Wi21sejx+MPD7wpIurWzK3+1yfwrC8b+ObbT9NC6ZL5s8yHDqpwvH5Z5rx83CDVZ5ZohCCMqm3g//AF6jvb5bxlTeEjI2kSsdoyRkcf1rup5fTjJN6nRXyxwhzU7tnSR/Fa80+OSIQPPdAqnmSnCqD1Le+fQV03h34n745Y9Ts3FwDuQp0cZ9/qK4Oz0HSdQ0+8LanClwE2rGVLM+OS2eM9h+FT6Fo9jZKJWmupdgAZ2Iyo9vbNa1MPh5J2WpyUsNWm/ejodDrfi2W7dvtLpFZqxKhjyT6f0rS+HlzZXgv7xpo1bBiILAYz/jXnHxA0e4t7VLiFZJLF+UdBkEE+v5dKxNL1VfDIgkt/Ma4flkYDBHQZzV/V4zpWp9Tvc04umtFbc+gPhdqMcmlXdqZB5ltMy+WOwrp7sSzZVMqH9xx65rx34Z6ms/ihri3maOC4XDxY43dP6V7DLAY0kMEhWVwdufmANeViafs6rfc5cTT9nU5u+p4l40+IOr6dq066XdeR9lnMKwSxhi4A6+pGeOKg8ReKrjxNYWF7qWmSWlzCCjrn5Xz3A6iu3+Guk6Zeazq02pRRz6raznYsgyEX+8B/vZ59qo/Hi6t0Gn28aqblss+P7vbNd0J01VVOMdV1NsDFLFKL1/Q86stRnBeK1jZ3mYCNBz/kV1w8NXqRwtqdxJJNccGKMngds4q/8ABbwxHK0ur36bhgRQqy9fevZREgC7EUYPpWeJxns58kEdWOzD2dT2dNbbnzdruhXthN5bRP5HJWVoyM/iasaboN7PbtcafLHNJEhYoOpA6j/PrXvXiC2jutLnikAO5SOa+edLg1Hwz4rNwglWBMnJPysrdQ3sa1w+IdeDa0a/EVHH1asLRWp2WuapY6r4LtooYvJvLRwZoG+UqR29wa9E8J+KLDXbKDy3EVwUGYXODkdceuK+fbq8udV1i5/s9LZN+5tqybWCA5xg1HpWq3ENnINLKxOsgczMNuxuc8n6duKdTBKpC19f8zjxHsppxjKzTe56F8XEtYPFmnquEMyg3CKPvYPBPvU48KWl/t3sUEgXbtGc56VxmqarLrN+s95L5tyFVXfHXbzjp9a9vs5Le4h065tQvksgZWQdRj2rKq5UIRj1OmpUlQo01BnmVr4T/szXo9P1FAmTmK66qw+nrVH4h+bcXEmnzMJpI5Nh2/d29uPxr0fx+0EttAkoPnB87kOGUV4prmoAauqxuwkVv3gPIbnH51ph5Sq2nI6cHKeIaqS7Gz4Q+GepXey9mnRdqiNTJliFHavQD4IlgtnFpqTC4UfKCvyk+hA7VoeAvEdlq+nxWcJdbiCPDKVwOO/8q0bnxDpNteiyl1C3S7LABWYcZ6Z/+vXLWxFdzce3keZUrVaMnTXupdDI8BaxE8Lw3RSG9V/KkhzyCOMg+ldSVXUpJFI/cnh/XA7V4P8AFKG40zxkXsp8rLIpyjbQGdQc/pXWfB/x9JqjXGlahHm5jOfMzndj3706+Fbh7eBhWcHJuO7scT8U9Kn0LW7i2gWUxy/vUdVz8nf649K1Pg2+o6prWnQaldhrfT0a8t1C53BsqRntjjivbtZ0TT9csnttSt0nibn3H0PrWT4U8GaV4Tmu5dLEmbrG5pPmIA/hB7D2pPHwnQcGveMvb1dr6HTg7uccdPeq2oTpZ2k9zcPiKJC7E8cAU9QQME8da86+MusvFp0GjwSFWuuZSOojHUfjivPo0nVqKKHh6LrVFTXU86tZZ/FniSeeZ9jXknzOTgJED0yegxjk12mmR2skZh0vULK8EYKvDBICyj6dx9K4bU9PubLwXdPbLIJ52RmwCf3API459M1yen4kvLaLS5ljvmYNEYcjaAQOfTPU+1fQey9qvddkjtx2M5aipQ2R6XrjkfuVOxi2Cqjt/wDrr0bwX4Yg0uyhurmFX1Bhvy3OzPYfhXK6ZaLqPi+ySeMMMb5MDIOOc8e4FeqEAd+vbrivLxdVqKguu4sXWcacacdL6sazbSWJ4965DxQYL6K1aa3LZLKCxAOPUV0l5Z+dlxIQ+RjuB+FU9Z0NdQtYYmuXgaNidyKOSa5KUowknc4qclBqR5tr+lxWcn2izldQUz19fX+tNW3i1DT3SRciWMjryCRjOPrXYa1oFrBo4jjVpLjhWfOSeRya4KO+MUz2mSjK5TkY56969OlU9pH3XserCftoJrdHX/B2/abRbnTJ2xcWch4J5we/0zXS6ro1nd3XmzgByMd+fevKLHUP+Ec8T2uqx/8AHpcERXSgdBng9Oor3NG3IGVuGAII7iuPFxdOpzx2Zw42nyz5+kjyU2oh35lVDjIjXLEf5/rVQT+VJH9rhfy5CMSDsD/+qul0uS3jYgZkc/IcrncD71LfmymtpTNFtdSIwhH3R611KetmjoVTW0lcz44YVcMskM8DALktlsUrWUaZVFEkXIQuBz7VgXelTM4awmjBHzFH6Y9MioPt2r2KbZ4JFROBIPnVQfUiteRv4WavDxmvckT+LLiOG3FqgHzYJGMYHcVk6ACmpxyxZDZz689quWunvqqvJuSQnoc5GTW1YaJHZSRNGWZ84KngZ9jWt4wjynfCUKFPke5yfxQ0SXW9PcxuWvGIdFXjp2/Kud0a3vm8FpHdRSrcWMvyB1OcV6zcRRHzRcLlHUqoZMDkj/CsO7WFIFVAS68MVPBHbI/KqhUvFR7HLRglVVVb7eR3nw08VQa9o0ELELeQrtdSfmOO9dlu3N1AI74r5z05v+Eb8W2d9bSN9kMyiUDgc9ePSvoWFoJlSePY3y4Vx6Hrz/npXk4yiqU7x2Zw5hh40anNDZk7RxsrCfawPBU8j8q818V+EjYTT6noqia1JzNa4LMvqU/wr0lW+YbiPxGakGGwARj6daxo1pUndHJRrSoy5onz94kFtc2UJiQGYnChRgj2rX8DeCZtRuo7rUogLSEgxpjh27k+o4qf4si40fUY00y0SYXH74MDt8s55+vOK6/4Wa9a6xoIijYpdW5ZJIj94HNerWrTVBThsz06mP5qVqe/U1tV8IaNqUareWqKF4DR/KR+IrnJfhxaB3Q6hc/Zm5VTgnr0Jr0TaOM849RWH4q12y0Kwa4vZYw5PyR78M30FedSrVr8sWcFGtWvywb1PM5xd6PKNMupUutAMyo0bD54lY8FT6Vh/GPwxplnO1zZyC1TygMMc7j16n8Kz9e8QXGsXl15UbJC7AiNTyFHI/WsnVku/EUckd880rqFG6TOYxXt0qcoyUm7dz2amFnyc++mq7s1/hNpsGst5Vtez2uoIpeKTKshwM8jqa9t8HzzajZzw6m4N/ZzNBMEJGSOjD2IryP4WiLRfEd/eXLSaldJCsdslrHhQuOSx456DpXoNtfz2N7eeIruy+y2d5GsewSDIZc4LDjOScVyYxOc2vu9ex5jjXnDlqKz6HJ/EtP+Ed8V21xosz20skRZmQ88nBHvXJ2tpca1q0pubhnYcyNIdzH8fwp/xEv77U9dE12jRKy7o1xkso6f/XrJ8J6jPbTyajIrNC7lDt547967KdOUaSfU9XC1VFKivjS3PoXRIjpXh6NIYi5RQQo/iPc+tYEnxGf7Y0EGnzzsg+dVAypzXReGZPO0KCZZmYhSRnqB2H6CuE8Q2mpWOprqPlxxTTKTGw6E+jflmvMowhOclNXZ59GEKk5RqK7NU+N/7VlAihlt3iO1kl9cdT7VozzaHa2UN9qTwtHIdzr97gjpXDNYfZ9Stp3vWkuzGJZh/eJB2rgdhk5/CtW38OLrai2mO2OM7y2RlevQVu6VOO2iN50YRjeOiOMtdE8OeLPFl3Ho1+LFgzOgdyGYf7OP5Zqtq/gO50S8MLXLyRR/MGjIZB/vDHB+temw/DnSrORJGmkfYdwXGCPYEdPwrvdJgtYrciCJY1b7ykdfrnrRUx3s9YO6/rqcDrJvnqQT/rufJupB9NnKJGSGCqpGOM9W966LwZ4r1fTJAlqWGdyhSDtcevpXqfxH8B2d1bNf6UohnXlo0Hyn3Hp9K8+0aS20reLu12XTYRGI4z/nBFdcK8K9O9rno4enGrerT2e8T0fRtBnedrvxBMzs6/dVjtQ89f8APavIPFGmGw8WXNvaTLJHNJ+6LjkAnivb/D+raTqenJ/pQlnXCSxM33T0rN1r4baXrmpR3ivNG6nnbIdvA4Pr6Vx0q/s5v2uhnTxk8PNtry8jz1bQ6XobNZ3M1vqgVo3I4WQHrgjr14rio7G8vNLmjC24meRWZ5pm80bR0UdDn3r2zxhpNqmmC3EqqLG32ow+87e5rx57t0LyMSGIwPX0rtoVeaLkjeODp5hFTqN3R0fgrSbrUtP1Kw/sr7eLhNrichVh9wex+ldVoHwn1DQj/aWlawp1NRkQyRZjOP4cg/rWX4H8YvoDO80Kz25T94I+CgGOcmtu5+L9nNvGk27SMeAcGueu8Q5NU1ozixFPkmlC2nW6/U7HwT4kl1Jb2y1W3FpqVi+yWIHIwehFdRLgrhTkE5yO9cf4C0y6ihvtT1BFa41KQSuc5wAMKK2fEutQ6HpM15Ou7yl4TpuP1ryatNOramjirKKm+U098NpASxVI4wWOT265rwPWb9vE/i15hgW/mbVYDjYMCq3ijVtdn1eG6vb5Ua6X93BGxKCNvpWl4as22zSQRM0kfyJt7EivSoYb6vFzbu2ell8FCnKs99kdHZDMgMWGUD7p4xx2HeqFyLO1uHkjtoYbqUlCUiUZPvgZxVm3mVD5LyK02MMm7kfhUWmwoPE1pNexF4pGDYcZHtQtLsUIxk25a2Op8BaC9rNJf3LHew2IpHQHBJrtHZEUs7KB6sQAK53UdQv7WMy2sCSdiB1AHfipdVs11bTIVu5Fzw+3HfFebV5qkuafU4KrdSfNI17d1lt0k3Ek9DiklmEYCk5JFULAm0sEhLqDGcDHIIzxj8O1RXAlF9NI8mIVGAOuPf8AWslG7M1C7KV1ewyPNbSlWUMFIXr681xnjfT/AC5baeOJgfuEH25HT/PFdZaWklxK1xaRJIGOSznAJGRn+dYPiu5uLfzFukRyP4AThR64ruoaTSid+GfLVSRyV6j6tplymxU2r26A9eK7z4d+K7ZvC9tHqUkn2mAmE8dQOn6Vx+mRgQNJIQEc7sA8muevHl066mihU+WzFx36111KMaycGdsqEa96fZnUPq72l6wCAYUBlcdSK04b77WrNw285Zt2ce1bD6VYaxcXkjN/q13cg/Njvnr3rE0XRZTCbyMlbB5RHIGUqQCcZH4/zrPng1fZo5vaUZx10ZYW7trKAmTKjJYIw+83+AqxpB+1wEySEQuwaQg4yM+9Tav4BnuJke1vuMDiRRn6HFYWlibS7+5065UNIDnB/TFKPJON4PUUVTnC8HqifUtEsorxn0yV7SQYJkjbG4ntt70kEHiS2gN1LHHfWajLeWwVwPXFbNhbv9ohUIvmu2AW5P69OlR+KvE+k+Gri1gcyXF/yskMTA7Aeue1PnnJqCV2ZyxTh7stfUz7a7s9SimnZGkdU27JThkPuKrX0Nu8kNvb2yiaVVVXjQ5bHUVJqMllq9t/bOgMYplCiSA5DOp6oc9x1H86NH1hrdhNZgAlSpVl6jvVpO119x0wftI89M5/WLB5LCePDiUdPQgV3Pw18Ti/023s5BiaPEeRyTx161ztxP595LFIAxY7izDGN3aub8A3w034hQwSEpFJKyYzwCRjNVWpqrSae61OitR+sUJX3Wp9AmNy6MrFcHJxUjBUXcSWI7ZxU6hTzgc9cVGIuOrflzXiLQ+cuc9rWm2upQyXFxHuMSkgA5J7457V5BeavHBOb3SWFrPFJtLwnJP+8D1r1L4ha3J4e0GS7ttjzlhGkXHzZyB+HrXiWgRzXWp3FxfEtcyPk4UAZP04BzXtYKLdNylsb0+b2keXqehaVqnjHxKqxR6ilrATgukYDkdz7Vu23hLR9LD3+rmbU51OPNunL5PYAGqGianNpqGWJCHC7QNuRirV9e3uuYWGymkjXJ/doQCfr+FZzUua0fdj5HpTg1K0bRj9xUudOh1rVIZlsxFbRnDvEmDgc4AHU1F4budN0vxLeNqLCOJ22o0y4xzxnPTiu+8J262+mICgE3O8dx9feuX+J1np66ZePEkQvHhJPqeRzUQrKcnS6bGca6nN0emxe8Q2FvZkazpLW9u4TLFFG1vf0Neda94pfVGtZ5l3WsMqy3CKQFXnHSn6ZqUy+G/9LJ8uBflLZO72rgdbb+0niV7VrWHdkiPjepPqa7MPQSdp626nbDDypQbtzOOx9BTz+EvEWlw+dNZlAAY9zBWRh3B6g/jg1zdv4f0xoZNN0nyXeV2IIw3ynq34814beQCyNuIN724LB4mYgKD0OR3zW14T1W80nWUubRz5EO3ZzwTk5H5VX1OUIvkmebhoP2rSTUvM9Vso9b8G+STi+0tQd+1cMh/p/wDrpmu/ETSdXXTYzaTuyTb3gC5yQCAAR2556dK2tW1OTX/DzNDMmZ/vRp945Hf8v5V4vNp81rqMqJ5jMrgoI+GIz2/HOayo0o1XzVFaSNpxlODm4++u3+R0z6q17rckdxZJYPHIHKZDHGfUfrXqfg8qYZ5sHeRg4xj8q8nvtITw9p8d5rl60l9cEtBDHgkL1w3vXffD/wAQRalFJHGjj5QSMYxjIOf50sVFOneGxKqSq4fll8SO4CJcEclWPAz3NWdkdshHO4DOPXNZ/mMrqYA8iqfvDkD6VBJPNJKPMVic98dP8/55ry+Vs43BvroaKyF4FYDO49DjFeJ/FeS00W+SOeEzecMRBf4cE5z+de02suYwZOIwOoHNeafG7R2vrWC/s0bzrZxhgBkjPI/WurAyUaqT2ZpRqTpt+z36HnkNs8EKahpVxNFKDghgeR6e9eieE/HEt1pQtZZI4buPILM2N3GeOeteK2MGoXdnqEzLeNJauBbhW+RGzkg+p4PNbaPs1CynYiNZ4Vkl3HhSRyf516tahGatLU76eJ/tCnJOPvRPXfGOo6ZpngmczBLrULuL5SWBYZ7j2HNeMXKP9jjdl+crtzn+I11fji8tdXvbaDTWE0UEKp5gTbuPBNc5PCIdNW8uJsmB9uwDkH1x9cVnh6fJHzZ3UIrDYdznfuzpvBfhK812ACT9zZzxkNkY7dOucdK0NE+Hl7BrKfbFSKEvtMoGAoA4Ax16VyXhvxNqyavZ+RFL9mEymQQg859D+tfRqYubPdan5cfxnJzWWLrVaDt0Z80nGfvJGjbxRxWyRoMRooAx3Fc/8RIwfCt9IY1dETeR7A8mtG3M4kQCUMxzyRkE1H4k2poV09zN8kaEtgdfQV49NctRPzFyXlyrqfNvh8PqOrJLcf6uIM6KQBxyV/nXceHGI0a4WMr5xlYqG9fXiufj04XGjXtx5rx3t1L+6AwMLnrW58PGjgnubGQbygyN3PHc17tZ80W+x7jpqnRdKK0VtSqnhzWUvfNf5VLBi2cFOPXrXT2shvL9bDdklQgc8478GrMl7Cd6w3HmyLwWA3cj+nFZZnks9XivGVd5cDag+8AewFczm6i13OTD0lqkdgp+wxrEkxcKMZPU01ryXYEBYgnOP/r1PG1tfxSXELBAiklW4IPeq0Nq967FpjHCpIUL1bHXNcWn2jO6W4pu58AFSxBGMr0p81/PNbMqx7owCGUDrn3pklhdWkDyGJmVeS2/O4etQXV9FYabM06hUZgVK9c/0otF7K4rKXwq51GmXFo9lEtsyoirjy+hXHtXG+ObNNU1O1lsrhSYoysuORjPfH41hXWqTy3UM1uY5IEJwHGByOQTTrUG0hlbdt8xjna33STnjFaQw/s5c99TSFD2L576mNfahFp9zJaovnNEMswOB+OetV757e4aKWORUDRgkZ6nJqTWLK1WZriUyO5bKx46ms2/uoI5wL5XMpUELEDtQdh0rvgk0mjbDOUJOpUdkexyaXeXdg9xbXdvFvjISONeCh52lj+X4UXN7NfaPBaW1m6CUeVI7DhDwCR6mqSazp1zp6Payk3PKbFbaFPuKualc3kGmQvAqJCBjcxO4v7e1eXaV1fe55vJJaSRBqpvo9QgjnuzmNv3TgYDkDOD6E1z3iaOVb2HVI5A7Rbt7d+vp9a17IveSpHIwlbzPMZh1DYxwa6J7DdayoYwLfyyHBXJIxWiqKk0mbRqexkm0cvod0byNdVuSzFW3eWB973H414p4mj1Cz1G8W8tHnupJnkjZ85cZ4APp3r2doRHoV1crMqG0UhIiecYz07niucg1ZtVlha5iYqvygsOh/HpXbhpuDlJK6CeGeIvKHQh8A6bPaeGjJeBI5biXe0Lkkrxjmr1/ZSAyS2MuyVsMUPKOcenb6ijXLpdNiWCCYKGXOevXt9c1X8PvcXrlXkJt9nzN1Ofan72tRl0qvsnyRJLW4gv7GVHhMVyhxIh42t3x+FcT4usbjSruHVrWT5hMCvYqRyD+Nd1rcKabm5toAoRQZQX3b19fTIrL1q2Oq6HNHEASQGU+uOR/hVU5dVsz2MPNXutnue0eGNVi1nQbLUImDJPErEgdG7j86084XqCfWvF/gN4jeOSbQLwjbky2+ex/iX+v5165dQ3UvyrIqIT0749K8etR9lUcDwMVh3QrOm9v0OK+MWnm90BZrcBpY5FJXrkCuf+H+gNeRXUzL+8Cgqr9R9Pxr0OLTsSl7geYhBUK3zFq5+w8Na/okk13otzbujZ/wBEnzyM8fN2NdVOval7NPUuEowjo9TFu2ureRogvlur7TmtvQvED2TKlwNxYc8Y/GsjUNTfWb90ayktdUiwJofQ+o9c1WuBKJNjghs5HHQ84rdxU42kj0OSNWCU0X/if4hu7Ozt5NKZ7SSbI3n/AJaf7I/x4qbRfBceu6Pb32rX11NeToCTnhPYVieJp21exgjugrS2koKqF7Hv+Na8vie6bRWsNHVLaZY/L84j7vXkD1pcs1CKp6PqzmjRqxVqe5y99pyzahPYRu/2WAhZWQYUkd8471ufD/w3YazeX19dr5tvbyiG2Q8dBncRj6VLo9k1toLW0Uke+4DGVpDuYse/P1pfC+qDwuDb3DRMjYZsnn8KupKUoOMHqdVWdSpBxg9To/FdnodlpU8l1ZW4JjZVZYgDnH0rifBfhI3ulW8M8fkrIS4cjBX6fpWle6kfF2uQwgpFYRuAxJwDznFdr4u1htC8NzX0EaNJEFWMAjGSQPyxXOpTpRVNfE/wOZSqUIqmvil+B59r3hd9GsvtWjXEyvE2Jgz5BPpiuV0LVLVfE9nfapEfs3zI6qckEDAJH416D4f8JJrOny6jrrfaLq+JkRN52xg85xnrVDxJ8L5HYPoBjjKrzHI2AT9a6IV4K8Jy17nXSxNKN6dWWvcyvibZW3iHT7S/0u9G+FsrkHPPXnH0qp8OlTTtTKXLhHl6KmdvuDUcMWoaAy22s2zxA4G8glSfY9KopKx1N2gk/iJAJ+8Petox/d+zT0NaeDp2bi91ufQlu0c9vGVxxg4B6Gs/xCyQQLLkBxwBnH1rE8Ma4lzpKyNKsYiHlszcfifer9whv1WdD5qEYBByCPb+VeP7NwnqeJ7L2dS0uha0W3ElorsxwR0/z9f1rmfihK+nafFJBGW3bg24ZDcfd5rpbK4+xx7JCOOg6Y//AFVleKobTXdPeyuhuVzlWU8oR3FXSdqqk9hNT5rxPG9c0bQdRuYtS0/zBFcxb5LWOTYFkHBDDB96r3F5bwHyk05boRvtZumAo+6B/npXWxeGlW61JLRnkkRPkTHLFccD9c1554kt7iO6BtScO24wsCVLZ5+nvXtU5Rl7rex6KpVfZf7OrTe/c6K31TTLq4jsdNs7qyldN8j3CjG3IwR7VveJdA0q88NGGxjebV2585DgOx7Y9v6VmeCPCWs+KdSl1O9f7NanEbOQR8o6IintXuOlaLZabGiQxAuo++wya48TiI0ZJReqMqlZ04pVneXVdPmcd8MfAMHh/S0k1LNxfuxdg4GEOOgH07+9dzJG4GYMAZyVAxkVNIVTdIx2gDB9PrXGeK/H+n6Z/o2msL3UGHCRHIX6mvOcquJndas4KNKdWXLTRs6nq2n6NJHJqNzHCmCQWPP5V514r8SXnjJ/sGhwSJpu7Ely6kBq5ebUPtOqPfasVvLtj8sQ+cJW5Brmqrpr+RpVwI34R/LKge/vXfTwqpNS3f4HrUsJ7FqSV5ee3yLNrYLNPZ2WzfFAvlkbep7k/lVPxZYP4f1a31G0QJAfkkUHoDxVfw54m/s25drpG3vzukGPyrofFWu2OtW8McRZmb5WyhCj861fPGok1odNqlOqote71IreKJYQtvEpWQh9yjBbj+VQavDNLgxq0csfIZfXHbFVrC7bSytpclmtTxHIRjjPAJqfXdYls9Oll3FlRflz3OOmR2qOWSlocc70Jc3QteH7m4UPFdYWA8NvOGcn1Heuk0S/tjJNJA2UBKneT+X6V4fpviXUrq5WRbpnjPzMhHQZxjB/nXYfYb0sPKbEb/NtLYGTVV8N/M7XIpzp4pybdj06XUoJtysyLC/BLNjGO1cp4zaFtMRopGmhHClTkK1YD6dM52vcAKGxnkikm0qdN6wzK3bB4yP/ANdZQoxhJNSN6NGlTkmplHU9W/s/w6jQoPNJ2gnt71gaT4vu3cNqSxiPORtUgt2z9a6i+06GbTFtZ8q/LBgeh7Z9q5a28MvPcRBZ0uFVQv3flXk12U/ZtPmOStTrTqt09jr7BoNRunlL74wPkyMg5qPWPC9tfXYmaSVH2BWEblBx7VauZYPD2lwwooww4bbya58X+q3uZrVJnjzjODxWSUnrF2R6H1f20U38PmXY9+nXrKwAI9ec1v6rrhu9Oto45m89fk2gYAHrUOq263aI6hfMOMgHH5VhOrW82yVcOnahKNSze6HFRxFnLdHeaIJLG3WR9pdMfMByOOuO9bK+Ir8M/m2inKjZhsFm+lcp4fu/ttq8xBLxN9xTjcMcZruNC08KHuJ/mnkGd2fug9cVw11GN3NXPLxEVGT51qVbXQ0ktGa+jje7kbewB6e1Z91bqySTNHG0UbBdoTaRxj866m5mS1DLk7yNwA6/hWDd2V1O4bzisRcOq5wDis6c29WzKFRnG+KdGaWxEseWKoGKD7yj/GsvR9UMMEVsqKIh8oPQj616SzTX93O0kUUUixbQhP3uetcn4j8Mstuby3UieNN8yZ4wa7KVZSShM7cNUpy9yotX1HtbCaAtz5Q/8eH0rzfx6+qeH7W2udNkYmxfeYf4ZoD2PuOn5V6D4cvFmgaCV9sq4CgnlqTXNMa6tSsaruj+dWfkMfQ57HpitqcuSVpbGk4tXpN28/yZ56FmX7F4k0UvCZQtxtGcqcZr2vwX8QLHXdLZrz9xewrmWM9+2RXI6dClxYRPFGihV+5jhMdRj9K5bxFpy6VeC609mjST7y5xg9SPp060p04V/dluup01aUcVD2cvjS0Z7xZ63p9xMFWdUmY8K/ynHtWs0gA5OfpXytrF9NF4f+1+c32jeFVd3T2Fe0/CLxRHrnh2K3mZhqEA+ZH+8Vz19648TgXRj7SLuj5v7Ti90WPFun3Vvrdv4i0+DMsK+VNGw++gzz9ea569ubzV9R8+BPvHoq9BXc+NPEdnoOkSNckPPKu2OEclieOlcXpXjZLq0SPTtMa1Y4V5HwTnjp+tVQ53Dm5fK56OFnO2kbvodZ4e8L28ViX1CLfPMdzBuoqnqngK3lmWWwmeFj94Z4NVdP8AFd0175ZQMAfmxngV3lvMs8CSRnIYZrGpOtSlzN7kVJ16MuZvc8p8ReF9TTcyozxJ12n/AArmdNiAneC7tykijOG6175I8auVLAN3HtXG+O9DtZrRLoR+VOr43p1wc8H15xW9HFuXuSR00Mwb92aOH8J+HbbWdRuVupJEhRQ6KhPXPauwl+H9vc2D26XV1Hn+9KWXHbg9a47R9Zm8N6l58wPlhdr59K6/Tfidpt3dlTDKLbcEMyjIVj61pX9vzc1PYvE1KznzUnoZ+nvqfgvUrWHVszWMo8rzUOU/2T7H+dekWN5BeWyy28gZcc88j61534o8eeHJ/tWj3e67kkXcuxcheODk9KyvA0d9rFoH069RXQFJV34IweOPp/Ksp0XUh7Sa5X+ZzOMcSnKbtJbnp2raZYanpskGoqjQyA8k4K/Q+1eAeIrFvDeqzxK5v0Rl2SBtoGfX3xXp0vgzUruR47y/dk6gq52j2xWT4h8FzWFneTmQNamPcy56N+P0rTCyhSfLzXv0OnBzjSvBVNzz8apLFZmOcn7HJJvdT6dBn6ZzXoXwr1S63XGl3EcSQRxBo2X1yc8fQivPtGeH+1Y7fU4vOsmk2TKe6Hgk49K9M8BaLp+n6zrdpYN9oaCTasrPuYIQML+GRXRi3H2bi0RmOH5aymtrHXxrFMC6uN/3SCe30qstssIzKM4JH0zV2JSz+Sqojudpbv3q4NNj2YeSRmP3iT1ryeaxxOoonJ+IoItH1bTtQgZQ80nlyKD1HriuN16wgF9cw3YAkDb454yF2Nxz+NdB8VJYNLjhkZ2ZnQiIEk7SD1/UVU+HER1PVJ49ZiMuIFkj3jhs5H6DFd1J8tL2rOynXjSjGbd3Yg8O+MdV0u1W3nt7a8QjcHE2w5468Y98VTu/iV4rurp47LRobOFM5lmBYHnHGcVn+JL7SrfxnqOnaaRutcM6dVXI5wfTmqFqLnxBerbROxgRdpznB9hWyo03+8cdzqjQo10q0UkupT1TWfEevTzLqWo3MkanHk2nyJx24q7ovhqTYhmJRX+VkH5ZPrXcaf4fGh20MVxF87/NG55Gccg1evZo9J0ySeMIZmwRG/3WHoKTrpe7SQqmNjCNqK0MG1trHRNLuJhal2j6Ecknpgn0rko/iN4j/ttonazS1RiDbeXuQr2GcZ59a7zwmI/EtldebhCpAZF6E5P6Vf0f4daPp+rG7eEzTFxKoK8KR/8Ar6VHtqVNyVZXZ4+JqSqyUkypruio6rcXEUYWZVwhB43AcfmTXnviT+zdMne3srmRZYuJNrZjJ9PrXs+v2VxqSTorjagHlBTghh3rxAeGPElldX0F5p8slopPk7F3mTJyTn9aeDmpL3n8jb65WpxXIzZ0y6MUSxalG81nONis44RupHv1p97p032J1s2+0Wmc+W33lI7qT/Wrek6Vdp4Qh0+9UqRI0wJHzBumT9BiqM+ozLpBKNIJ7dikwXk4xwQfTvWt7y93ud3tXUo88lfuv1Kuk6fYW1550sjm5yAElTaV78f/AFq6dnR1++q7hj2FZOlTR6to7S3hD7CUzIv3hj+dT6R4In1iRTZSzWtuPvOWPH0FTVa1c3awqVOhyc6fKiaW4VAGMiqccjruqjea3ArAQANKBjANdSnwm09kP2zVdRmYHOVcKM/TFUfFngPT9E0S6v8ATRcySW8Zcq77ifpWMK9CUlG9yY18NF6ts5qwtLjVJi1zJgZyEZsZ74robO0tltyzTi1gQ5JAyQM14TpF5q8+uSSK90BkErvOBn+deqNJLerBAGPm4AbHQnua661Jx6m9GssUm43jFFrVJYtcuxZ2gdrOE5kuH6tj0rYWx8lESAmOMAYBHX3qSztI7O1+VWAIxtH4c59aillTeTJJJuPtmuVyvpHoZVJ865Y7Iwke+0K/Ola6m1s/u5SOG+hq1qdt9qBlg5KgZr13xBoGn6/ZG2v4Q6/wupwyH1B/OvJtT0u/8K3i2moEzWchxBcr39m9DRRrxq6rSXb/ACFQxKqyutJfgzGt7i4sJN8RIl5H1Fej6b47shpKtMrLMihfLA6kcViaZpUOpwnzVRwnOA3b61hXmkNbas8ca4hY5XJqpxp1naW6OifscTpUVmj0DTdQa7uo77UWVY5QfLReqr2BrZTVLKZg8rKqBj1bgAen5Zrl4ovMiKKgZXVUZRj06CrkWl20csu4BiDsIDZIGAeK5J04vU8qcYuVtjX1nyJprKW3C+XuPzI2Cx7D+dVpr2KBXhuwWlkU5Qc8ds1i27xLr0XnXAWCM7whPLHkD+vSt2+kVjJe2oHmquPQ9MYo5eW0WNw5LI85sNKuY7/eQBGrDkg856Vv3VzYWsqxXGoQCYtnY7Yx3PFXLnUAY/Od4pLlU9OA2MfjXhV7b6hNOrLb3Et6JC7BIyxfJwR716FKm6+snaxeKxk202j1iSSGzuRcRyK1lcOA7A5Cs3Qj2Pf8KoeJtJuL2MiIZMZ+XB+8DjH41leEdP1Ka21BdTgkhtplKJFKckMTnI9MYrTsvEVhothazaxHLPvDQmNDg717n0/+vT5ZRl7urR10MVan7Z6NHDSte2gMcsEUjwSBwsiZ59D+FaOm3cmn6lZeINGaG1WAEzxs5+Zu6Fa6bSJbLX7W5uUjKpuwxbllPYH/ADzXL6zCukXF0VhWRSmQG6Z6g/hXQpc94MMXhqeMXt6Okt35/wDBPX/BOh2evmTxDfxee1ySY45PmCg9a7C10bTYDmGziTB4G39a8r+B3ju1uNNXRb6VYpI3byN3HBOdpr2fjHvXiYpVIVHGWn+R5decua6ej29DntZ8Ox3TedYsIJ8Yx0U+9c/Lp/iKw+W0y4xk7W4r0E4xkdaGIzk4Az1qIV5RVnqOGKnFWeq8zybWbTWNLl/tG482aVsSSBWJG3uPwrrxqNr4ghtY9KnjbK733HlRjpj1yaxPiP4wisy+l6bH9qucB5HQ5WMc8H3ry6bVIrHSm1F7qS3Z38tI05Jb2rvhRlWipSVn0PQjT9tSVWp7tj0XxJpltHMIZTFJK43MJMD/ADxXMaVpNqZGtLV0S3mfdIsXr6153ZeKItSv1hmglcSShTI773yfQV6JokS+HPEl22rTfYo44xKu9cbwOcCuh05Uo2b1NKMqLg5Qkm15HBeKdA8t7g3QldiQqSocbsev4VY0Oa+06KGe1lnhuYh+7uA2GI7hvWvQZfFGgeJdMXSnT7KXJKSOBvduwH+e1cpbxCF5Le4kRkiBxJ1/D61tGcpR5Zo3wqpVpuqlZ9ezOm0T4rahZNIur2wumLAHZwRwBkevStTU/iXp2s6XPaS21xbrKuCSAQD1rE8P+CLzxDpK31qsMEbcR7urY6muWs9D1K91p9JtIQ95GzI+5vlXHqa5vY4dybW6L9hg5zbWjj57CmZTe5VgwcMoJBAzjg8/lXdeA76aC0leMsL2AnajMMyw9QCfUdK5TUvCOu6PEJdQtv8AR423GVGyAM459qvi5a01mztdLimlnaMPNOAcDJ6L/wDXrSfLVjaOosbKi0qnNdPTuj2vS9V0y8tIZoZ4wxXdtc4YHHOQe9X5bqCKMyPKgQfxZ4ryi4tY7W8eW4CzoybieMAn9KmuZJbuOEQssducblduMV5rwqbunoeY8Cm7qWgvjK5tdYvbS4ul3WKylCT/AAjjn2p3xN1dfD2nafa6CpgnmYB5oeSkePX1PGKyNdkgjuI7eGRWV+HPvRcNcbnjt1DRbMuGGQAB1yeldcaaXK+i6HTVwinGKTtZM8/0fQHl1OV0EjTXX3SeWbuzMa9g0nTYtCs4ltCN2zdvUclq5jwO0jalLdBUEnMSbhwo4z+Neg6jpl3c2MdtaTxiRQWeTbjP0/Sniqzc1F7GddfV4KhHYxtf1mT7MhnAdlBILcYGK57StXg8Tar/AGRMcTAYG0Hp65/pWnpvhPxFJeQW+s3NtNaO+5sZ3KME8e9dp4e8LadoVxLLEivcP/y0ZRkD0rnlUp0Y2Wr6WPOdRvbYy/DnhyDw4LgtLiMjOT94nOa6KwJuizyeaEXhSRtDZ+n4VanjjkciRQy57irCJ8vJGRwcdK8+pVc9ZbkcysVVCRziPbtXqCe/NS3Dqu0KMuegHc1JLGkqYY9e4rNibY7vI3CH7xPSoWuoLXUzvEWnxxwK5AZpHCMgH381514j05bSRpUHlvHw6ngmrfiH4iyQ+I4re1tBefZmYbAcDp19z147Umu+MdL8T6CFhga21EYZ42HIGccHuK9WhTq0+VtaM7MJXcaqgtTPWNEtI5dp3SEFRjGemSMV0+k6w2mwgiYMjLjY3RT615TfXN7PrSRQu+YSECgkY7M34nP5V1MVnOYgkyncBy7ZOfpXTVopxSk9zvjONfmU9kzv7DxpbfavJvnjVSPlYdM1Y17xLpYsnht7uGaVztKjsMc15lPpUghDFlbtg0y03WNwd8YRvda5/qlPm5osX1KjJ80H8hZ9JtbSSW8tYzG7/KPftkenWr/hm1TzZppcFvupz371V1S4zCPNYs7MM85AHtV3wvrOnRWstncDcWPmeZjIUen/ANat6nM4GtWKo0Hyq12bN1iRCuCGAwBmmJFGwLNAZSf4iKNTmi023a/Yh4AuVzwGB/pXn2o+KfE6XJ+xJb/Z2AZQAvAI6ZPWsaVOU/hPLlWjT3PpG2ljnhEkMgKN6HvTdRsrXUrR7a+hEsLggq3b3rhvCmszxxRKACkgDbSfumu+tmMkKs3UivMqU5UpaHNVpSoyszy7UbO68F3nloxk0u4O2KZuTGf7rH+tRsfOlVgBk9OvevQfEccF7Y3NldQiSKSMjr09xXmGgykxyRc4jbrnk130J+0hzPc7qUnVg5vdHQfa106bznjEqbfkHXnoDUmnz300DliYVmLbg4yQPUVOiJp2hteFFnlzuIk6YA3Ae1ecSePtYl1O5kYxeRK6xmHb/CfeqhSlUvyo5alVRlZndRaAZ9S/tCE+YIjgtjnj0FdDb3Frdwyl4wSQRIFHSq9rqbWWnyeXErHlgSelS+Es3PhrzydsskruzfieP0rnnJyXM/RG1SUnG8umiOb1bw9FqKXU9hIYJo2AjU8h/b+dYOhT3EF1LbXTFGiJ6rjBHvXoD2ws5o5VbcZDgjGAMf8A6q8/mnMviKSQjBZjnnrXXRm5Jp7Hbh5ucXCWqOil8t4nk2Ntx1HeuU1LQIdXvpbJj5bXGJoGbs3Q/wBK6u5uzHarlQ2U5HQcAdq5rxTM0NtBfxfJPbyqybeO/T9Kuk2noRTipXpy66G/4P8ACCeGNKuLK8Zbm8uiJHO3AUgcBTXM+LLJLiOWQjY6Nswxxkd69SlvWuNEt7p1HnSR8t6cV59qUa3cF5vzna3J55wef0qMPUlOTlLcnAydG76I8z0jQ5hdPPp37u5tphIOfvD0x6/4V7JafGDw5Y2KQ6xdNBfxrhoypOT25rjP2f5Te60xuAHCwsMHnoetd58Tvhf4f8UabcXMlutpfRoXFxCuCcDuOAa0xU6c6vs63TqcmMjGnLlprSVpLyuZmmfEK+uonubVI5onOUR26ZNZ/iHWNfvoN97ei2hI+ZIDj5epOay/gh4cjukmtby4aWGCc4G3BYDsTmvU9W8PWUOi3MSJ95GAZuStZzlRo1OVI3lWpRScY2k0eS+GfGOi6U1zbyWE7/aFHlyTAMCe5J+tdn4R8DaL4l8FWkmsQNcRyyNOm1yu3qOorzW8sIrq4hUkqrs2QOmRxxXrXwnv3t/D9xprLvSxlZEfOCwPPT2zWuLXs4c1J2fU5fa1KtOUX5G34c8B+G/Djh9L0yGOQch3+cg+uT0rhfjvYz6le6RaWMYmu5AzLF3bB/8Ar16tLelP4M5964fwhOdZ+ImtXt0oL2kSQwDr5anJOK4KFSam60ne3/DE0qbSlJ7JHN6P8LbnWLi2vPESR2AiwVhtm+YDHTPat7xB8OQ1uYtFYLuU/wCtY9fc16WcbfxpKUsbVcr3Io1pUXeB5foh8ZadpR0aDR0jZiQt00oKRg9SP5/jXU+FPCNpokZmlJuNRl+aadj1J9Paun7UHtWU8Q5p20vvYupiZTv0vvbqcd8VrkWXgi9IJBl2xADvuI/wrgtNttRk0y5nltmtItP2LMpbDtkZyvbHr9a6f4v3Befw1ppB8m6vl3nPYEDp+NZXxMvbpDq9nBN5VvIiK6qOvGOv0FduGuoRiuv/AAEehhZONFRS3u/yRn6Pr+nXN9Lp736lZk2AHBAYjoW6A/4VHc2sy2s7W8qXcCyFVkhYSYCnHzY6V5Fp+n/ar6Sy81kVSTuxnNejfCuE6Pf36LI0irHtVR8o5zyR3ruq0VSTlF/I56GOqqa91WZIJLe1D3l0xYw7jvPC8VN4M1BruzuL+WVZrN2dmQ9Rjt9KreKQLy5ewdUWL5W4X17VDpSLp2kvZ2w2oX6/U4PH4Umk4anquNSpJN/C0dF4CSK+aaRt0O8kxjsfXmvRrJ3jtlVZMsBwD9K8n3PpMsMcDkohLBeg+ldtp+ryXHlyPGAVTAwa48TTcnzLY58bRcnzLY3Jb24g1COWcFYlyAAcjPer9rq9vfny0c7j0x3/ABrhfFmo3DeFL5gwVkw4IHPXpmsfRb64soIJkkLM5875uoz2+lY/VueHM9zyakkmtD18p5MTYAwvPJqxHIjIpB4IqpE5eJC38ShsfUf/AF6nEY37AcAc157S6kNdyRiBuJ6445rB15XWwmMPBbGcfWszx34km8NaS11BCszh8AO2O2a4HRPHGoa1qjQXccexlDYHQceldWHws2udbIuC5ZK5kavpV9pV3enSUE17LN5lvKQSBnr9DS6bYz/a1utTjiS5jjVGjhPGc8knvmup1Rzb6d5kfDyE8+lcP4h1OXT/AC1hH+sbBOea9enKU1Y78Nh40lLEN3tsV7i6uIrqeWxUwsWG0sAep6/nXoulW0xtoJNSh+8gLMDjaSPSuB8HznUr3dcqCHDcehAGD+lemSSSyx7Zn3grtBIxgAcVOKdrRsY0pym3NvcrX1qtsCRICFIIJ9KqzW8coKttUnjcTTbyRpEZTwPlX9P/AK1UbeUzMxbPyEEDPHFYJNK52qDS5rlLU4ZFbyHUZTo4/i+lZ1vDFBfrJIpx/Guetdfd26XMUjOMBRuA9DXOanbfZ7koHLHZu3H+VbQnfQ66VSNaPs5HTaokWsaXDYmU7SpGCoIGPu/04rGbwZrW1FuLa0uCi7VdmAO3txVDTb97e3lcDcY4mkXJ6ECskX+pXIE0mpXKs4DYRsAZHQCphTnF2i18zxMbRVOfIz//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph of a normal glomerulus. There are only 1 or 2 cells per capillary tuft, the capillary lumens are open, the thickness of the glomerular capillary wall (long arrow) is similar to that of the tubular basement membranes (short arrow), and the mesangial cells and mesangial matrix are located in the central or stalk regions of the tuft (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut G Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_55_22393=[""].join("\n");
var outline_f21_55_22393=null;
var title_f21_55_22394="Acute liver failure in children: Etiology and evaluation";
var content_f21_55_22394=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Acute liver failure in children: Etiology and evaluation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/55/22394/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/55/22394/contributors\">",
"     Robert H Squires, Jr, MD, FAAP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/55/22394/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/55/22394/contributors\">",
"     Elizabeth B Rand, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/55/22394/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/55/22394/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/55/22394/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 1, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H18338558\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pediatric acute liver failure (PALF) is a complex, rapidly progressive clinical syndrome that is the final common pathway for many disparate conditions, some known and others yet to be identified [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. The estimated frequency of acute liver failure (ALF) in all age groups in the United States is about 17 cases per 100,000 population per year, but the frequency in children is unknown. PALF accounts for 10 to 15 percent of pediatric liver transplants performed in the United States annually.",
"   </p>",
"   <p>",
"    PALF is a rapidly evolving clinical condition. There are no adequately powered studies to inform diagnostic algorithms, to assess markers of disease severity and trajectory, or to guide decisions about liver transplantation (LT). The clinician must construct an individualized diagnostic approach and management strategy. Management requires a multidisciplinary team involving the hepatologist, critical care specialist, and liver transplant surgeon.",
"   </p>",
"   <p>",
"    The pressing clinical questions faced when children with PALF first present are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Does the patient have a condition that is treatable?",
"     </li>",
"     <li>",
"      What is the risk of deterioration or improvement on each day the child is alive with his or her native liver?",
"     </li>",
"     <li>",
"      Is a liver transplant necessary for patient survival?",
"     </li>",
"     <li>",
"      Are associated morbidities reversible?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An organized approach to answering these questions, including an overview of the causes of PALF, will be outlined in this topic review. Management of PALF and its complications in children are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/39/6777?source=see_link\">",
"     \"Acute liver failure in children: Management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    ALF in adults is addressed in separate reviews. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/17/2330?source=see_link\">",
"     \"Acute liver failure in adults: Etiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/40/38538?source=see_link\">",
"     \"Acute liver failure in adults: Management and prognosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18338289\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pediatric acute liver failure (PALF) typically presents in a previously healthy patient with a nonspecific prodrome of variable duration with features that might include abdominal discomfort and malaise with or without fever. With the exception of acute ingestions (eg, mushrooms,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/15/19705?source=see_link\">",
"     acetaminophen",
"    </a>",
"    ), the precise onset of disease is rarely identified. Symptoms may persist or wax and wane for days or weeks before the child is brought to medical attention. In the absence of jaundice or other clinically evident signs of liver dysfunction, the child may receive empiric treatment to relieve symptoms, and some children undoubtedly recover before PALF is recognized. However, if there are clinical signs of liver injury or encephalopathy, or if blood work is obtained that reveals hepatic dysfunction, the clinical syndrome of PALF can be recognized.",
"   </p>",
"   <p>",
"    Common features at presentation of PALF were described in a study from a multicenter registry [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Encephalopathy &ndash; 53 percent (13 percent grade 3 or 4)",
"     </li>",
"     <li>",
"      Seizure &ndash; 7 percent",
"     </li>",
"     <li>",
"      Ascites &ndash; 22 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition to the 53 percent of patients with encephalopathy on admission, an additional 15 percent of patients developed encephalopathy within the next seven days [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/1\">",
"     1",
"    </a>",
"    ]. Encephalopathy is less common among children younger than three years and those with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/15/19705?source=see_link\">",
"     acetaminophen",
"    </a>",
"    -induced PALF. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/39/6777?source=see_link&amp;anchor=H18340160#H18340160\">",
"     \"Acute liver failure in children: Management\", section on 'Encephalopathy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18338296\">",
"    <span class=\"h1\">",
"     CAUSES OF PEDIATRIC ACUTE LIVER FAILURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Specific etiologies of pediatric acute liver failure (PALF) can be broadly categorized as infectious, immunologic, metabolic, and toxin or drug-related. In more than 50 percent of patients, a specific cause is not discovered, and in this case, the PALF is categorized as indeterminate.",
"   </p>",
"   <p>",
"    Worldwide, the causes of PALF vary depending on the age group and region. The causes of PALF in developed countries are outlined in the Table (",
"    <a class=\"graphic graphic_table graphicRef83285 \" href=\"UTD.htm?39/58/40877\">",
"     table 1",
"    </a>",
"    ), which is derived from a registry of PALF in children from 19 pediatric liver transplantation (LT) centers in the United States, Canada, and the United Kingdom between 2000 and 2007, known as the Pediatric Acute Liver Failure Study Group (PALFSG) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/3\">",
"     3",
"    </a>",
"    ]. In developing countries, the etiologies are similar but are dominated by infectious etiologies, among which hepatitis A is the most common (",
"    <a class=\"graphic graphic_table graphicRef83764 \" href=\"UTD.htm?34/22/35182\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18338303\">",
"    <span class=\"h2\">",
"     Acetaminophen",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/15/19705?source=see_link\">",
"     Acetaminophen",
"    </a>",
"    (N-acetyl-p-aminophenol [APAP]; paracetamol) is widely used in children for management of fever and pain. APAP is safe and well tolerated when dosing instructions are strictly followed. However, APAP has a low therapeutic index, and in certain individuals or clinical scenarios, chronic administration of therapeutic dosages of APAP can result in significant hepatotoxic effects [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Two clinical scenarios are associated with APAP hepatotoxicity:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute single ingestion of a hepatotoxic dose of APAP that is greater than 100",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      (typically an intentional ingestion by an older child or adolescent, or rarely an exploratory ingestion by a young child).",
"     </li>",
"     <li>",
"      Chronic ingestion of inappropriately high doses of APAP (&gt;90",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day, ie, &gt;15",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      given every four hours) for more than one day. Risk factors for developing severe hepatotoxicity include concomitant use of other medicines that alter hepatic metabolism, delayed medical care, younger age, and prolonged periods of fasting [",
"      <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/4,6\">",
"       4,6",
"      </a>",
"      ]. In the PALFSG registry, chronic APAP may have contributed to livery injury in about 10 percent of patients [",
"      <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In patients with PALF, acute or chronic APAP exposure typically is characterized by high alanine aminotransferase (ALT) levels and relatively modest elevations in total bilirubin. In the PALFSG registry, children with chronic APAP exposure were younger than those with acute APAP exposure, and also had worse 21-day outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/7\">",
"     7",
"    </a>",
"    ]. Whether the difference in outcome was related to age, differences in treatment (eg, use of n-acetylcysteine), or other underlying contributors to liver disease remains to be determined. The pathophysiology, diagnosis, and management of APAP poisoning in children are discussed in detail in separate topic reviews. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/42/22186?source=see_link\">",
"     \"Clinical manifestations and diagnosis of acetaminophen (paracetamol) poisoning in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/51/13114?source=see_link\">",
"     \"Management of acetaminophen (paracetamol) poisoning in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18338310\">",
"    <span class=\"h2\">",
"     Other medications or toxins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Liver injury caused by drugs and toxins other than",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/15/19705?source=see_link\">",
"     acetaminophen",
"    </a>",
"    was identified in less than 3 percent of cases in the PALFSG registry; the vast majority of the cases occurred in children over 10 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/1\">",
"     1",
"    </a>",
"    ]. The list of toxins associated with liver failure is extensive and expanding; a partial list is shown in the Table (",
"    <a class=\"graphic graphic_table graphicRef83765 \" href=\"UTD.htm?12/21/12637\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18338317\">",
"    <span class=\"h3\">",
"     Intrinsic hepatotoxins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Agents with predictable dose-dependent hepatotoxicity are known as intrinsic hepatotoxins, and include industrial solvents and mushroom toxin (as well as APAP, which is discussed above). The diagnosis of hepatotoxic liver injury is based upon the interval between drug ingestion and the onset of symptoms, the known hepatotoxicity of the offending agent, serum drug levels (if available), and liver biopsy findings [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/28/10698?source=see_link\">",
"     \"Amatoxin-containing mushroom poisoning including ingestion of Amanita phalloides\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18338324\">",
"    <span class=\"h3\">",
"     Idiosyncratic hepatotoxic effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many agents have idiosyncratic hepatotoxic effects, such that toxicity is not predictable or dose-dependent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/27/13754?source=see_link&amp;anchor=H16#H16\">",
"     \"Drugs and the liver: Metabolism and mechanisms of injury\", section on 'Idiosyncratic reactions'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An idiosyncratic hepatotoxic effect is well established for each of the following drugs; if a patient with ALF was recently exposed to these drugs, a causal association is likely:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/24/38278?source=see_link\">",
"       Isoniazid",
"      </a>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/61/41943?source=see_link\">",
"       \"Isoniazid hepatotoxicity\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/50/15142?source=see_link\">",
"       Propylthiouracil",
"      </a>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/21/41303?source=see_link&amp;anchor=H12#H12\">",
"       \"Pharmacology and toxicity of thionamides\", section on 'Hepatotoxicity'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Halothane (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/3/34871?source=see_link\">",
"       \"Halothane hepatitis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For many other drugs, idiosyncratic hepatotoxicity is less well established. If a patient with acute liver failure (ALF) was recently exposed to such a drug, a degree of skepticism should be maintained regarding the role of drug exposure in causing the hepatic injury [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/5,9\">",
"     5,9",
"    </a>",
"    ]. In children, idiosyncratic reactions causing PALF have been reported for the following drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Anticonvulsant drugs &ndash;",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?26/54/27497?source=see_link\">",
"       Valproate",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?32/19/33082?source=see_link\">",
"       phenytoin",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/36/5706?source=see_link\">",
"       carbamazepine",
"      </a>",
"      , and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?27/25/28055?source=see_link\">",
"       felbamate",
"      </a>",
"      are the most common drugs associated with PALF. Patients with unsuspected mitochondrial disease are particularly at risk for hepatotoxicity from valproate.",
"     </li>",
"     <li>",
"      Antimicrobial agents &ndash;",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/26/34214?source=see_link\">",
"       Amoxicillin-clavulanate",
"      </a>",
"      , roxithromycin, and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?10/21/10581?source=see_link\">",
"       nitrofurantoin",
"      </a>",
"      , as well as a number of antiviral agents used in the treatment of HIV, have been reported to cause PALF (as well as",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/24/38278?source=see_link\">",
"       isoniazid",
"      </a>",
"      , for which the hepatotoxic effect is well established).",
"     </li>",
"     <li>",
"      Chemotherapeutic agents &ndash;",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/62/38886?source=see_link\">",
"       Cyclophosphamide",
"      </a>",
"      and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/45/22229?source=see_link\">",
"       dacarbazine",
"      </a>",
"      are associated with hepatic vein injury, resulting in veno-occlusive disease and PALF.",
"     </li>",
"     <li>",
"      Other medications &ndash; Other potential medications that should be considered in the proper clinical setting include",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?9/41/9882?source=see_link\">",
"       amiodarone",
"      </a>",
"      (antiarrhythmic) and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/46/744?source=see_link\">",
"       trazodone",
"      </a>",
"      (antidepressant).",
"     </li>",
"     <li>",
"      Recreational drugs &ndash; Recreational drug use, particularly cocaine and ecstasy (3,4-methylenedioxyamphetamine [MDMA]), is associated with PALF in teenagers and even younger children who live in environments where these compounds are accessible. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/3/21560?source=see_link\">",
"       \"MDMA (ecstasy) intoxication\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/61/33753?source=see_link\">",
"       \"Inhalant abuse in children and adolescents\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Complementary or alternative medicines &ndash; Complementary or alternative medical therapies associated with liver failure include pyrrolizidine alkaloids, germander, Chinese herbal medicine, ma huang, chaparral, black cohosh root, pennyroyal, and kava [",
"      <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/10\">",
"       10",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/2/25642?source=see_link\">",
"       \"Hepatotoxicity due to herbal medications and dietary supplements\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18338331\">",
"    <span class=\"h2\">",
"     Immune dysregulation",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18338340\">",
"    <span class=\"h3\">",
"     Autoimmune marker positive",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical significance of autoimmune markers in patients with PALF is not clear. In some cases, these markers are nonspecific, since they can be found in patients with other known causes of liver failure, such as Wilson disease (WD) and drug-induced liver failure. In other cases of PALF, patients have a clinical picture consistent with autoimmune hepatitis, with markedly elevated autoimmune markers",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    total serum protein, characteristic histological features, and apparent response to treatment with corticosteroids.",
"   </p>",
"   <p>",
"    About 7 percent of the cases in the PALFSG registry had positive autoimmune markers (antinuclear antibody [ANA], anti-smooth muscle antibody [SMA],",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    liver-kidney microsomal antibody [LKM]) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/1\">",
"     1",
"    </a>",
"    ]. The true frequency of positive autoimmune markers in PALF is not known because these tests are not consistently obtained in the patient population [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/11\">",
"     11",
"    </a>",
"    ]. The frequency of autoimmune markers in PALF is similar across age groups, including in infants between 9 weeks and 12 months of age, and is evenly distributed among males and females [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/3\">",
"     3",
"    </a>",
"    ]. Therefore, an autoimmune mechanism should be considered in all age groups outside of the neonatal period. This pattern is in contrast to chronic autoimmune hepatitis, which is most frequent in adolescents and adults and has a female predominance.",
"   </p>",
"   <p>",
"    Establishing a firm diagnosis for autoimmune hepatitis is challenging in patients with PALF, and in many cases only a presumptive diagnosis can be made. Isolated mild elevations of ANA are common and are not diagnostic of autoimmune hepatis. Elevated serum globulins support the diagnosis of autoimmune hepatitis, but are not always present. Similarly, the diagnosis can be supported by a liver biopsy if it reveals histologic features suggestive of autoimmune hepatitis. The interpretation of autoimmune markers and other laboratory and histologic findings is discussed in detail in a separate topic review. Of note, the simplified scoring system that is often used for diagnosis of autoimmune hepatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/12\">",
"     12",
"    </a>",
"    ] may not be sufficiently sensitive for children presenting with ALF [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/44/35528?source=see_link&amp;anchor=H5#H5\">",
"     \"Clinical manifestations and diagnosis of autoimmune hepatitis\", section on 'Diagnosis'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    If autoimmune hepatitis is suspected, patients are usually treated with corticosteroids, because these drugs can interrupt the liver injury in many patients. Among children who respond to corticosteroids, some children appear to tolerate weaning of the corticosteroids without recurrence of their disease. Recurrent disease appears to be somewhat less common in children with autoimmune-mediated ALF as compared with adults. Initiation of steroid therapy in the setting of PALF is a difficult decision. Steroid treatment may be the only option for a critically ill deteriorating child, and can be valuable if the patient does have an autoimmune mechanism of disease. On the other hand, steroids also may cause mental status changes that interfere with assessments of encephalopathy and also increase risk for sepsis, which is a frequent cause of death in this population. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18338347\">",
"    <span class=\"h3\">",
"     Hemophagocytic lymphohistiocytosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemophagocytic lymphohistiocytosis is an enigmatic condition involving cytokine dysfunction. Up to 25 percent of cases are familial, and mutations in genes affecting granule-dependent cytotoxicity are identified in about half of affected patients. The remainder of cases (and some of the genetic cases) may be triggered by acute viral infection, particularly Epstein-Barr virus (EBV) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The disorder is most commonly diagnosed in the first five years of life, but can present in adolescence or adulthood. It is characterized by fever, hepatosplenomegaly, marked elevation in serum aminotransferase levels, cytopenias, hypertriglyceridemia, hyperferritinemia (serum ferritin concentrations are often over 5,000",
"    <span class=\"nowrap\">",
"     ng/mL),",
"    </span>",
"    and hypofibrinogenemia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/5/41050?source=see_link\">",
"     \"Hemophagocytic lymphohistiocytosis\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18338354\">",
"    <span class=\"h3\">",
"     Gestational alloimmune liver disease (neonatal hemochromatosis)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gestational alloimmune liver disease (GALD, previously known as neonatal hemochromatosis) is a rare disorder characterized by hepatic failure and hepatic and extrahepatic iron accumulation (hemosiderosis) during the neonatal period. The new name reflects the recognition that an alloimmune mechanism is responsible for the disorder. Maternal immunoglobulin G appears to activate fetal complement that leads to the formation of membrane attack complex, resulting in liver cell injury [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/17\">",
"     17",
"    </a>",
"    ]. The degree of liver injury can be so profound, that death from liver failure can occur within the first few weeks of life. Therefore, liver failure associated with GALD is technically a terminal event of a chronic intrauterine liver disease. However, the typical phenotype of the family&rsquo;s index case of GALD is one of acute liver failure presenting during the neonatal period, so it is discussed here for clinical purposes. &nbsp;",
"   </p>",
"   <p>",
"    Characteristic clinical features of GALD include refractory hypoglycemia, severe coagulopathy, hypoalbuminemia, elevated serum ferritin (&gt;1000",
"    <span class=\"nowrap\">",
"     ng/mL),",
"    </span>",
"    and ascites. Strikingly, serum aminotransferase levels are normal or near normal, which helps to distinguish GALD from other causes of liver failure that present during the neonatal period. Extrahepatic iron deposition is a hallmark finding. Hemosiderin deposition in the minor salivary glands obtained by a buccal mucosal biopsy is often seen. Characteristic findings on magnetic resonance imaging (MRI) of the abdomen include reduced T2-weighted intensity of the liver",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the pancreas relative to the spleen.",
"   </p>",
"   <p>",
"    Exchange transfusion and high-dose intravenous immune globulin is the preferred treatment for GALD [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/18\">",
"     18",
"    </a>",
"    ]. For pregnant women with a previous pregnancy that resulted in an infant with GALD, treatment with high-dose immune globulin beginning at 14 weeks gestation dramatically reduces the risk for recurrence of the disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/50/16169?source=see_link&amp;anchor=H23#H23\">",
"     \"Causes of neonatal cholestasis\", section on 'Gestational alloimmune liver disease (neonatal hemochromatosis)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18338361\">",
"    <span class=\"h2\">",
"     Inherited metabolic disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Metabolic diseases do not fit the definition of ALF precisely, as the condition was certainly present prior to presentation. However, a number of inherited metabolic diseases are diagnosed only after the child presents with ALF. Thus, these conditions are important considerations in the differential diagnosis of PALF. Overall, metabolic diseases account for just over 10 percent of PALF cases in North America and Europe [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/2\">",
"     2",
"    </a>",
"    ]. While some conditions, such as mitochondrial disease, may present at any age, many metabolic conditions presenting as liver failure segregate within age groups. Metabolic conditions that should be considered in these age groups are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef83766 \" href=\"UTD.htm?29/29/30171\">",
"     table 4A",
"    </a>",
"    ). The conditions that have been associated with a presentation of ALF are outlined briefly below. Details of the specific conditions can be found in the linked topic reviews. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21413563\">",
"    <span class=\"h3\">",
"     Young infants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Metabolic conditions affecting infants in the first few months of life include galactosemia, tyrosinemia, Niemann-Pick type C, mitochondrial hepatopathies, and urea cycle defects [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/19\">",
"     19",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Galactosemia (",
"      <a class=\"external\" href=\"file://omim.org/entry/230400\">",
"       MIM #230400",
"      </a>",
"      ) should be considered in a child consuming breast milk or other lactose-containing formulas who develops liver failure associated with reducing substances in the urine; reducing substances are detected by a test for reducing sugars (such as Clinitest tablets). Galactosemia can present in association with gram negative sepsis. Galactosemia is included in the newborn screen in all states in the United States, but if the condition is suspected, definitive testing should be performed even if the newborn screen is negative. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/10/30886?source=see_link\">",
"       \"Clinical features and diagnosis of galactosemia\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/5/36950?source=see_link\">",
"       \"Management and outcome of galactosemia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hereditary tyrosinemia type 1 (",
"      <a class=\"external\" href=\"file://omim.org/entry/276700\">",
"       MIM #276700",
"      </a>",
"      ) can present with a profound coagulopathy and normal or near normal serum aminotransferase levels. Like galactosemia, tyrosinemia can present in association with gram negative sepsis. Almost all states in the United States include tyrosinemia in the newborn screen. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/4/23624?source=see_link&amp;anchor=H4#H4\">",
"       \"Disorders of tyrosine metabolism\", section on 'Hereditary tyrosinemia type 1'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/2/2088?source=see_link\">",
"       \"Newborn screening\"",
"      </a>",
"      .) &nbsp;",
"     </li>",
"     <li>",
"      Niemann-Pick type C (",
"      <a class=\"external\" href=\"file://omim.org/entry/257220\">",
"       MIM #257220",
"      </a>",
"      ) is a lysosomal storage disease; marked splenomegaly is often noted. Although most individuals present with progressive neurologic disease in middle to late childhood, a minority of cases present during early infancy with severe hepatic disease",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      respiratory failure [",
"      <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/20\">",
"       20",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/0/20489?source=see_link&amp;anchor=H5#H5\">",
"       \"Overview of Niemann-Pick disease\", section on 'NPD type C'",
"      </a>",
"      .) &nbsp;",
"     </li>",
"     <li>",
"      Mitochondrial hepatopathies (MH) are increasingly recognized as an important cause of liver failure due to deficiencies in respiratory complexes I, III, or IV or mitochondrial DNA depletion. With rare exceptions, MH are associated with systemic mitochondrial dysfunction, characterized by progressive neurologic deficiencies or cardiomyopathy or myopathy. Lactic acidosis and an elevated molar ratio of lactate to pyruvate (&gt;25",
"      <span class=\"nowrap\">",
"       mol/mol)",
"      </span>",
"      should alert the clinician to the possibility of MH, although it is not specific. Defects in fatty acid oxidation, a primary function of mitochondria, may become clinically apparent during a period of fasting as a consequence of anorexia associated with an acute illness, or when the infant begins to sleep through the night. These patients are particularly vulnerable to hepatotoxic effects of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?26/54/27497?source=see_link\">",
"       valproate",
"      </a>",
"      . (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/12/7370?source=see_link\">",
"       \"Mitochondrial myopathies: Clinical features and diagnosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/50/16169?source=see_link&amp;anchor=H20#H20\">",
"       \"Causes of neonatal cholestasis\", section on 'Mitochondrial disorders'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      In such patients, hepatomegaly is often evident and serum aminotransferase levels usually are elevated, but only to a mild to moderate degree (usually &lt;400 international",
"      <span class=\"nowrap\">",
"       units/L).",
"      </span>",
"      Jaundice can be minimal (serum bilirubin concentration usually &lt;10",
"      <span class=\"nowrap\">",
"       mg/dL),",
"      </span>",
"      which suggests that certain organelle functions remain intact, and also that bilirubin production probably is not increased.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21413578\">",
"    <span class=\"h3\">",
"     Older infants and young children",
"    </span>",
"    &nbsp;&mdash;&nbsp;In older infants and young children up to five years of age presenting with ALF, the following metabolic diseases are sometimes identified [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/1\">",
"     1",
"    </a>",
"    ]: &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      MH, particularly disorders of fatty acid oxidation, occur relatively commonly in this age group [",
"      <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/21\">",
"       21",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H21413563\">",
"       'Young infants'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hereditary fructose intolerance (HFI) presents only after the introduction of fructose",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      sucrose into an infant&rsquo;s diet, and is characterized by recurrent hypoglycemia and vomiting. Therefore, most cases present at the age of weaning, when fructose or sucrose typically is added to the infant diet. However, some infants may present earlier, because many commercial formulas and medications contain sucrose. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/40/16010?source=see_link&amp;anchor=H15#H15\">",
"       \"Etiology of hypoglycemia in infants and children\", section on 'Hereditary fructose intolerance'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Arginosuccinate synthetase deficiency (citrullinemia type 1) and ornithine transcarbamylase deficiency have been associated with PALF, although the mechanism of liver injury is uncertain. Most other urea cycle defects (UCD) present with hyperammonemia, mental status changes, and seizures, but without liver synthetic dysfunction. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/49/20248?source=see_link\">",
"       \"Urea cycle disorders: Clinical features and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6015390\">",
"    <span class=\"h3\">",
"     Older children and adolescents",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Wilson disease &ndash; Wilson disease (WD) is the most common metabolic condition associated with PALF in children over five years of age [",
"      <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/1\">",
"       1",
"      </a>",
"      ]. The presence of a Coombs-negative hemolytic anemia, marked hyperbilirubinemia, low serum ceruloplasmin, and a normal or subnormal low serum alkaline phosphatase should prompt consideration of WD, but confirming the diagnosis remains a challenge. Findings in a predominately adult population suggest that the combination of an alkaline phosphatase to total bilirubin ratio of less than 4 and an aspartate aminotransferase (AST) to alanine aminotransferase (ALT) ratio of more than 2.2 provided a rapid and accurate method for diagnosis of WD presenting as ALF [",
"      <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/22\">",
"       22",
"      </a>",
"      ]. However, these findings have not yet been confirmed in a pediatric population. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/48/14088?source=see_link\">",
"       \"Tests used in the diagnosis of Wilson disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Mitochondrial disease (fatty acid oxidation defects) occasionally present with PALF in older children and adolescents. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/26/27047?source=see_link&amp;anchor=H8#H8\">",
"       \"Inborn errors of metabolism: Classification\", section on 'Fatty acid oxidation disorders'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18338368\">",
"    <span class=\"h2\">",
"     Infectious diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;A nonspecific prodrome consisting of fever, nausea, vomiting, and abdominal discomfort precedes many cases of ALF in children regardless of etiology. Therefore, in the past, ALF often was attributed to a virus or infection. When rigorous techniques are applied in an attempt to identify specific infectious agents, the common hepatitis viruses have not often been found in ALF, except in association with a community outbreak, or in regions in which the virus is endemic. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18338375\">",
"    <span class=\"h3\">",
"     Hepatitis viruses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Less than 1 percent of children with symptomatic hepatitis A virus (HAV) develop ALF. Nonetheless, acute HAV accounts for up to 80 percent of PALF cases in developing countries, reflecting high rates of HAV infection in the population [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/23\">",
"     23",
"    </a>",
"    ]. In North America and Western Europe, HAV infection causes only 0.8 percent of cases of PALF, reflecting low rates of HAV infection, especially since the introduction of the HAV vaccine in the United States in 1995 [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/58/16295?source=see_link\">",
"     \"Overview of hepatitis A virus infection in children\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    Similarly, acute hepatitis B virus (HBV) infection resulting in ALF is uncommon in pediatric series from Western Europe and North America, where HBV is not endemic. Among the first 653 PALFSG patients, none were ultimately diagnosed with HBV. However, in areas where HBV is endemic, it accounts for up to 20 percent of PALF cases. Death occurs more commonly in older patients and in individuals who acquired HBV following a blood transfusion rather than from perinatal infection. Mutations in the HBV genome appear to be a risk factor in the development of ALF [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/41/31386?source=see_link&amp;anchor=H5#H5\">",
"     \"Overview of hepatitis B virus infection in children\", section on 'Acute HBV infection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hepatitis C virus (HCV) infection has rarely been identified as the cause for ALF, and ALF has not been observed in large studies of transfusion-acquired HCV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/25\">",
"     25",
"    </a>",
"    ]. HCV RNA has not been detected in the serum of patients with sporadic fulminant hepatitis without defined cause [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/26\">",
"     26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/2/6186?source=see_link&amp;anchor=H19#H19\">",
"     \"Hepatitis C virus infection in children\", section on 'Acute infection'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    Hepatitis E virus (HEV) infection is rare in the United States, but endemic in many developing countries. HEV appears to be a common cause of acute hepatitis and sometimes of ALF in these endemic areas, but the true incidence may be underestimated because serologic testing is not consistently performed [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/11\">",
"     11",
"    </a>",
"    ]. Most experience with HEV comes from the Indian subcontinent, where 38 percent of PALF cases were attributed to HEV alone or in combination with HAV [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/27\">",
"     27",
"    </a>",
"    ]. Pregnant women have a high risk of fulminant hepatitis, with a case fatality rate from ALF of 10 to 20 percent, with particularly high risk during the third trimester of pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/3,28,29\">",
"     3,28,29",
"    </a>",
"    ]. Among women with HEV infection during pregnancy, the risk of symptomatic hepatitis in the newborn is high. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/63/37881?source=see_link&amp;anchor=H21#H21\">",
"     \"Hepatitis viruses and the newborn: Clinical manifestations and treatment\", section on 'Hepatitis E'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/11/33976?source=see_link\">",
"     \"Hepatitis E virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18338382\">",
"    <span class=\"h3\">",
"     Infection with viruses other than hepatitis viruses",
"    </span>",
"    &nbsp;&mdash;&nbsp;The viruses in the herpes family are highly cytopathic and can cause severe hepatic necrosis, often in the absence of significant inflammation. Little is known about the incidence or case fatality rates among children with ALF secondary to herpesvirus infection. However, early detection utilizing newer diagnostic techniques, such as real-time polymerase chain reaction (PCR), and early institution of specific therapy may improve survival [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/30\">",
"     30",
"    </a>",
"    ]. Each of the following has been reported to cause ALF in both immunocompromised and immunocompetent hosts [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Herpes simplex virus &ndash; Herpes simplex virus (HSV) most commonly affects infants and newborns. Affected infants present with symptoms resembling sepsis, and may or may not have lesions of the skin, eye, or mouth. Because HSV is a sexually transmitted disease, it should also be considered in sexually active adolescents. HSV-associated hepatitis is rare in immunocompetent individuals; 30 percent of affected patients have skin lesions. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/31/35321?source=see_link\">",
"       \"Neonatal herpes simplex virus infection: Clinical features and diagnosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/20/40265?source=see_link&amp;anchor=H22#H22\">",
"       \"Clinical manifestations and diagnosis of herpes simplex virus type 1 infection\", section on 'Hepatitis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Epstein-Barr virus &ndash; Epstein-Barr virus (EBV) is the virus most frequently implicated in PALF older children and adolescents in regions where hepatitis A and B are not endemic. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/55/14202?source=see_link&amp;anchor=H2#H2\">",
"       \"Clinical manifestations and treatment of Epstein-Barr virus infection\", section on 'Primary infection'",
"      </a>",
"      .) &nbsp;",
"     </li>",
"     <li>",
"      Human herpesvirus 6 &ndash; The role of Human herpesvirus 6 (HHV-6) in ALF is unclear. In a small series in adults, HHV-6 was detected in 80 percent of the explanted livers of patients who underwent liver transplant for ALF of unknown cause [",
"      <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/31\">",
"       31",
"      </a>",
"      ]. However, HHV-6 is prevalent as a latent infection in humans, so the presence of HHV-6 does not prove that it caused the ALF. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/53/31577?source=see_link&amp;anchor=H7#H7\">",
"       \"Human herpesvirus 6 infection in children: Clinical manifestations; diagnosis; and treatment\", section on 'Other manifestations'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/1/10265?source=see_link&amp;anchor=H3557047#H3557047\">",
"       \"Clinical manifestations, diagnosis, and treatment of human herpesvirus-6 infection in adults\", section on 'Unproven associations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Parvovirus B19 &ndash; Whether parvovirus B19 infection is associated with PALF is unclear. When detected, it may be an incidental finding, or an exacerbating factor for another viral infection. This virus causes one of the common childhood exanthemas (erythema infectiosum, or fifth disease) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/2\">",
"       2",
"      </a>",
"      ]. It rarely can cause severe bone marrow depression and has been associated with mild hepatitis. A few studies suggest that the rate of parvovirus B19 infection among individuals with ALF and aplastic anemia are higher than among patients with ALF due to known causes [",
"      <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/32,33\">",
"       32,33",
"      </a>",
"      ]. However, in a large study in adults with ALF, there was no serologic evidence of parvovirus B19 infection [",
"      <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/34\">",
"       34",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/54/22377?source=see_link&amp;anchor=H18#H18\">",
"       \"Clinical manifestations and pathogenesis of human parvovirus B19 infection\", section on 'Other disease associations'",
"      </a>",
"      .) &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other viruses associated with ALF include adenovirus, dengue fever, members of the enterovirus family (including echovirus [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/8,21\">",
"     8,21",
"    </a>",
"    ] and Coxsackie A and B), and paramyxovirus. Paramyxovirus infection (other than measles and mumps) was associated with a syncytial giant cell hepatitis with ALF in a series from Toronto [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/35\">",
"     35",
"    </a>",
"    ]. Several of the patients in this report had chronic progressive hepatitis or late-onset hepatic failure rather than ALF.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18338389\">",
"    <span class=\"h3\">",
"     Non-viral infectious hepatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infectious agents other than viruses only rarely have been recorded as producing ALF. Despite the rarity of occurrence, they should be considered carefully in every case because they are potentially treatable.",
"   </p>",
"   <p>",
"    Systemic sepsis occasionally presents in a manner that is virtually indistinguishable from ALF. Reported infectious etiologies include",
"    <em>",
"     Neisseria meningitides",
"    </em>",
"    infection, septic shock and intra-abdominal abscesses, and portal sepsis with enteric organisms. Spirochetal infection (syphilis) can affect liver function and produce severe hepatitis, even hepatic failure. ALF is a rare complication of congenital syphilis, and also has been reported in adolescents and adults with acquired syphilis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. Leptospirosis very rarely causes hepatic failure. Finally, in endemic areas, brucellosis and",
"    <em>",
"     Coxiella burnetii",
"    </em>",
"    (Q fever),",
"    <em>",
"     Plasmodium falciparum",
"    </em>",
"    , and",
"    <em>",
"     Entamoeba histolytica",
"    </em>",
"    infections have presented as ALF.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18338396\">",
"    <span class=\"h2\">",
"     Other rare causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Liver failure may be the presenting manifestation of the following systemic conditions:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Leukemia [",
"      <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/1\">",
"       1",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Cardiovascular shock associated with systemic hypotension &ndash; as seen in patients with trauma, sepsis, hemorrhage, or left heart failure (eg, hypoplastic left heart), or following cardiac bypass",
"     </li>",
"     <li>",
"      Celiac disease [",
"      <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/38\">",
"       38",
"      </a>",
"      ] &ndash; if recognized, this is potentially treatable following institution of a gluten free diet",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18338403\">",
"    <span class=\"h2\">",
"     Indeterminate",
"    </span>",
"    &nbsp;&mdash;&nbsp;A specific diagnosis is not identified in approximately 50 percent of children with PALF [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/1\">",
"     1",
"    </a>",
"    ]. If a specific diagnosis is not possible after a thorough evaluation, these cases should be classified as indeterminant PALF (I-PALF). Historically, I-PALF cases were sometimes classified as either non-A non-B hepatitis, neonatal hepatitis, or non-A-E hepatitis. Such nomenclature implies the etiology is due to an undetected or yet-to-be discovered virus. However, efforts to identify novel or unexpected hepatotropic viruses in adults have been unrevealing; similar efforts have not yet been rigorously undertaken in children [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One study reported that APAP-cysteine adducts (a biomarker of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/15/19705?source=see_link\">",
"     acetaminophen",
"    </a>",
"    exposure) were found in 12 percent of children with I-PALF and no clear history of toxic exposure to acetaminophen [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/40\">",
"     40",
"    </a>",
"    ]. This finding raises the possibility that unsuspected APAP toxicity may be present in some patients with I-PALF, but the relative importance of acetaminophen in the etiopathogenesis of PALF in those patients is uncertain. &nbsp;",
"   </p>",
"   <p>",
"    I-PALF likely consists of multiple patient sub-groups (",
"    <a class=\"graphic graphic_figure graphicRef83775 \" href=\"UTD.htm?30/53/31568\">",
"     figure 1",
"    </a>",
"    ). One subgroup reflects patients with an incomplete diagnostic evaluation, either because of variation in diagnostic prioritization or premature interruption of the planned diagnostic tests by death, LT, or clinical improvement. For example, in one series, the majority of patients classified as I-PALF were incompletely evaluated for autoimmune hepatitis (AIH), since only 79 percent underwent any testing for AIH and only 55 percent had all three auto-antibodies determined [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/11\">",
"     11",
"    </a>",
"    ]. Another subgroup of I-PALF likely comprises patients with a pathophysiological injury that is not identified using our current diagnostic strategies, including types of immune dysregulation or infection that are not captured by current diagnostic methods. It is important to monitor hemoglobin, WBCs, and platelets in all indeterminate patients for at least four months, regardless of their transplant status, for evidence of aplastic anemia, which can develop following an episode of PALF. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/39/6777?source=see_link&amp;anchor=H18340189#H18340189\">",
"     \"Acute liver failure in children: Management\", section on 'Aplastic anemia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18338410\">",
"    <span class=\"h2\">",
"     &ldquo;Recurrent&rdquo; liver failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;In rare instances, a child will appear to recover completely from an episode of I-PALF only to experience a second or even third episode. Conditions associated with recurrent PALF include metabolic disease, particularly fatty acid oxidation defects, and re-exposure to an unsuspected drug or herbal remedy. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22321080\">",
"    <span class=\"h1\">",
"     DIAGNOSIS OF ACUTE LIVER FAILURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;In adults, acute liver failure (ALF) is defined as the onset of hepatic encephalopathy (HE) less than eight weeks after the first signs of hepatic dysfunction, or the onset of HE within two weeks of developing jaundice, even in a patient with previous underlying liver dysfunction. Rapid deterioration of liver function with the development of HE within six months is sometimes termed &ldquo;subfulminant&rdquo; or &ldquo;subacute&rdquo; liver failure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/17/2330?source=see_link\">",
"     \"Acute liver failure in adults: Etiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    There are no definite criteria for diagnosing pediatric acute liver failure (PALF). HE is often present, but is not required to make the diagnosis because HE is difficult to assess in this age group and may not be clinically apparent until the terminal stages of the disease process [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/41\">",
"     41",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Each of the following criteria was required to enter into the PALF registry [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/42\">",
"     42",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Onset of hepatic failure within eight weeks of onset of clinical liver disease, in a patient with no previous evidence of chronic liver disease",
"     </li>",
"     <li>",
"      Biochemical evidence of acute liver injury, generally as elevated aspartate aminotransferase (AST), alanine aminotransferase (ALT),",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      total and conjugated bilirubin",
"     </li>",
"     <li>",
"      Coagulopathy not corrected by vitamin K (prothrombin time [PT] &ge;15 or international normalized ratio [INR] &ge;1.5)",
"     </li>",
"     <li>",
"      Encephalopathy &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Encephalopathy was not required if the coagulopathy was severe (PT &ge;20 seconds or INR &ge;2.0).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18338417\">",
"    <span class=\"h1\">",
"     FURTHER EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Every effort should be made to rapidly identify a cause of pediatric acute liver failure (PALF) if possible. For some causes, an effective treatment is available that could alter the cause of the disease. For other disorders, the diagnosis gives important information about prognosis and informs decisions about liver transplantation (LT). However, the ability to do a complete diagnostic evaluation of children with acute liver failure (ALF) is limited by the volume of blood needed to complete diagnostic tests, and sometimes by a rapid clinical trajectory ending in death or LT prior to a complete evaluation. As discussed above, nearly 50 percent of patients with PALF are left with an indeterminate diagnosis. Given the rarity of PALF, an age-based diagnostic approach is useful to improve diagnostic yield.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6018173\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;A detailed history is essential [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/2\">",
"     2",
"    </a>",
"    ]. Each of the following issues should be explored:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Time of onset of symptoms such as jaundice, change in mental status, easy bruising, vomiting, and fever &nbsp;",
"     </li>",
"     <li>",
"      Exposure to contacts with infectious hepatitis",
"     </li>",
"     <li>",
"      History of blood transfusions",
"     </li>",
"     <li>",
"      In teenagers, a history of depression, suicide attempts, and risk-taking behaviors",
"     </li>",
"     <li>",
"      A list of prescription and over-the-counter medications in the home, including complementary and alternative medicines, and whether these medications might have been ingested intentionally or accidentally (",
"      <a class=\"graphic graphic_table graphicRef83765 \" href=\"UTD.htm?12/21/12637\">",
"       table 3",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Use of intravenous drugs or other recreational drugs that are hepatotoxins, including ecstasy, cocaine, or solvent-sniffing. Any exposure to hepatotoxic drugs or chemicals should be considered possibly related to the liver injury. However, a history of exposure to a drug or toxin should not preclude a thorough search for other causes of liver injury. (See",
"      <a class=\"local\" href=\"#H18338324\">",
"       'Idiosyncratic hepatotoxic effects'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Family history of Wilson disease, infectious hepatitis, infant deaths or autoimmune conditions, which might lead to a specific diagnosis.",
"     </li>",
"     <li>",
"      In neonates, review of maternal records for TORCH infection risk, including syphilis and herpes simplex (see",
"      <a class=\"local\" href=\"#H18338382\">",
"       'Infection with viruses other than hepatitis viruses'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H18338389\">",
"       'Non-viral infectious hepatitis'",
"      </a>",
"      above) &nbsp;",
"     </li>",
"     <li>",
"      Evidence of developmental delay",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      seizures, which should prompt a careful assessment for metabolic disease (see",
"      <a class=\"local\" href=\"#H18338361\">",
"       'Inherited metabolic disease'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Pruritus, ascites, splenomegaly, or growth failure, which might suggest a chronic liver condition with an acute presentation",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6018188\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physical examination should assess for each of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Evaluation of growth, development, and nutrition status &ndash; Abnormal growth or development may suggest an underlying disorder, including metabolic disease.",
"     </li>",
"     <li>",
"      Evidence of coagulopathy, including bruises, bleeding following venipuncture, and petechiae",
"     </li>",
"     <li>",
"      Findings related to liver function and blood flow, including jaundice, hepatomegaly alone or with splenomegaly, ascites, peripheral edema",
"     </li>",
"     <li>",
"      Evidence of hepatic encephalopathy &ndash; Altered mental status should be assessed, but may be difficult to assess in infants and young children. Fetor hepaticus is a sweet, distinctive aroma to the breath associated with hepatic encephalopathy, but is rarely present.",
"     </li>",
"     <li>",
"      Findings suggestive of chronic liver disease, including digital clubbing, palmar erythema, cutaneous xanthoma, and prominent abdominal vessels suggesting longstanding portal hypertension. If present, these findings suggest that the patient is experiencing a decompensation or complication of a chronic liver disease rather than a true ALF, and this helps to narrow the diagnostic considerations. &nbsp;",
"     </li>",
"     <li>",
"      Slit-lamp examination for Kayser-Fleischer rings &ndash; This should be performed in older children and adolescents if possible, to evaluate for Wilson disease (WD). However, the yield of the examination is low because this finding is common among patients with neurologic manifestations of WD, but is usually not present in patients with WD who present with ALF.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6018198\">",
"    <span class=\"h2\">",
"     Laboratory testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Careful coordination of laboratory and diagnostic tests is helpful to ensure that high priority tests are performed expeditiously. Because more than 30 percent of children with ALF are younger than three years of age, limitations on the volume of blood that can be drawn require a knowledgeable prioritization of tests. Laboratory tests needed for management and diagnosis should be prioritized into four areas: &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Liver specific tests to assess the degree of inflammation, injury and function, and to guide transplant decisions &ndash; At a minimum, measure serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), total and conjugated bilirubin, alkaline phosphatase, albumin, prothrombin time (PT), and partial thromboplastin time (PTT).",
"     </li>",
"     <li>",
"      General labs to assess hematological, renal, pancreatic, and electrolyte abnormalities, and to guide management of these complications &ndash; At a minimum, perform a complete blood count with differential, and measure electrolytes, blood glucose, blood urea nitrogen and creatinine, amylase, and lipase. &nbsp;",
"     </li>",
"     <li>",
"      Diagnostic tests to determine the cause of the liver disease &ndash; Depending on age and presentation, as discussed immediately below &nbsp;",
"     </li>",
"     <li>",
"      Tests required in preparation for a liver transplant (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/39/6777?source=see_link&amp;anchor=H18340290#H18340290\">",
"       \"Acute liver failure in children: Management\", section on 'Liver transplant'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18591103\">",
"    <span class=\"h3\">",
"     Diagnostic testing for the cause of PALF",
"    </span>",
"    &nbsp;&mdash;&nbsp;Priorities for diagnostic testing should be guided by the frequency of a disorder within an age group and population. While some conditions such as herpes simplex virus (HSV) can occur within all age categories, others such as neonatal hemochromatosis and WD are found within a more narrow age range. Therefore, age-based diagnostic prioritization enhances the likelihood of establishing a diagnosis as quickly as possible. The table lists diagnostic tests that would be most useful for children of different ages based upon the expected diagnoses (",
"    <a class=\"graphic graphic_table graphicRef83772 \" href=\"UTD.htm?18/1/18461\">",
"     table 4B",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Priority should be given to identifying conditions that are amenable to specific therapy, that would be relevant to subsequent pregnancies, or would be a contraindication to LT [",
"    <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/2\">",
"     2",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    The following disorders should be specifically considered because they are amenable to specific therapy:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/15/19705?source=see_link\">",
"       acetaminophen",
"      </a>",
"      toxicity &ndash; We suggest measuring the serum acetaminophen level in all adolescents presenting with unexplained ALF, and in other children in whom an accidental ingestion or inadvertent overdosage seems possible. (See",
"      <a class=\"local\" href=\"#H18338303\">",
"       'Acetaminophen'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"     <li>",
"      HSV &ndash; We suggest viral cultures",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      direct immunofluorescence assays of any vesicular skin lesions, or of liver tissue if a biopsy is performed. In neonates presenting with PALF, we suggest HSV DNA testing of the blood. (See",
"      <a class=\"local\" href=\"#H18338382\">",
"       'Infection with viruses other than hepatitis viruses'",
"      </a>",
"      above.) &nbsp; &nbsp;",
"     </li>",
"     <li>",
"      Hemophagocytic lymphohistiocytosis &ndash; In patients younger than five years with fever and cytopenia in two or more cell lines, we suggest measurement of ferritin, triglycerides, and fibrinogen to screen for this disorder. (See",
"      <a class=\"local\" href=\"#H18338347\">",
"       'Hemophagocytic lymphohistiocytosis'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"     <li>",
"      Autoimmune hepatitis",
"      <strong>",
"      </strong>",
"      &ndash; Because autoimmune hepatitis (AIH) is a potentially treatable cause of ALF in children of all ages, it should be considered early in the evaluation process to enable prompt initiation of treatment. Screening requires testing serological antinuclear antibody (ANA), anti-smooth muscle antibody (SMA), liver-kidney microsomal antibody (LKM), and total immunoglobulin G (IgG), which can be estimated by subtracting the serum albumin",
"      <span class=\"nowrap\">",
"       (mg/dL)",
"      </span>",
"      from the serum total protein",
"      <span class=\"nowrap\">",
"       (mg/dL).",
"      </span>",
"      However, autoimmune markers are found in conditions other than AIH, thus necessitating subjective clinical judgment to influence the final diagnosis and treatment strategy [",
"      <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/11\">",
"       11",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H18338340\">",
"       'Autoimmune marker positive'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"     <li>",
"      Wilson Disease &ndash; Patients older than five years with PALF should be screened for WD by measuring serum ceruloplasmin. In addition to low serum ceruloplasmin, suggestive laboratory findings include a marked mixed or primarily unconjugated hyperbilirubinemia, a low serum alkaline phosphatase, and hemolytic anemia with negative test for direct antiglobulin (DAT [also known as the Coombs test]). (See",
"      <a class=\"local\" href=\"#H6015390\">",
"       'Older children and adolescents'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"     <li>",
"      Metabolic defects &ndash; Certain metabolic defects related to carbohydrate, fatty acid, and protein metabolism are important to diagnose because they are responsive to dietary management. Selection of tests depends on the age and presentation of the patient (",
"      <a class=\"graphic graphic_table graphicRef83766 graphicRef83772 \" href=\"UTD.htm?41/45/42717\">",
"       table 4A-B",
"      </a>",
"      ). At a minimum, tests should include measurements of serum glucose, lactate, pyruvate, and creatinine kinase to screen for mitochondrial hepatopathies. Lactic acidosis and an elevated molar ratio of lactate to pyruvate (&gt;25",
"      <span class=\"nowrap\">",
"       mol/mol)",
"      </span>",
"      suggests the possibility of mitochondrial hepatopathy. In infants and younger children, serum amino acids and",
"      <span class=\"nowrap\">",
"       acylcarnitine/acylcarnitine",
"      </span>",
"      profile should be included in the initial evaluation. (See",
"      <a class=\"local\" href=\"#H18338361\">",
"       'Inherited metabolic disease'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      For neonates and young infants presenting with PALF, the newborn screen may help identify patients at risk or who have developed symptoms of PALF. However, the newborn screen should not be used as a &ldquo;specific&rdquo; test to diagnose a metabolic disease, nor should it be used to exclude a diagnosis should one be suspected. Some children will present before results of the newborn screen are available. Thus, the following tests should be performed in a newborn infant if the newborn screen is not available, or if there is a reasonable clinical suspicion for these disorders (see",
"      <a class=\"local\" href=\"#H21413563\">",
"       'Young infants'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Galactosemia &ndash; Screen by testing urine for reducing substances (eg, Clinitest tablet), and also perform specific testing of red-blood cell galactose-1-phosphate uridyl transferase before the patient receives a blood transfusion.",
"     </li>",
"     <li>",
"      Tyrosinemia &ndash; Test urine for succinylacetone.",
"     </li>",
"     <li>",
"      Hereditary fructose intolerance &ndash; For infants presenting with PALF after exposure to fructose or sucrose (in medications, juice, or formula), testing for hereditary fructose intolerance is essential.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Gestational alloimmune liver disease &ndash; Gestational alloimmune liver disease (GALD; also known as neonatal hemochromatosis) should be considered in any neonate presenting with ALF, particularly if there is a history of neonatal liver disease or death in older siblings,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      if the degree of coagulopathy is more severe than the aminotransferase elevation. (See",
"      <a class=\"local\" href=\"#H18338354\">",
"       'Gestational alloimmune liver disease (neonatal hemochromatosis)'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If there is a strong clinical suspicion of other disorders (such as exposure to hepatitis A), specific testing is appropriate even if no specific treatment is available. This is because establishing the cause of PALF may reduce the need for other in-depth diagnostic testing and sometimes provides prognostic information that is useful when making transplant decisions. For example, a patient with a systemic mitochondrial disease presenting as ALF, either independent of or in association with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?26/54/27497?source=see_link\">",
"     valproate",
"    </a>",
"    toxicity, will not benefit from LT as outcome is uniformly poor. (See",
"    <a class=\"local\" href=\"#H21413563\">",
"     'Young infants'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23661634\">",
"    <span class=\"h2\">",
"     Liver biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Establishing a pathologic diagnosis by liver biopsy has not been considered critical in the management of a patient with PALF, primarily because percutaneous biopsy is associated with substantial risks of hemorrhage because patients with ALF usually have a coagulopathy. In addition, the histopathology analysis appears to have limited value in determining the treatment strategy or establishing the diagnosis. However, liver biopsies are increasingly performed by the transvenous (eg, transjugular) approach, because this technique markedly reduces the risks of hemorrhage in this population. The frequency of liver biopsy in PALF patients varies widely among institutions. Liver biopsy may be considered for those patients suspected to have WD if other diagnostic criteria are inconclusive, or for patients with indeterminate or autoimmune marker-positive PALF for whom corticosteroid therapy is being considered. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/37/9814?source=see_link\">",
"     \"Transjugular liver biopsy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22358670\">",
"    <span class=\"h3\">",
"     Nonspecific findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most causes of PALF result in diffuse hepatocellular necrosis. This pattern is typical of ALF resulting from viral infections, most toxic and ischemic injuries, and some metabolic diseases. The degree of hepatocellular necrosis and its histologic pattern vary by cause and by individual case. Most liver samples from children with ALF show massive confluent or multilobular necrosis, with or without a moderate inflammatory infiltrate and evidence of regeneration. Occasionally there is a marked inflammatory infiltrate, consisting primarily of lymphocytes with a scattering of plasma cells, neutrophils, and eosinophils (",
"    <a class=\"graphic graphic_picture graphicRef83773 \" href=\"UTD.htm?6/18/6437\">",
"     picture 1",
"    </a>",
"    ). The inflammatory infiltrate is not limited to the portal tracts, but can be found within the lobule and around the central vein.",
"   </p>",
"   <p>",
"    Occasionally, if orthotopic LT is performed early in the course of rapidly progressive ALF, the gross surgical and microscopic appearances of the liver are relatively normal. The lobular structure and framework may be intact, including a normal cord pattern, but the hepatocytes are necrotic. Inflammation is absent. This lesion suggests widespread, simultaneous lethal injury of hepatocytes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22358466\">",
"    <span class=\"h3\">",
"     Characteristics suggesting a specific diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following histologic characteristics support a specific cause of ALF. However, these findings are not diagnostic, and should be interpreted in the context of the patient&rsquo;s other clinical characteristics.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Steatosis &ndash; Diffuse hepatic steatosis is observed rarely in ALF in children. When present, the typical lesion is characterized by hepatocellular fat in a microvesicular (small fat droplet) pattern. The absence of cell necrosis in association with failure of liver function implies organelle failure as the cause. In adults, this pattern is seen most often in fatty liver of pregnancy. In children with ALF, the presence of steatosis suggests a mitochondrial disorder or other inborn error of metabolism (see",
"      <a class=\"local\" href=\"#H18338361\">",
"       'Inherited metabolic disease'",
"      </a>",
"      above). Alternatively, steatosis can be caused by toxins or drugs. Certain drugs (eg,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?26/54/27497?source=see_link\">",
"       valproate",
"      </a>",
"      and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?9/41/9882?source=see_link\">",
"       amiodarone",
"      </a>",
"      ) tend to cause steatosis, whereas others (",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/24/38278?source=see_link\">",
"       isoniazid",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/50/15142?source=see_link\">",
"       propylthiouracil",
"      </a>",
"      , and halothane) do not. If the observed histology differs from that expected by the drug in question, another cause should be sought. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/63/29690?source=see_link\">",
"       \"Drugs and the liver: Patterns of drug-induced liver injury\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Macrovesicular (large fat droplet) steatosis is seen in patients with non-alcoholic fatty liver disease (NAFLD). NAFLD is not known to be a cause of PALF, but given the increasing prevalence of NAFLD in the pediatric population, macrovesicular steatosis may be a coincidental finding in PALF. Whether NAFLD increases a patient&rsquo;s risk of liver injury from other insults such as infections or",
"      <span class=\"nowrap\">",
"       drugs/medications",
"      </span>",
"      to the degree that PALF develops is not known. Macrovesicular steatosis also can be seen with WD.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Diffuse swelling of hepatocytes, with only spotty necrosis &ndash; This lesion is characterized by diffuse swelling of hepatocytes with condensation of organelles and cytoplasmic elements, and is seen in association with some inborn errors of metabolism. Hepatocyte necrosis is spotty and usually not prominent. Macrovesicular fat with displacement of nuclei is seen in a variable proportion of hepatocytes, sometimes a majority. This lesion suggests organelle injury that is severe enough to cause the death of some hepatocytes. Aminotransferase levels and serum bilirubin levels are elevated moderately. Full histologic recovery can occur if the metabolic injury is controlled.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Characteristics suggesting AIH &ndash; Histologic features of AIH causing ALF include evidence of immune activation with the presence of a plasma cell enriched infiltrate, central perivenulitis, and lymphoid follicles with evidence of massive hepatic necrosis [",
"      <a class=\"abstract\" href=\"UTD.htm?21/55/22394/abstract/43\">",
"       43",
"      </a>",
"      ]. Inflammation is often most intense at the limiting plate. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/44/35528?source=see_link&amp;anchor=H7#H7\">",
"       \"Clinical manifestations and diagnosis of autoimmune hepatitis\", section on 'Histology'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6223342\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pediatric acute liver failure (PALF) is a complex, rapidly progressive clinical syndrome that is the final common pathway for many disparate conditions, some known and others yet to be identified. Management requires an individualized diagnostic approach to assess disease severity and trajectory, and to guide decisions about liver transplant.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      PALF typically presents in a previously healthy patient with a nonspecific prodrome of variable duration with features that might include abdominal discomfort and malaise with or without fever. Jaundice, encephalopathy, and hepatomegaly are common. (See",
"      <a class=\"local\" href=\"#H18338289\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      PALF is diagnosed when an infant or child with no previous evidence of chronic liver disease presents with biochemical evidence of acute liver injury (elevated aminotransferase activity), coagulopathy not corrected by vitamin K (prothrombin time [PT] &ge;15 or international normalized ratio [INR] &ge;1.5), and encephalopathy. The encephalopathy is not required if the coagulopathy is severe. (See",
"      <a class=\"local\" href=\"#H22321080\">",
"       'Diagnosis of acute liver failure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The causes of PALF vary depending on the age group and region. The primary causes of PALF in developed countries are outlined in the Table (",
"      <a class=\"graphic graphic_table graphicRef83285 \" href=\"UTD.htm?39/58/40877\">",
"       table 1",
"      </a>",
"      ). In more than 50 percent of patients, a specific cause is not discovered, and in this case, the PALF is categorized as indeterminate.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/15/19705?source=see_link\">",
"       Acetaminophen",
"      </a>",
"      (APAP) is an important cause of PALF, particularly among adolescents. It may be caused by an acute or chronic overdose and is potentially treatable if diagnosed rapidly. Other medications that can cause PALF in a dose-related manner include",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/24/38278?source=see_link\">",
"       isoniazid",
"      </a>",
"      , halothane, and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/50/15142?source=see_link\">",
"       propylthiouracil",
"      </a>",
"      . Many other medications and recreational drugs have idiosyncratic hepatotoxic effects (",
"      <a class=\"graphic graphic_table graphicRef83765 \" href=\"UTD.htm?12/21/12637\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H18338303\">",
"       'Acetaminophen'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H18338310\">",
"       'Other medications or toxins'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Infectious causes of PALF, particularly hepatitis A, are far more common in countries in which these infections are endemic (",
"      <a class=\"graphic graphic_table graphicRef83764 \" href=\"UTD.htm?34/22/35182\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H18338368\">",
"       'Infectious diseases'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Autoimmune hepatitis (AIH) is most common among adolescents, but is responsible for more than 5 percent of PALF in younger age groups beyond the neonatal period. (See",
"      <a class=\"local\" href=\"#H18338340\">",
"       'Autoimmune marker positive'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      During the neonatal period, important causes of PALF include gestational alloimmune liver disease (GALD [also known as neonatal hemochromatosis]), herpes simplex, and inborn errors of metabolism, including tyrosinemia and galactosemia. (See",
"      <a class=\"local\" href=\"#H18338354\">",
"       'Gestational alloimmune liver disease (neonatal hemochromatosis)'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H21413563\">",
"       'Young infants'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Inborn errors of metabolism also may present with PALF during later infancy and early childhood. Causes include mitochondrial disorders such as fatty acid oxidation defects and urea cycle defects (",
"      <a class=\"graphic graphic_table graphicRef83766 \" href=\"UTD.htm?29/29/30171\">",
"       table 4A",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H18338361\">",
"       'Inherited metabolic disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Wilson disease (WD) is the most common metabolic condition associated with PALF in children over five years of age. It is characterized by a Coombs negative hemolytic anemia, marked hyperbilirubinemia, low serum ceruloplasmin, and a low serum alkaline phosphatase. (See",
"      <a class=\"local\" href=\"#H6015390\">",
"       'Older children and adolescents'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/48/14088?source=see_link\">",
"       \"Tests used in the diagnosis of Wilson disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      An indeterminate diagnosis occurs commonly, particularly among children between 1 and 10 years of age. (See",
"      <a class=\"local\" href=\"#H18338403\">",
"       'Indeterminate'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Every effort should be made to rapidly identify a cause of PALF if possible. A focused history and physical examination help to narrow the diagnostic possibilities. Careful coordination of laboratory and diagnostic tests is helpful to ensure that high priority tests are performed expeditiously, with the highest priorities given to potentially treatable disorders (",
"      <a class=\"graphic graphic_table graphicRef83772 \" href=\"UTD.htm?18/1/18461\">",
"       table 4B",
"      </a>",
"      ). Tests needed for supportive care and transplant decisions necessarily compete with those needed for diagnosing the cause of the PALF. (See",
"      <a class=\"local\" href=\"#H18338417\">",
"       'Further evaluation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/1\">",
"      Squires RH Jr, Shneider BL, Bucuvalas J, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr 2006; 148:652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/2\">",
"      Squires RH Jr. Acute liver failure in children. Semin Liver Dis 2008; 28:153.",
"     </a>",
"    </li>",
"    <li>",
"     Squires RH, Alonso EM. Acute liver failure in children. In: Liver Disease in Children, 4th ed, Suchy FJ, Sokol RJ, Balistreri WF (Eds), Cambridge University Press, New York 2012.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/4\">",
"      Heubi JE, Barbacci MB, Zimmerman HJ. Therapeutic misadventures with acetaminophen: hepatoxicity after multiple doses in children. J Pediatr 1998; 132:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/5\">",
"      Watkins PB, Seeff LB. Drug-induced liver injury: summary of a single topic clinical research conference. Hepatology 2006; 43:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/6\">",
"      Rivera-Penera T, Gugig R, Davis J, et al. Outcome of acetaminophen overdose in pediatric patients and factors contributing to hepatotoxicity. J Pediatr 1997; 130:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/7\">",
"      Leonis MA, Alonso EM, Im K, et al. Chronic acetaminophen exposure in pediatric acute liver failure. Pediatrics 2013; 131:e740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/8\">",
"      Abboud G, Kaplowitz N. Drug-induced liver injury. Drug Saf 2007; 30:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/9\">",
"      Reuben A, Koch DG, Lee WM, Acute Liver Failure Study Group. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology 2010; 52:2065.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/10\">",
"      Stickel F, Patsenker E, Schuppan D. Herbal hepatotoxicity. J Hepatol 2005; 43:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/11\">",
"      Narkewicz MR, Dell Olio D, Karpen SJ, et al. Pattern of diagnostic evaluation for the causes of pediatric acute liver failure: an opportunity for quality improvement. J Pediatr 2009; 155:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/12\">",
"      Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008; 48:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/13\">",
"      Mileti E, Rosenthal P, Peters MG. Validation and modification of simplified diagnostic criteria for autoimmune hepatitis in children. Clin Gastroenterol Hepatol 2012; 10:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/14\">",
"      McClain K, Gehrz R, Grierson H, et al. Virus-associated histiocytic proliferations in children. Frequent association with Epstein-Barr virus and congenital or acquired immunodeficiencies. Am J Pediatr Hematol Oncol 1988; 10:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/15\">",
"      Parizhskaya M, Reyes J, Jaffe R. Hemophagocytic syndrome presenting as acute hepatic failure in two infants: clinical overlap with neonatal hemochromatosis. Pediatr Dev Pathol 1999; 2:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/16\">",
"      Henter JI, Horne A, Aric&oacute; M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/17\">",
"      Pan X, Kelly S, Melin-Aldana H, et al. Novel mechanism of fetal hepatocyte injury in congenital alloimmune hepatitis involves the terminal complement cascade. Hepatology 2010; 51:2061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/18\">",
"      Rand EB, Karpen SJ, Kelly S, et al. Treatment of neonatal hemochromatosis with exchange transfusion and intravenous immunoglobulin. J Pediatr 2009; 155:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/19\">",
"      Sundaram SS, Alonso EM, Narkewicz MR, et al. Characterization and outcomes of young infants with acute liver failure. J Pediatr 2011; 159:813.",
"     </a>",
"    </li>",
"    <li>",
"     Patterson M. Niemann-Pick disease type C. GeneReviews. Available at: file://www.ncbi.nlm.nih.gov/books/NBK1296/ (Accessed on April 18, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/21\">",
"      Shneider BL, Rinaldo P, Emre S, et al. Abnormal concentrations of esterified carnitine in bile: a feature of pediatric acute liver failure with poor prognosis. Hepatology 2005; 41:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/22\">",
"      Korman JD, Volenberg I, Balko J, et al. Screening for Wilson disease in acute liver failure: a comparison of currently available diagnostic tests. Hepatology 2008; 48:1167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/23\">",
"      Moreira-Silva SF, Frauches DO, Almeida AL, et al. Acute liver failure in children: observations in Vit&oacute;ria, Esp&iacute;rito Santo State, Brazil. Rev Soc Bras Med Trop 2002; 35:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/24\">",
"      Bartholomeusz A, Locarnini S. Hepatitis B virus mutants and fulminant hepatitis B: fitness plus phenotype. Hepatology 2001; 34:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/25\">",
"      Farci P, Alter HJ, Shimoda A, et al. Hepatitis C virus-associated fulminant hepatic failure. N Engl J Med 1996; 335:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/26\">",
"      Liang TJ, Jeffers L, Reddy RK, et al. Fulminant or subfulminant non-A, non-B viral hepatitis: the role of hepatitis C and E viruses. Gastroenterology 1993; 104:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/27\">",
"      Poddar U, Thapa BR, Prasad A, Singh K. Changing spectrum of sporadic acute viral hepatitis in Indian children. J Trop Pediatr 2002; 48:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/28\">",
"      Hamid SS, Jafri SM, Khan H, et al. Fulminant hepatic failure in pregnant women: acute fatty liver or acute viral hepatitis? J Hepatol 1996; 25:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/29\">",
"      Khuroo MS, Teli MR, Skidmore S, et al. Incidence and severity of viral hepatitis in pregnancy. Am J Med 1981; 70:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/30\">",
"      Verma A, Dhawan A, Zuckerman M, et al. Neonatal herpes simplex virus infection presenting as acute liver failure: prevalent role of herpes simplex virus type I. J Pediatr Gastroenterol Nutr 2006; 42:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/31\">",
"      H&auml;rm&auml; M, H&ouml;ckerstedt K, Lautenschlager I. Human herpesvirus-6 and acute liver failure. Transplantation 2003; 76:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/32\">",
"      Tung J, Hadzic N, Layton M, et al. Bone marrow failure in children with acute liver failure. J Pediatr Gastroenterol Nutr 2000; 31:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/33\">",
"      Karetnyi YV, Beck PR, Markin RS, et al. Human parvovirus B19 infection in acute fulminant liver failure. Arch Virol 1999; 144:1713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/34\">",
"      Lee WM, Brown KE, Young NS, et al. Brief report: no evidence for parvovirus B19 or hepatitis E virus as a cause of acute liver failure. Dig Dis Sci 2006; 51:1712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/35\">",
"      Phillips MJ, Blendis LM, Poucell S, et al. Syncytial giant-cell hepatitis. Sporadic hepatitis with distinctive pathological features, a severe clinical course, and paramyxoviral features. N Engl J Med 1991; 324:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/36\">",
"      Listernick R. Liver failure in a 2-day-old infant. Pediatr Ann 2004; 33:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/37\">",
"      Lo JO, Harrison RA, Hunter AJ. Syphilitic hepatitis resulting in fulminant hepatic failure requiring liver transplantation. J Infect 2007; 54:e115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/38\">",
"      Stevens FM, McLoughlin RM. Is coeliac disease a potentially treatable cause of liver failure? Eur J Gastroenterol Hepatol 2005; 17:1015.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/39\">",
"      Umemura T, Tanaka E, Ostapowicz G, et al. Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A-E hepatitis. J Infect Dis 2003; 188:1545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/40\">",
"      James LP, Alonso EM, Hynan LS, et al. Detection of acetaminophen protein adducts in children with acute liver failure of indeterminate cause. Pediatrics 2006; 118:e676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/41\">",
"      Rivera-Penera T, Moreno J, Skaff C, et al. Delayed encephalopathy in fulminant hepatic failure in the pediatric population and the role of liver transplantation. J Pediatr Gastroenterol Nutr 1997; 24:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/42\">",
"      Lee WS, McKiernan P, Kelly DA. Etiology, outcome and prognostic indicators of childhood fulminant hepatic failure in the United kingdom. J Pediatr Gastroenterol Nutr 2005; 40:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/55/22394/abstract/43\">",
"      Stravitz RT, Lefkowitch JH, Fontana RJ, et al. Autoimmune acute liver failure: proposed clinical and histological criteria. Hepatology 2011; 53:517.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16142 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-27.109.116.13-83254367CA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_55_22394=[""].join("\n");
var outline_f21_55_22394=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H6223342\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18338558\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18338289\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18338296\">",
"      CAUSES OF PEDIATRIC ACUTE LIVER FAILURE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18338303\">",
"      Acetaminophen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18338310\">",
"      Other medications or toxins",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18338317\">",
"      - Intrinsic hepatotoxins",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18338324\">",
"      - Idiosyncratic hepatotoxic effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18338331\">",
"      Immune dysregulation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18338340\">",
"      - Autoimmune marker positive",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18338347\">",
"      - Hemophagocytic lymphohistiocytosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18338354\">",
"      - Gestational alloimmune liver disease (neonatal hemochromatosis)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18338361\">",
"      Inherited metabolic disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21413563\">",
"      - Young infants",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21413578\">",
"      - Older infants and young children",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6015390\">",
"      - Older children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18338368\">",
"      Infectious diseases",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18338375\">",
"      - Hepatitis viruses",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18338382\">",
"      - Infection with viruses other than hepatitis viruses",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18338389\">",
"      - Non-viral infectious hepatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18338396\">",
"      Other rare causes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18338403\">",
"      Indeterminate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18338410\">",
"      &ldquo;Recurrent&rdquo; liver failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22321080\">",
"      DIAGNOSIS OF ACUTE LIVER FAILURE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18338417\">",
"      FURTHER EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6018173\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6018188\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6018198\">",
"      Laboratory testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18591103\">",
"      - Diagnostic testing for the cause of PALF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23661634\">",
"      Liver biopsy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22358670\">",
"      - Nonspecific findings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22358466\">",
"      - Characteristics suggesting a specific diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6223342\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/16142\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/16142|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?30/53/31568\" title=\"figure 1\">",
"      Categories of idiopathic pediatric acute liver failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/16142|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/18/6437\" title=\"picture 1\">",
"      Liver biopsy in a child with indeterminate acute liver failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/16142|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?39/58/40877\" title=\"table 1\">",
"      Causes of PALF in North America and Europe",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?34/22/35182\" title=\"table 2\">",
"      Causes of PALF worldwide",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?12/21/12637\" title=\"table 3\">",
"      Medications and toxins associated with acute liver failure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/29/30171\" title=\"table 4A\">",
"      Metabolic diseases associated with ALF in children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?18/1/18461\" title=\"table 4B\">",
"      Age-specific diagnostic priorities for children with ALF",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/17/2330?source=related_link\">",
"      Acute liver failure in adults: Etiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/40/38538?source=related_link\">",
"      Acute liver failure in adults: Management and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/39/6777?source=related_link\">",
"      Acute liver failure in children: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/28/10698?source=related_link\">",
"      Amatoxin-containing mushroom poisoning including ingestion of Amanita phalloides",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/50/16169?source=related_link\">",
"      Causes of neonatal cholestasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/10/30886?source=related_link\">",
"      Clinical features and diagnosis of galactosemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/42/22186?source=related_link\">",
"      Clinical manifestations and diagnosis of acetaminophen (paracetamol) poisoning in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/44/35528?source=related_link\">",
"      Clinical manifestations and diagnosis of autoimmune hepatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/20/40265?source=related_link\">",
"      Clinical manifestations and diagnosis of herpes simplex virus type 1 infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/54/22377?source=related_link\">",
"      Clinical manifestations and pathogenesis of human parvovirus B19 infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/55/14202?source=related_link\">",
"      Clinical manifestations and treatment of Epstein-Barr virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/1/10265?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of human herpesvirus-6 infection in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/4/23624?source=related_link\">",
"      Disorders of tyrosine metabolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/27/13754?source=related_link\">",
"      Drugs and the liver: Metabolism and mechanisms of injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/63/29690?source=related_link\">",
"      Drugs and the liver: Patterns of drug-induced liver injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/40/16010?source=related_link\">",
"      Etiology of hypoglycemia in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/3/34871?source=related_link\">",
"      Halothane hepatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/5/41050?source=related_link\">",
"      Hemophagocytic lymphohistiocytosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/2/6186?source=related_link\">",
"      Hepatitis C virus infection in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/11/33976?source=related_link\">",
"      Hepatitis E virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/63/37881?source=related_link\">",
"      Hepatitis viruses and the newborn: Clinical manifestations and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/2/25642?source=related_link\">",
"      Hepatotoxicity due to herbal medications and dietary supplements",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/53/31577?source=related_link\">",
"      Human herpesvirus 6 infection in children: Clinical manifestations; diagnosis; and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/26/27047?source=related_link\">",
"      Inborn errors of metabolism: Classification",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/61/33753?source=related_link\">",
"      Inhalant abuse in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/61/41943?source=related_link\">",
"      Isoniazid hepatotoxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/3/21560?source=related_link\">",
"      MDMA (ecstasy) intoxication",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/5/36950?source=related_link\">",
"      Management and outcome of galactosemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/51/13114?source=related_link\">",
"      Management of acetaminophen (paracetamol) poisoning in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/12/7370?source=related_link\">",
"      Mitochondrial myopathies: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/31/35321?source=related_link\">",
"      Neonatal herpes simplex virus infection: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/2/2088?source=related_link\">",
"      Newborn screening",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/0/20489?source=related_link\">",
"      Overview of Niemann-Pick disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/58/16295?source=related_link\">",
"      Overview of hepatitis A virus infection in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/41/31386?source=related_link\">",
"      Overview of hepatitis B virus infection in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/21/41303?source=related_link\">",
"      Pharmacology and toxicity of thionamides",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/48/14088?source=related_link\">",
"      Tests used in the diagnosis of Wilson disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/37/9814?source=related_link\">",
"      Transjugular liver biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/49/20248?source=related_link\">",
"      Urea cycle disorders: Clinical features and diagnosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_55_22395="Methionine challenge";
var content_f21_55_22395=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F79494&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F79494&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Plasma homocysteine response to methionine challenge",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Gender",
"       </td>",
"       <td class=\"subtitle1\">",
"        Baseline",
"       </td>",
"       <td class=\"subtitle1\">",
"        4 hours",
"       </td>",
"       <td class=\"subtitle1\">",
"        8 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Male",
"       </td>",
"       <td>",
"        6.2",
"       </td>",
"       <td>",
"        16.3",
"       </td>",
"       <td>",
"        17.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"4\" rowspan=\"1\">",
"        Female",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Premenopausal",
"       </td>",
"       <td class=\"sublist_other\">",
"        6.3",
"       </td>",
"       <td class=\"sublist_other\">",
"        14.7",
"       </td>",
"       <td class=\"sublist_other\">",
"        17.6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Postmenopausal",
"       </td>",
"       <td class=\"sublist_other\">",
"        4.8",
"       </td>",
"       <td class=\"sublist_other\">",
"        22.4",
"       </td>",
"       <td class=\"sublist_other\">",
"        24.7",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Plasma homocysteine levels (mean plus two standard deviations, in &micro;mol/L) at baseline and four and eight hours after an oral mathionine load in men and women. Homocysteine metabolism is considered to be impaired if values above these levels are obtained.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Dudman, NP, Wilcken, DE, Wang, J, et al, Arterioscl Thromb 1993; 13:2253.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_55_22395=[""].join("\n");
var outline_f21_55_22395=null;
var title_f21_55_22396="Low-fat low-sugar guide A";
var content_f21_55_22396=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F67313&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F67313&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Tips for maintaining a healthy weight: Low-fat, low-sugar eating guidelines",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup width=\"20%\">",
"     </colgroup>",
"     <colgroup span=\"2\" width=\"40%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Food group",
"       </td>",
"       <td class=\"subtitle1\">",
"        Food to choose more often",
"       </td>",
"       <td class=\"subtitle1\">",
"        Food to limit",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Breads, cereals, starches and starchy vegetables",
"       </td>",
"       <td>",
"        Barley, bulgur, buckwheat (kasha); whole grain breads, bagels, English muffins, hamburger buns, rolls, tortillas, crackers, cereals, pancakes, and waffles; brown rice, whole wheat pasta, whole wheat couscous, unflavored oatmeal, winter squash, sweet potatoes, corn, corn tortillas",
"       </td>",
"       <td>",
"        Biscuits; store brought muffins, croissants, sweet rolls, Danish, and donuts; sugar coated cereals, crackers made with saturated fats; pasta and rice dishes prepared in a butter cream sauce; baked, fried, mashed or scalloped potatoes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vegetables",
"       </td>",
"       <td>",
"        Any fresh or frozen vegetable such as artichoke and artichoke hearts, asparagus, beans (green, wax, Italian), bean sprouts, beets, broccoli, brussel sprouts, cabbage, carrots, cauliflower, celery, cucumber, eggplant, green onions, greens (collard, kale, mustard, turnip), mushrooms, okra, onions, pea pods, peppers, radishes, salad greens (endive, escarole, lettuce, romaine, spinach), sauerkraut, spinach, summer squash, tomatoes and tomato sauce, vegetable juices, water chestnuts, watercress, zucchini",
"       </td>",
"       <td>",
"        Any vegetables prepared in butter, cream, or cheese sauce; fried vegetables",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fruits",
"       </td>",
"       <td>",
"        Whole fresh and frozen fruits such as apple, banana, blueberries, cantaloupe, cherries, grapefruit, grapes, honeydew melon, kiwi, mango, orange, peach, pear, pineapple, plums, and strawberries",
"       </td>",
"       <td>",
"        Canned fruit, fruit juices, dried fruit and fried fruits",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Meat, poultry, fish, dried beans, eggs",
"       </td>",
"       <td>",
"        Fish, shellfish, skinned white-meat chicken and turkey, beans, peas, lentils, egg substitutes, egg whites, soybeans, and tofu",
"       </td>",
"       <td>",
"        Regular beef, pork, lamb, veal, and luncheon meats; fried chicken and fish, eggs, sausage, hot dogs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Milk, yogurt and cheese",
"       </td>",
"       <td>",
"        Skim and 1 percent milk, plain nonfat yogurt, nonfat yogurt sweetened with aspartame or nonnutritive sweetener; fat-free or low-fat cheese and cottage cheese",
"       </td>",
"       <td>",
"        2 percent and whole milk, 1 percent and whole chocolate milk, goat's milk, kefir, low-fat yogurt (plain or fruit flavored), custard-style yogurt, regular cheese and cottage cheese",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Texas Children's Hospital.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_55_22396=[""].join("\n");
var outline_f21_55_22396=null;
var title_f21_55_22397="Risk of progressive CKD";
var content_f21_55_22397=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F65211&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F65211&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Risk of progressive CKD",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 448px; height: 334px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Kaplan-Meier curves showing long-term risk of progressive chronic kidney disease (CKD) (stage 4 or higher) among patients who did (dashed line) or did not (solid line) suffer acute renal failure.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reprinted by permission from: Macmillan Publishers Ltd. Lo LJ, Go AS, Chertow GM, et al. Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int 2009; 76:893. Copyright &copy; 2009.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_55_22397=[""].join("\n");
var outline_f21_55_22397=null;
var title_f21_55_22398="Contents: Lung transplantation";
var content_f21_55_22398=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?8/24/8590\">",
"       Pulmonary, Critical Care, and Sleep Medicine",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Lung transplantation",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Lung transplantation",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Complications",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/32/26121\">",
"           Airway complications after lung transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/13/12505\">",
"           Clinical manifestations and diagnosis of acute renal allograft rejection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/23/34170\">",
"           Development of malignancy following solid organ transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/63/31738\">",
"           Epidemiology, clinical manifestations, and diagnosis of post-transplant lymphoproliferative disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/60/12233\">",
"           Noninfectious complications following lung transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/55/29561\">",
"           Osteoporosis after solid organ or stem cell transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/13/36057\">",
"           Primary lung graft dysfunction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/50/23338\">",
"           Treatment and prevention of post-transplant lymphoproliferative disorders",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Indications",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/29/31192\">",
"           Lung transplantation: Disease-based choice of procedure",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/20/26953\">",
"           Lung transplantation: General guidelines for recipient selection",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Infection",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/30/12778\">",
"           Bacterial infections following lung transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/62/31718\">",
"           Evaluation for infection before solid organ transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/34/15914\">",
"           Fungal infections following lung transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/48/23306\">",
"           Immunizations in solid organ transplant candidates and recipients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/47/29433\">",
"           Infection in the solid organ transplant recipient",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/59/6073\">",
"           Prevention of cytomegalovirus infection in lung transplant recipients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/29/10714\">",
"           Prophylaxis of infections in solid organ transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/26/12712\">",
"           Tuberculosis in solid organ transplant candidates and recipients",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Other",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/6/99\">",
"           Heart-lung transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/50/17194\">",
"           Physiologic changes following lung transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/22/32103\">",
"           The pleura in lung transplantation",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Procedure and posttransplant management",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/38/3688\">",
"           Induction immunosuppression following lung transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/25/3480\">",
"           Lung transplantation: An overview",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/8/12425\">",
"           Lung transplantation: Deceased donor evaluation and management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/32/5640\">",
"           Lung transplantation: Donor lung preservation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/50/38697\">",
"           Lung transplantation: Procedure and postoperative management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/11/12474\">",
"           Maintenance immunosuppression following lung transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/27/28090\">",
"           Pharmacology and side effects of cyclosporine and tacrolimus",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Rejection",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/25/18841\">",
"           Chronic lung transplant rejection: Bronchiolitis obliterans",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/57/3994\">",
"           Evaluation and treatment of acute lung transplant rejection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/38/24167\">",
"           Human leukocyte antigens (HLA): A roadmap",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/41/27283\">",
"           Major histocompatibility complex (MHC) structure and function",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-1EEBE59653-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f21_55_22398=[""].join("\n");
var outline_f21_55_22398=null;
var title_f21_55_22399="TEE left upper pulmonary vein";
var content_f21_55_22399=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F54962&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F54962&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 514px\">",
"   <div class=\"ttl\">",
"    Left upper pulmonary vein on transesophageal echocardiogram",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 494px; height: 225px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Panel A: Horizontal (0&ordm;) imaging shows the left upper pulmonary vein (LUPV, panel A). Note the position of the pulsed Doppler sample volume obtained from the proximal portion of the vein (red arrow). Panel B shows the normal pulsed Doppler spectra of pulmonary venous flow; there is a biphasic pattern with a predominance of pulmonary venous flow during ventricular systole (*). There is also mild flow reversal in the pulmonary vein related to atrial systole (+).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Warren Manning, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_55_22399=[""].join("\n");
var outline_f21_55_22399=null;
